UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM N-CSR
CERTIFIED SHAREHOLDER REPORT OF REGISTERED
MANAGEMENT INVESTMENT COMPANIES
Investment Company Act file number 811-03583
Fidelity Mt. Vernon Street Trust
(Exact name of registrant as specified in charter)
245 Summer St., Boston, MA 02210
(Address of principal executive offices) (Zip code)
Cynthia Lo Bessette, Secretary
245 Summer St.
Boston, Massachusetts 02210
(Name and address of agent for service)
Registrant's telephone number, including area code:
617-563-7000
Date of fiscal year end: | November 30 |
Date of reporting period: | May 31, 2022 |
Item 1.
Reports to Stockholders
Contents
Board Approval of Investment Advisory Contracts and Management Fees |
Top Holdings (% of Fund's net assets) | ||
Apple, Inc. | 9.2 | |
NVIDIA Corp. | 6.7 | |
Amazon.com, Inc. | 5.5 | |
Microsoft Corp. | 5.0 | |
Alphabet, Inc. Class A | 4.4 | |
lululemon athletica, Inc. | 3.3 | |
Alphabet, Inc. Class C | 2.5 | |
Tesla, Inc. | 2.3 | |
Salesforce.com, Inc. | 2.0 | |
Meta Platforms, Inc. Class A | 1.5 | |
42.4 | ||
Market Sectors (% of Fund's net assets) | ||
Information Technology | 35.7 | |
Consumer Discretionary | 19.3 | |
Health Care | 11.6 | |
Communication Services | 10.1 | |
Industrials | 6.8 | |
Consumer Staples | 5.0 | |
Energy | 3.7 | |
Materials | 2.2 | |
Financials | 2.0 | |
Real Estate | 0.5 | |
Utilities | 0.1 | |
Asset Allocation (% of Fund's net assets) |
Foreign investments - 5.8% |
Common Stocks - 95.2% | |||
Shares | Value ($) | ||
COMMUNICATION SERVICES - 10.1% | |||
Diversified Telecommunication Services - 0.1% | |||
IHS Holding Ltd. | 38,900 | 455,519 | |
Starry, Inc. | 1,218,562 | 10,254,199 | |
10,709,718 | |||
Entertainment - 0.9% | |||
Electronic Arts, Inc. | 5,754 | 797,792 | |
Live Nation Entertainment, Inc. (a) | 34,800 | 3,307,740 | |
Netflix, Inc. (a) | 225,529 | 44,528,446 | |
Roblox Corp. (a)(b) | 267,600 | 8,011,944 | |
Roku, Inc. Class A (a) | 441,376 | 41,886,582 | |
The Walt Disney Co. (a) | 36,976 | 4,083,629 | |
102,616,133 | |||
Interactive Media & Services - 8.6% | |||
Alphabet, Inc.: | |||
Class A (a) | 230,199 | 523,757,973 | |
Class C (a) | 130,343 | 297,283,708 | |
IAC (a) | 14,400 | 1,228,320 | |
Kuaishou Technology Class B (a)(c) | 79,600 | 770,925 | |
Match Group, Inc. (a) | 23,953 | 1,887,017 | |
Meta Platforms, Inc. Class A (a) | 925,530 | 179,219,629 | |
Snap, Inc. Class A (a) | 450,381 | 6,354,876 | |
Taboola.com Ltd. (a) | 543,383 | 1,760,561 | |
Twitter, Inc. (a) | 129,781 | 5,139,328 | |
Vimeo, Inc. (a) | 1,276,520 | 11,092,959 | |
1,028,495,296 | |||
Media - 0.0% | |||
Comcast Corp. Class A | 71,810 | 3,179,747 | |
Wireless Telecommunication Services - 0.5% | |||
T-Mobile U.S., Inc. (a) | 475,353 | 63,359,801 | |
TOTAL COMMUNICATION SERVICES | 1,208,360,695 | ||
CONSUMER DISCRETIONARY - 19.0% | |||
Automobiles - 2.8% | |||
Neutron Holdings, Inc. (a)(d)(e) | 438,358 | 12,669 | |
Rad Power Bikes, Inc. (a)(d)(e) | 249,183 | 1,380,474 | |
Rivian Automotive, Inc. (b) | 1,655,719 | 51,989,577 | |
Tesla, Inc. (a) | 362,485 | 274,857,876 | |
XPeng, Inc. ADR (a) | 254,600 | 5,983,100 | |
334,223,696 | |||
Hotels, Restaurants & Leisure - 2.0% | |||
Airbnb, Inc. Class A (a) | 56,900 | 6,877,503 | |
Booking Holdings, Inc. (a) | 30,772 | 69,038,828 | |
Chipotle Mexican Grill, Inc. (a) | 12,670 | 17,770,309 | |
Dutch Bros, Inc. (b) | 24,800 | 931,240 | |
Expedia, Inc. (a) | 140,400 | 18,157,932 | |
F45 Training Holdings, Inc. | 142,300 | 905,028 | |
Hyatt Hotels Corp. Class A (a) | 50,783 | 4,488,709 | |
Marriott International, Inc. Class A | 354,850 | 60,885,163 | |
McDonald's Corp. | 6,325 | 1,595,228 | |
Penn National Gaming, Inc. (a) | 695,100 | 22,215,396 | |
Shake Shack, Inc. Class A (a) | 9,936 | 483,386 | |
Sonder Holdings, Inc. | 1,006,784 | 2,152,001 | |
Sonder Holdings, Inc. (a) | 362,188 | 814,923 | |
Sonder Holdings, Inc.: | |||
rights (a)(e) | 14,240 | 12,389 | |
rights (a)(e) | 14,240 | 11,107 | |
rights (a)(e) | 14,239 | 9,967 | |
rights (a)(e) | 14,239 | 9,113 | |
rights (a)(e) | 14,238 | 8,258 | |
rights (a)(e) | 14,238 | 7,689 | |
Starbucks Corp. | 265,053 | 20,806,661 | |
Sweetgreen, Inc. Class A | 241,551 | 4,415,552 | |
Yum China Holdings, Inc. | 136,512 | 6,205,836 | |
237,802,218 | |||
Household Durables - 0.3% | |||
Lennar Corp. Class A | 391,269 | 31,399,337 | |
PulteGroup, Inc. | 32,700 | 1,480,002 | |
Purple Innovation, Inc. (a) | 804,887 | 4,169,315 | |
Vizio Holding Corp. (a)(b) | 78,900 | 699,843 | |
37,748,497 | |||
Internet & Direct Marketing Retail - 6.2% | |||
Amazon.com, Inc. (a) | 272,918 | 656,146,726 | |
Etsy, Inc. (a) | 15,581 | 1,263,931 | |
JD.com, Inc. sponsored ADR | 61,129 | 3,430,559 | |
Pinduoduo, Inc. ADR (a) | 75,700 | 3,811,495 | |
Revolve Group, Inc. (a) | 464,900 | 13,658,762 | |
RumbleON, Inc. Class B (a)(b) | 93,400 | 1,485,994 | |
The RealReal, Inc. (a) | 15,318 | 50,243 | |
thredUP, Inc. (a)(b) | 292,400 | 1,222,232 | |
Wayfair LLC Class A (a)(b) | 808,770 | 48,032,850 | |
Zomato Ltd. (a)(d) | 6,700,000 | 6,123,189 | |
735,225,981 | |||
Leisure Products - 0.0% | |||
Peloton Interactive, Inc. Class A (a)(b) | 56,942 | 794,910 | |
Multiline Retail - 0.5% | |||
Dollar General Corp. | 58,140 | 12,810,568 | |
Dollar Tree, Inc. (a) | 79,394 | 12,729,240 | |
Ollie's Bargain Outlet Holdings, Inc. (a) | 425,982 | 20,008,375 | |
Target Corp. | 36,713 | 5,943,100 | |
51,491,283 | |||
Specialty Retail - 2.3% | |||
Carvana Co. Class A (a) | 29,824 | 878,019 | |
Fanatics, Inc. Class A (d)(e) | 153,984 | 10,446,275 | |
Five Below, Inc. (a) | 66,700 | 8,710,353 | |
Floor & Decor Holdings, Inc. Class A (a) | 85,300 | 6,435,032 | |
Lowe's Companies, Inc. | 395,523 | 77,245,642 | |
RH (a) | 49,629 | 14,396,380 | |
The Home Depot, Inc. | 295,977 | 89,607,037 | |
TJX Companies, Inc. | 1,098,272 | 69,817,151 | |
Volta, Inc. (a)(d) | 8,029 | 18,764 | |
277,554,653 | |||
Textiles, Apparel & Luxury Goods - 4.9% | |||
Canada Goose Holdings, Inc. (a) | 343,271 | 6,893,373 | |
Deckers Outdoor Corp. (a) | 146,170 | 39,255,415 | |
lululemon athletica, Inc. (a) | 1,340,767 | 392,429,093 | |
NIKE, Inc. Class B | 386,654 | 45,953,828 | |
On Holding AG (b) | 1,269,100 | 26,206,915 | |
Skechers U.S.A., Inc. Class A (sub. vtg.) (a) | 1,661,979 | 65,481,973 | |
Tory Burch LLC (a)(d)(e)(f) | 248,840 | 10,817,075 | |
587,037,672 | |||
TOTAL CONSUMER DISCRETIONARY | 2,261,878,910 | ||
CONSUMER STAPLES - 4.9% | |||
Beverages - 1.7% | |||
Constellation Brands, Inc. Class A (sub. vtg.) | 37,100 | 9,106,937 | |
Fever-Tree Drinks PLC | 139,977 | 2,712,802 | |
Keurig Dr. Pepper, Inc. | 704,071 | 24,459,427 | |
Monster Beverage Corp. (a) | 626,535 | 55,836,799 | |
PepsiCo, Inc. | 194,864 | 32,688,436 | |
The Coca-Cola Co. | 1,315,307 | 83,364,158 | |
208,168,559 | |||
Food & Staples Retailing - 1.2% | |||
Albertsons Companies, Inc. | 205,800 | 6,287,190 | |
Blink Health LLC Series A1 (a)(d)(e) | 8,589 | 275,363 | |
Costco Wholesale Corp. | 127,644 | 59,510,186 | |
Grocery Outlet Holding Corp. (a)(b) | 161,500 | 6,177,375 | |
Kroger Co. | 428,440 | 22,694,467 | |
Ocado Group PLC (a) | 36,920 | 433,035 | |
Performance Food Group Co. (a) | 393,768 | 17,065,905 | |
Sysco Corp. | 320,600 | 26,988,108 | |
The Real Good Food Co. LLC Class B (e) | 131,479 | 1 | |
139,431,630 | |||
Food Products - 0.6% | |||
Archer Daniels Midland Co. | 104,900 | 9,527,018 | |
Bunge Ltd. | 216,154 | 25,575,341 | |
Darling Ingredients, Inc. (a) | 172,869 | 13,841,621 | |
Kellogg Co. (b) | 62,100 | 4,330,854 | |
Mondelez International, Inc. | 85,217 | 5,416,393 | |
Oatly Group AB ADR (a)(b) | 784,400 | 3,239,572 | |
The Hershey Co. | 40,100 | 8,489,571 | |
The Real Good Food Co. LLC Class B unit (c) | 131,479 | 886,168 | |
The Real Good Food Co., Inc. | 11,600 | 78,184 | |
71,384,722 | |||
Household Products - 0.3% | |||
Church & Dwight Co., Inc. | 73,021 | 6,576,271 | |
Colgate-Palmolive Co. | 91,491 | 7,210,406 | |
Procter & Gamble Co. | 146,878 | 21,720,319 | |
35,506,996 | |||
Personal Products - 0.2% | |||
Olaplex Holdings, Inc. (b) | 1,047,700 | 16,888,924 | |
The Beauty Health Co. (a) | 246,698 | 3,520,380 | |
The Beauty Health Co. (a)(d) | 553,828 | 7,903,126 | |
28,312,430 | |||
Tobacco - 0.9% | |||
Altria Group, Inc. | 743,950 | 40,240,256 | |
JUUL Labs, Inc. Class A (a)(d)(e) | 13,297 | 532,678 | |
Philip Morris International, Inc. | 590,000 | 62,687,500 | |
103,460,434 | |||
TOTAL CONSUMER STAPLES | 586,264,771 | ||
ENERGY - 3.7% | |||
Energy Equipment & Services - 0.8% | |||
Baker Hughes Co. Class A | 501,700 | 18,051,166 | |
Halliburton Co. | 1,066,400 | 43,189,200 | |
Schlumberger Ltd. | 732,600 | 33,670,296 | |
94,910,662 | |||
Oil, Gas & Consumable Fuels - 2.9% | |||
Cameco Corp. (b) | 442,500 | 10,827,975 | |
Devon Energy Corp. | 130,200 | 9,751,980 | |
EOG Resources, Inc. | 250,200 | 34,267,392 | |
Hess Corp. | 1,027,006 | 126,393,628 | |
Occidental Petroleum Corp. | 271,500 | 18,817,665 | |
Phillips 66 Co. | 73,100 | 7,369,211 | |
Pioneer Natural Resources Co. | 126,900 | 35,270,586 | |
Range Resources Corp. (a) | 1,057,100 | 35,888,545 | |
Reliance Industries Ltd. | 1,151,559 | 39,068,685 | |
Valero Energy Corp. | 192,100 | 24,896,160 | |
342,551,827 | |||
TOTAL ENERGY | 437,462,489 | ||
FINANCIALS - 2.0% | |||
Banks - 0.8% | |||
Bank of America Corp. | 812,817 | 30,236,792 | |
First Republic Bank | 108,400 | 16,805,252 | |
HDFC Bank Ltd. sponsored ADR | 440,722 | 25,372,366 | |
JPMorgan Chase & Co. | 138,023 | 18,250,781 | |
Wells Fargo & Co. | 61,200 | 2,801,124 | |
93,466,315 | |||
Capital Markets - 0.6% | |||
B3 SA - Brasil Bolsa Balcao | 546,400 | 1,468,165 | |
BlackRock, Inc. Class A | 36,697 | 24,553,229 | |
Charles Schwab Corp. | 771,351 | 54,071,705 | |
80,093,099 | |||
Consumer Finance - 0.3% | |||
American Express Co. | 194,800 | 32,886,136 | |
Discover Financial Services | 23,382 | 2,653,623 | |
35,539,759 | |||
Diversified Financial Services - 0.3% | |||
Adimab LLC (a)(d)(e)(f) | 762,787 | 31,473,278 | |
Ant International Co. Ltd. Class C (a)(d)(e) | 617,086 | 1,178,634 | |
32,651,912 | |||
TOTAL FINANCIALS | 241,751,085 | ||
HEALTH CARE - 11.1% | |||
Biotechnology - 5.8% | |||
AbbVie, Inc. | 129,249 | 19,047,425 | |
ACADIA Pharmaceuticals, Inc. (a) | 1,093,671 | 17,662,787 | |
Adagio Therapeutics, Inc. | 1,230,517 | 3,642,330 | |
ADC Therapeutics SA (a) | 171,500 | 1,173,060 | |
Akouos, Inc. (a) | 100,900 | 314,808 | |
Akouos, Inc. (a)(c) | 113,263 | 353,381 | |
Alector, Inc. (a) | 300,960 | 2,666,506 | |
Allovir, Inc. (a)(b) | 497,510 | 1,925,364 | |
Alnylam Pharmaceuticals, Inc. (a) | 692,431 | 87,107,820 | |
Ambrx Biopharma, Inc. ADR | 81,486 | 320,240 | |
Amgen, Inc. | 118,104 | 30,322,021 | |
Arcutis Biotherapeutics, Inc. (a) | 169,300 | 3,534,984 | |
Argenx SE ADR (a) | 195,760 | 60,548,568 | |
Arrowhead Pharmaceuticals, Inc. (a) | 42,659 | 1,423,104 | |
Ascendis Pharma A/S sponsored ADR (a) | 9,489 | 801,915 | |
aTyr Pharma, Inc. (a) | 219,931 | 618,006 | |
Avidity Biosciences, Inc. (a) | 220,700 | 3,074,351 | |
Axcella Health, Inc. (a) | 677,970 | 1,437,296 | |
Beam Therapeutics, Inc. (a)(b) | 70,400 | 2,476,672 | |
BeiGene Ltd. ADR (a) | 277,839 | 38,125,068 | |
Biogen, Inc. (a) | 1,742 | 348,400 | |
BioNTech SE ADR (a) | 1,502 | 245,367 | |
BioXcel Therapeutics, Inc. (a)(b) | 308,998 | 3,615,277 | |
Century Therapeutics, Inc. | 255,600 | 2,221,164 | |
Cerevel Therapeutics Holdings (a) | 1,493,622 | 39,028,343 | |
ChemoCentryx, Inc. (a) | 588,847 | 13,113,623 | |
Cibus Corp.: | |||
Series C (a)(d)(e)(f) | 1,142,857 | 2,800,000 | |
Series D (a)(d)(e)(f) | 750,960 | 1,839,852 | |
Series E (a)(d)(e)(f) | 123,690 | 303,041 | |
Codiak Biosciences, Inc. (a) | 309,262 | 862,841 | |
CRISPR Therapeutics AG (a)(b) | 157,400 | 9,137,070 | |
Cyclerion Therapeutics, Inc. (a) | 5,547 | 3,454 | |
Cyclerion Therapeutics, Inc. (a)(d) | 150,550 | 93,732 | |
Day One Biopharmaceuticals, Inc. (a) | 46,100 | 286,742 | |
Denali Therapeutics, Inc. (a) | 48,674 | 1,182,291 | |
Deverra Therapeutics, Inc. (e) | 20,487 | 29,296 | |
EQRx, Inc. (a)(b) | 1,585,046 | 8,812,856 | |
EQRx, Inc.: | |||
rights (a)(e) | 90,566 | 241,811 | |
rights (a)(e) | 38,814 | 81,898 | |
Erasca, Inc. | 66,700 | 361,514 | |
Evelo Biosciences, Inc. (a)(b) | 1,263,014 | 2,652,329 | |
Exelixis, Inc. (a) | 27,673 | 507,246 | |
Foghorn Therapeutics, Inc. (a) | 318,683 | 4,111,011 | |
Gemini Therapeutics, Inc. (a)(b) | 17,800 | 22,784 | |
Generation Bio Co. (a)(b) | 647,360 | 3,638,163 | |
Graphite Bio, Inc. | 43,200 | 101,520 | |
Icosavax, Inc. (a) | 59,700 | 405,363 | |
Imago BioSciences, Inc. | 28,000 | 452,480 | |
Immunocore Holdings PLC ADR (a) | 97,770 | 2,771,780 | |
Inhibrx, Inc. (a) | 75,500 | 986,785 | |
Instil Bio, Inc. (a) | 75,900 | 455,780 | |
Intarcia Therapeutics, Inc. warrants 12/6/24 (a)(e) | 7,022 | 0 | |
Ionis Pharmaceuticals, Inc. (a) | 1,970,769 | 71,972,484 | |
iTeos Therapeutics, Inc. (a) | 8,600 | 150,500 | |
Janux Therapeutics, Inc. | 94,100 | 1,047,333 | |
Karuna Therapeutics, Inc. (a) | 362,899 | 37,857,624 | |
Kinnate Biopharma, Inc. (a) | 36,300 | 288,222 | |
Kronos Bio, Inc. (a)(b) | 13,071 | 48,624 | |
Lexicon Pharmaceuticals, Inc. (a) | 155,122 | 274,566 | |
Lyell Immunopharma, Inc. (b) | 425,700 | 1,762,398 | |
Moderna, Inc. (a) | 202,841 | 29,478,883 | |
Monte Rosa Therapeutics, Inc. | 241,400 | 1,868,436 | |
Morphic Holding, Inc. (a) | 318,314 | 7,461,280 | |
Nuvalent, Inc. Class A (a) | 300,676 | 2,663,989 | |
Omega Therapeutics, Inc. (a) | 305,824 | 694,220 | |
ORIC Pharmaceuticals, Inc. (a) | 141,108 | 471,301 | |
Poseida Therapeutics, Inc. (a) | 538,059 | 1,221,394 | |
Praxis Precision Medicines, Inc. (a) | 245,000 | 2,033,500 | |
Protagonist Therapeutics, Inc. (a) | 144,695 | 1,267,528 | |
Prothena Corp. PLC (a) | 173,705 | 4,729,987 | |
PTC Therapeutics, Inc. (a) | 225,830 | 6,632,627 | |
Recursion Pharmaceuticals, Inc. (a)(b) | 338,400 | 2,071,008 | |
Regeneron Pharmaceuticals, Inc. (a) | 79,521 | 52,860,790 | |
Relay Therapeutics, Inc. (a) | 118,000 | 1,921,040 | |
Rigel Pharmaceuticals, Inc. (a) | 1,740,899 | 3,151,027 | |
Rubius Therapeutics, Inc. (a)(b) | 1,107,317 | 1,218,049 | |
Sage Therapeutics, Inc. (a) | 541,013 | 16,917,477 | |
Saluda Medical Pty Ltd. warrants (a)(d)(e) | 32,997 | 94,701 | |
Sana Biotechnology, Inc. (a)(b) | 145,100 | 744,363 | |
Scholar Rock Holding Corp. (a)(b) | 329,734 | 1,655,265 | |
Seagen, Inc. (a) | 6,200 | 841,216 | |
Seres Therapeutics, Inc. (a) | 1,051,826 | 3,260,661 | |
Shattuck Labs, Inc. (a) | 321,000 | 918,060 | |
Sigilon Therapeutics, Inc. (a) | 61,100 | 46,314 | |
Silverback Therapeutics, Inc. (a)(b) | 233,584 | 815,208 | |
Springworks Therapeutics, Inc. (a)(b) | 704,800 | 13,348,912 | |
Synlogic, Inc. (a) | 577,000 | 628,930 | |
Syros Pharmaceuticals, Inc. (a) | 100,438 | 82,520 | |
Syros Pharmaceuticals, Inc. (a)(c) | 301,001 | 247,302 | |
Syros Pharmaceuticals, Inc. warrants 10/10/22 (a) | 35,253 | 0 | |
Tango Therapeutics, Inc. (a) | 246,956 | 1,652,136 | |
Taysha Gene Therapies, Inc. (a) | 154,108 | 392,975 | |
Tenaya Therapeutics, Inc. (a) | 55,200 | 369,840 | |
TG Therapeutics, Inc. (a) | 512,200 | 2,263,924 | |
Twist Bioscience Corp. (a) | 243,100 | 8,275,124 | |
Tyra Biosciences, Inc. | 29,500 | 201,485 | |
Ultragenyx Pharmaceutical, Inc. (a) | 9,452 | 443,299 | |
uniQure B.V. (a) | 75,849 | 1,089,192 | |
Vaxcyte, Inc. (a) | 251,580 | 6,035,404 | |
Vera Therapeutics, Inc. (a) | 127,182 | 1,849,226 | |
Vertex Pharmaceuticals, Inc. (a) | 36,293 | 9,750,114 | |
Verve Therapeutics, Inc. | 84,700 | 1,284,052 | |
Vor Biopharma, Inc. (a) | 79,411 | 334,320 | |
Yumanity Therapeutics, Inc. (a) | 82,392 | 88,159 | |
Zai Lab Ltd. ADR (a) | 109,586 | 3,188,953 | |
Zentalis Pharmaceuticals, Inc. (a) | 162,944 | 3,928,580 | |
691,184,041 | |||
Health Care Equipment & Supplies - 2.5% | |||
Abbott Laboratories | 70,701 | 8,304,539 | |
DexCom, Inc. (a) | 85,221 | 25,390,745 | |
Insulet Corp. (a) | 404,683 | 86,391,727 | |
Intuitive Surgical, Inc. (a) | 198,323 | 45,146,248 | |
Novocure Ltd. (a)(b) | 1,113,907 | 89,535,845 | |
Oddity Tech Ltd. (d)(e) | 2,226 | 958,093 | |
Outset Medical, Inc. (a) | 389,353 | 8,487,895 | |
Presbia PLC (a)(e) | 454,926 | 6,824 | |
PROCEPT BioRobotics Corp. (c) | 108,462 | 4,243,033 | |
PROCEPT BioRobotics Corp. | 162,600 | 6,360,912 | |
Shockwave Medical, Inc. (a) | 175,267 | 28,780,594 | |
303,606,455 | |||
Health Care Providers & Services - 0.9% | |||
1Life Healthcare, Inc. (a) | 159,700 | 1,352,659 | |
23andMe Holding Co. Class A (a)(b) | 296,418 | 889,254 | |
Alignment Healthcare, Inc. (a) | 461,922 | 4,933,327 | |
AmerisourceBergen Corp. | 45,500 | 7,042,945 | |
Centene Corp. (a) | 193,590 | 15,765,970 | |
Guardant Health, Inc. (a) | 48,700 | 1,995,726 | |
Humana, Inc. | 32,043 | 14,554,892 | |
McKesson Corp. | 34,500 | 11,339,805 | |
Privia Health Group, Inc. (a)(b) | 11,900 | 285,124 | |
Progyny, Inc. (a) | 36,700 | 1,160,087 | |
The Oncology Institute, Inc. (d) | 377,375 | 3,400,149 | |
UnitedHealth Group, Inc. | 89,154 | 44,289,924 | |
107,009,862 | |||
Health Care Technology - 0.0% | |||
DNA Script (d)(e) | 85 | 65,017 | |
DNA Script (d)(e) | 324 | 247,829 | |
312,846 | |||
Life Sciences Tools & Services - 0.8% | |||
10X Genomics, Inc. Class B (a)(c) | 640,857 | 32,805,470 | |
Absci Corp. (b) | 953,492 | 3,480,246 | |
Akoya Biosciences, Inc. (a) | 900 | 10,485 | |
Danaher Corp. | 13,133 | 3,464,748 | |
ICON PLC (a) | 7,800 | 1,745,562 | |
Nanostring Technologies, Inc. (a) | 58,634 | 917,036 | |
Olink Holding AB ADR (a) | 310,735 | 3,654,244 | |
Seer, Inc. (a) | 371,717 | 3,300,847 | |
Thermo Fisher Scientific, Inc. | 44,574 | 25,298,865 | |
WuXi AppTec Co. Ltd. (H Shares) (c) | 298,940 | 3,689,512 | |
Wuxi Biologics (Cayman), Inc. (a)(c) | 2,046,810 | 15,135,367 | |
93,502,382 | |||
Pharmaceuticals - 1.1% | |||
4D Pharma PLC (a)(b) | 596,200 | 246,851 | |
Arvinas Holding Co. LLC (a) | 56,000 | 2,334,640 | |
Atea Pharmaceuticals, Inc. (a) | 1,114,730 | 8,784,072 | |
Bristol-Myers Squibb Co. | 135,465 | 10,220,834 | |
Dragonfly Therapeutics, Inc. (a)(d)(e) | 126,113 | 1,443,994 | |
Eli Lilly & Co. | 36,300 | 11,377,872 | |
Fulcrum Therapeutics, Inc. (a) | 221,397 | 1,576,347 | |
GH Research PLC | 318,300 | 3,189,366 | |
Hansoh Pharmaceutical Group Co. Ltd. (c) | 330,400 | 595,353 | |
Harmony Biosciences Holdings, Inc. (a)(b) | 561,423 | 24,478,043 | |
Intra-Cellular Therapies, Inc. (a) | 912,409 | 52,372,277 | |
Jiangsu Hengrui Medicine Co. Ltd. (A Shares) | 29,191 | 132,655 | |
Nuvation Bio, Inc. (a)(b) | 965,937 | 3,409,758 | |
OptiNose, Inc. (a) | 1,279,100 | 2,628,551 | |
Pfizer, Inc. | 83,700 | 4,439,448 | |
Pharvaris BV (a) | 41,400 | 733,608 | |
Pliant Therapeutics, Inc. (a) | 143,200 | 806,216 | |
Sienna Biopharmaceuticals, Inc. (a) | 589,618 | 1 | |
Skyhawk Therapeutics, Inc. (d)(e) | 126,063 | 1,221,550 | |
Theravance Biopharma, Inc. (a) | 306,445 | 2,690,587 | |
Theseus Pharmaceuticals, Inc. | 42,800 | 288,900 | |
UCB SA | 14,700 | 1,296,582 | |
134,267,505 | |||
TOTAL HEALTH CARE | 1,329,883,091 | ||
INDUSTRIALS - 6.5% | |||
Aerospace & Defense - 1.1% | |||
AeroVironment, Inc. (a) | 9,100 | 836,836 | |
Lockheed Martin Corp. | 41,700 | 18,352,587 | |
Raytheon Technologies Corp. | 155,400 | 14,781,648 | |
Space Exploration Technologies Corp. Class A (a)(d)(e) | 1,375,690 | 96,298,300 | |
The Boeing Co. (a) | 26,536 | 3,486,830 | |
133,756,201 | |||
Air Freight & Logistics - 0.2% | |||
Delhivery Private Ltd. (d) | 646,600 | 3,976,568 | |
FedEx Corp. | 32,300 | 7,253,934 | |
United Parcel Service, Inc. Class B | 95,184 | 17,347,284 | |
28,577,786 | |||
Airlines - 1.7% | |||
Delta Air Lines, Inc. (a) | 998,990 | 41,647,893 | |
JetBlue Airways Corp. (a) | 2,328,214 | 25,005,018 | |
Ryanair Holdings PLC sponsored ADR (a) | 12,378 | 1,079,362 | |
Southwest Airlines Co. (a) | 1,376,737 | 63,137,159 | |
Spirit Airlines, Inc. (a) | 575,933 | 12,065,796 | |
United Airlines Holdings, Inc. (a) | 618,425 | 29,455,583 | |
Wheels Up Experience, Inc.: | |||
Class A (a)(b) | 2,610,077 | 6,603,495 | |
rights (a)(e) | 23,018 | 17,954 | |
rights (a)(e) | 23,018 | 14,501 | |
rights (a)(e) | 23,018 | 11,739 | |
Wizz Air Holdings PLC (a)(c) | 668,983 | 24,615,176 | |
203,653,676 | |||
Building Products - 0.1% | |||
Trane Technologies PLC | 64,022 | 8,838,877 | |
Construction & Engineering - 0.1% | |||
Fluor Corp. (a) | 105,000 | 2,964,150 | |
MasTec, Inc. (a) | 35,000 | 2,925,650 | |
Quanta Services, Inc. | 42,800 | 5,093,200 | |
10,983,000 | |||
Electrical Equipment - 0.4% | |||
AMETEK, Inc. | 22,507 | 2,733,925 | |
Eaton Corp. PLC | 70,324 | 9,746,906 | |
Emerson Electric Co. | 110,549 | 9,801,274 | |
Fluence Energy, Inc. (b) | 16,000 | 156,800 | |
Generac Holdings, Inc. (a) | 58,000 | 14,330,640 | |
Rockwell Automation, Inc. | 28,800 | 6,140,160 | |
42,909,705 | |||
Industrial Conglomerates - 0.1% | |||
3M Co. | 23,680 | 3,535,187 | |
Honeywell International, Inc. | 44,183 | 8,554,712 | |
12,089,899 | |||
Machinery - 0.8% | |||
Caterpillar, Inc. | 121,160 | 26,152,386 | |
Deere & Co. | 97,752 | 34,973,711 | |
Illinois Tool Works, Inc. | 61,553 | 12,807,333 | |
Ingersoll Rand, Inc. | 49,444 | 2,331,285 | |
Xylem, Inc. | 223,917 | 18,865,007 | |
95,129,722 | |||
Professional Services - 0.0% | |||
Clarivate Analytics PLC (a) | 30,500 | 450,485 | |
LegalZoom.com, Inc. (b) | 243,700 | 3,192,470 | |
Sterling Check Corp. (b) | 49,300 | 915,994 | |
4,558,949 | |||
Road & Rail - 2.0% | |||
Avis Budget Group, Inc. (a) | 472,600 | 89,926,328 | |
Bird Global, Inc. (d) | 228,339 | 172,921 | |
Bird Global, Inc.: | |||
rights (a)(e) | 28,568 | 1,714 | |
rights (a)(e) | 28,568 | 857 | |
rights (a)(e) | 28,567 | 286 | |
Class A (a) | 762,283 | 577,277 | |
Canadian Pacific Railway Ltd. (b) | 126,677 | 9,049,805 | |
CSX Corp. | 453,100 | 14,404,049 | |
Hertz Global Holdings, Inc. (b) | 1,188,100 | 23,845,167 | |
Lyft, Inc. (a) | 339,168 | 5,996,490 | |
Uber Technologies, Inc. (a) | 1,184,804 | 27,487,453 | |
Union Pacific Corp. | 281,261 | 61,815,543 | |
233,277,890 | |||
TOTAL INDUSTRIALS | 773,775,705 | ||
INFORMATION TECHNOLOGY - 35.2% | |||
Communications Equipment - 0.6% | |||
Arista Networks, Inc. (a) | 117,232 | 11,990,489 | |
Ciena Corp. (a) | 767,697 | 39,014,362 | |
Infinera Corp. (a)(b) | 2,970,411 | 17,020,455 | |
68,025,306 | |||
Electronic Equipment & Components - 0.1% | |||
Arlo Technologies, Inc. (a) | 137,111 | 970,746 | |
II-VI, Inc. (a)(b) | 114,490 | 7,155,625 | |
TE Connectivity Ltd. | 2,041 | 264,085 | |
Trimble, Inc. (a) | 136,400 | 9,282,020 | |
17,672,476 | |||
IT Services - 3.8% | |||
Accenture PLC Class A | 64,200 | 19,161,132 | |
Actua Corp. (a)(e) | 562,258 | 5,623 | |
Block, Inc. Class A (a) | 207,885 | 18,192,016 | |
CI&T, Inc. Class A | 49,700 | 718,165 | |
Cloudflare, Inc. (a) | 1,067,281 | 59,767,736 | |
IBM Corp. | 3,595 | 499,130 | |
MasterCard, Inc. Class A | 369,949 | 132,393,649 | |
MongoDB, Inc. Class A (a) | 9,541 | 2,262,648 | |
Okta, Inc. (a) | 64,281 | 5,338,537 | |
PayPal Holdings, Inc. (a) | 467,427 | 39,829,455 | |
Shopify, Inc. Class A (a) | 59,949 | 22,506,054 | |
Snowflake, Inc. (a) | 26,925 | 3,436,976 | |
Thoughtworks Holding, Inc. | 39,200 | 678,552 | |
Toast, Inc. (b) | 6,000 | 97,440 | |
Twilio, Inc. Class A (a) | 900 | 94,653 | |
Visa, Inc. Class A | 673,112 | 142,814,173 | |
447,795,939 | |||
Semiconductors & Semiconductor Equipment - 10.8% | |||
Advanced Micro Devices, Inc. (a) | 924,236 | 94,142,679 | |
Applied Materials, Inc. | 405,985 | 47,617,981 | |
ASML Holding NV | 46,785 | 26,961,728 | |
Broadcom, Inc. | 38,225 | 22,175,469 | |
Cirrus Logic, Inc. (a) | 355,766 | 29,009,160 | |
Enphase Energy, Inc. (a) | 68,000 | 12,660,920 | |
First Solar, Inc. (a) | 168,300 | 11,883,663 | |
GlobalFoundries, Inc. | 141,000 | 8,416,290 | |
Intel Corp. | 121,862 | 5,413,110 | |
KLA Corp. | 55,486 | 20,244,067 | |
Lam Research Corp. | 12,400 | 6,448,372 | |
Marvell Technology, Inc. | 631,241 | 37,337,905 | |
Micron Technology, Inc. | 27,431 | 2,025,505 | |
NVIDIA Corp. | 4,277,140 | 798,627,581 | |
onsemi (a) | 65,700 | 3,986,676 | |
Qualcomm, Inc. | 152,109 | 21,785,051 | |
Silicon Laboratories, Inc. (a) | 429,439 | 64,055,121 | |
SiTime Corp. (a) | 98,585 | 20,998,605 | |
Taiwan Semiconductor Manufacturing Co. Ltd. sponsored ADR | 168,068 | 16,016,880 | |
Teradyne, Inc. | 56,450 | 6,167,727 | |
Texas Instruments, Inc. | 132,994 | 23,508,019 | |
Wolfspeed, Inc. (a)(b) | 86,529 | 6,509,577 | |
1,285,992,086 | |||
Software - 10.0% | |||
Adobe, Inc. (a) | 189,412 | 78,886,310 | |
Atlassian Corp. PLC (a) | 10,326 | 1,831,006 | |
Autodesk, Inc. (a) | 123,742 | 25,707,401 | |
Avalara, Inc. (a) | 26,304 | 2,227,160 | |
Bill.Com Holdings, Inc. (a) | 6,100 | 721,264 | |
Black Knight, Inc. (a) | 47,370 | 3,216,897 | |
C3.Ai, Inc. (a)(b) | 222,500 | 4,209,700 | |
Clear Secure, Inc. | 1,500 | 41,160 | |
Clearwater Analytics Holdings, Inc. (b) | 27,100 | 382,381 | |
Coupa Software, Inc. (a) | 11,704 | 805,118 | |
Crowdstrike Holdings, Inc. (a) | 85,433 | 13,668,426 | |
Datadog, Inc. Class A (a) | 21,730 | 2,072,825 | |
Elastic NV (a) | 52,194 | 3,217,760 | |
Epic Games, Inc. (a)(d)(e) | 11,800 | 10,974,000 | |
ForgeRock, Inc. (b) | 31,200 | 597,792 | |
HubSpot, Inc. (a) | 37,017 | 12,500,271 | |
Informatica, Inc. (b) | 56,713 | 1,156,945 | |
Intuit, Inc. | 59,094 | 24,492,099 | |
Microsoft Corp. | 2,192,036 | 595,948,827 | |
Nutanix, Inc. Class A (a) | 2,735,057 | 44,307,923 | |
Oracle Corp. | 848,904 | 61,053,176 | |
Paycom Software, Inc. (a) | 10,800 | 3,070,872 | |
Paylocity Holding Corp. (a) | 15,597 | 2,727,291 | |
RingCentral, Inc. (a) | 5,842 | 368,864 | |
Riskified Ltd. (a) | 73,462 | 382,002 | |
Riskified Ltd.: | |||
Class A (c) | 32,525 | 169,130 | |
Class B | 417,774 | 2,172,425 | |
Salesforce.com, Inc. (a) | 1,476,449 | 236,586,188 | |
Samsara, Inc. | 55,700 | 626,625 | |
SentinelOne, Inc. | 51,800 | 1,232,322 | |
ServiceNow, Inc. (a) | 57,900 | 27,066,513 | |
Stripe, Inc. Class B (a)(d)(e) | 43,500 | 1,181,025 | |
The Trade Desk, Inc. (a) | 13,000 | 676,650 | |
UiPath, Inc. Class A (a)(b) | 751,948 | 12,835,752 | |
Workday, Inc. Class A (a) | 26,732 | 4,178,212 | |
Zoom Video Communications, Inc. Class A (a) | 45,753 | 4,916,160 | |
Zscaler, Inc. (a) | 77,465 | 11,859,117 | |
1,198,067,589 | |||
Technology Hardware, Storage & Peripherals - 9.9% | |||
Apple, Inc. | 7,390,328 | 1,099,976,402 | |
Pure Storage, Inc. Class A (a) | 3,043,058 | 72,211,766 | |
Samsung Electronics Co. Ltd. | 140,003 | 7,595,049 | |
1,179,783,217 | |||
TOTAL INFORMATION TECHNOLOGY | 4,197,336,613 | ||
MATERIALS - 2.1% | |||
Chemicals - 1.1% | |||
Albemarle Corp. U.S. | 28,400 | 7,395,928 | |
CF Industries Holdings, Inc. | 286,000 | 28,248,220 | |
Corteva, Inc. | 686,200 | 42,969,844 | |
DuPont de Nemours, Inc. | 223,746 | 15,181,166 | |
Nutrien Ltd. | 172,900 | 16,896,999 | |
The Mosaic Co. | 332,800 | 20,849,920 | |
131,542,077 | |||
Containers & Packaging - 0.0% | |||
Sealed Air Corp. | 48,800 | 3,034,384 | |
Metals & Mining - 1.0% | |||
Barrick Gold Corp. (Canada) | 762,800 | 15,625,685 | |
Freeport-McMoRan, Inc. | 1,775,200 | 69,374,816 | |
Newmont Corp. | 346,200 | 23,489,670 | |
Rio Tinto PLC sponsored ADR | 186,600 | 13,703,904 | |
122,194,075 | |||
TOTAL MATERIALS | 256,770,536 | ||
REAL ESTATE - 0.5% | |||
Equity Real Estate Investment Trusts (REITs) - 0.3% | |||
American Tower Corp. | 87,098 | 22,308,411 | |
Equinix, Inc. | 4,900 | 3,366,741 | |
Simon Property Group, Inc. | 73,300 | 8,403,845 | |
34,078,997 | |||
Real Estate Management & Development - 0.2% | |||
CBRE Group, Inc. (a) | 150,700 | 12,483,988 | |
WeWork, Inc. (a) | 1,982,338 | 14,451,243 | |
26,935,231 | |||
TOTAL REAL ESTATE | 61,014,228 | ||
UTILITIES - 0.1% | |||
Electric Utilities - 0.1% | |||
ORSTED A/S (c) | 102,700 | 11,575,257 | |
TOTAL COMMON STOCKS (Cost $6,060,413,463) | 11,366,073,380 | ||
Preferred Stocks - 1.8% | |||
Shares | Value ($) | ||
Convertible Preferred Stocks - 1.7% | |||
COMMUNICATION SERVICES - 0.0% | |||
Interactive Media & Services - 0.0% | |||
Reddit, Inc.: | |||
Series B(a)(d)(e) | 37,935 | 1,399,802 | |
Series E(d)(e) | 5,127 | 189,186 | |
Series F(d)(e) | 40,428 | 1,491,793 | |
3,080,781 | |||
CONSUMER DISCRETIONARY - 0.2% | |||
Automobiles - 0.0% | |||
Rad Power Bikes, Inc.: | |||
Series A(a)(d)(e) | 32,487 | 179,978 | |
Series C(a)(d)(e) | 127,831 | 708,184 | |
Series D(d)(e) | 215,900 | 1,196,086 | |
2,084,248 | |||
Hotels, Restaurants & Leisure - 0.1% | |||
Discord, Inc. Series I (d)(e) | 1,400 | 770,874 | |
MOD Super Fast Pizza Holdings LLC: | |||
Series 3(a)(d)(e)(f) | 16,248 | 3,779,442 | |
Series 4(a)(d)(e)(f) | 1,483 | 327,521 | |
Series 5(a)(d)(e)(f) | 5,955 | 1,218,810 | |
6,096,647 | |||
Internet & Direct Marketing Retail - 0.1% | |||
GoBrands, Inc.: | |||
Series G(a)(d)(e) | 26,833 | 5,408,191 | |
Series H(d)(e) | 21,372 | 4,307,527 | |
Instacart, Inc.: | |||
Series H(a)(d)(e) | 13,904 | 673,371 | |
Series I(a)(d)(e) | 6,341 | 307,095 | |
10,696,184 | |||
Textiles, Apparel & Luxury Goods - 0.0% | |||
Freenome, Inc.: | |||
Series C(a)(d)(e) | 190,858 | 1,748,259 | |
Series D(d)(e) | 91,538 | 838,488 | |
Laronde, Inc. Series B (d)(e) | 66,432 | 1,115,393 | |
3,702,140 | |||
TOTAL CONSUMER DISCRETIONARY | 22,579,219 | ||
CONSUMER STAPLES - 0.1% | |||
Food & Staples Retailing - 0.1% | |||
Blink Health LLC Series C (a)(d)(e) | 197,068 | 6,318,000 | |
Food Products - 0.0% | |||
AgBiome LLC: | |||
Series C(a)(d)(e) | 338,565 | 2,065,247 | |
Series D(d)(e) | 126,371 | 762,017 | |
Bowery Farming, Inc. Series C1 (d)(e) | 27,136 | 964,685 | |
3,791,949 | |||
Tobacco - 0.0% | |||
JUUL Labs, Inc. Series E (a)(d)(e) | 6,648 | 266,319 | |
TOTAL CONSUMER STAPLES | 10,376,268 | ||
FINANCIALS - 0.0% | |||
Diversified Financial Services - 0.0% | |||
Paragon Biosciences Emalex Capital, Inc.: | |||
Series B(a)(d)(e) | 198,234 | 892,053 | |
Series C(a)(d)(e) | 115,792 | 521,064 | |
1,413,117 | |||
HEALTH CARE - 0.5% | |||
Biotechnology - 0.4% | |||
Ankyra Therapeutics Series B (d)(e) | 257,347 | 844,098 | |
Asimov, Inc. Series B (d)(e) | 15,783 | 964,973 | |
Bright Peak Therapeutics AG Series B (d)(e) | 239,403 | 550,627 | |
Caris Life Sciences, Inc. Series D (d)(e) | 255,590 | 1,415,969 | |
Castle Creek Biosciences, Inc.: | |||
Series D1(d)(e) | 4,460 | 729,076 | |
Series D2(d)(e) | 1,412 | 230,820 | |
Deep Genomics, Inc. Series C (d)(e) | 129,534 | 1,077,723 | |
Dianthus Therapeutics, Inc. Series A (d)(e) | 287,993 | 862,539 | |
Element Biosciences, Inc.: | |||
Series B(a)(d)(e) | 250,956 | 3,428,059 | |
Series C(d)(e) | 101,911 | 1,392,104 | |
ElevateBio LLC Series C (a)(d)(e) | 332,500 | 1,520,523 | |
Generate Biomedicines Series B (d)(e) | 157,390 | 1,060,809 | |
Inscripta, Inc.: | |||
Series D(a)(d)(e) | 308,833 | 1,877,705 | |
Series E(a)(d)(e) | 222,357 | 1,351,931 | |
Intarcia Therapeutics, Inc. Series EE (a)(d)(e) | 116,544 | 1 | |
Korro Bio, Inc.: | |||
Series B1(d)(e) | 241,420 | 369,373 | |
Series B2(d)(e) | 226,657 | 346,785 | |
LifeMine Therapeutics, Inc. Series C (d)(e) | 1,780,790 | 2,439,682 | |
National Resilience, Inc.: | |||
Series B(a)(d)(e) | 251,448 | 15,288,038 | |
Series C(d)(e) | 44,850 | 2,726,880 | |
Quell Therapeutics Ltd. Series B (d)(e) | 760,965 | 745,746 | |
SalioGen Therapeutics, Inc. Series B (d)(e) | 8,766 | 524,470 | |
Saluda Medical Pty Ltd. Series D (d)(e) | 109,988 | 1,105,197 | |
Sonoma Biotherapeutics, Inc.: | |||
Series B(d)(e) | 481,325 | 673,855 | |
Series B1(d)(e) | 256,702 | 359,383 | |
T-Knife Therapeutics, Inc. Series B (d)(e) | 199,356 | 633,952 | |
Treeline Biosciences Series A (d)(e) | 250,200 | 1,185,948 | |
43,706,266 | |||
Health Care Equipment & Supplies - 0.0% | |||
Kardium, Inc. Series D6 (a)(d)(e) | 1,136,853 | 846,137 | |
Health Care Providers & Services - 0.0% | |||
Boundless Bio, Inc. Series B (a)(d)(e) | 616,102 | 462,077 | |
Conformal Medical, Inc. Series C (a)(d)(e) | 240,750 | 792,068 | |
Scorpion Therapeutics, Inc. Series B (a)(d)(e) | 242,077 | 244,498 | |
1,498,643 | |||
Health Care Technology - 0.1% | |||
Aledade, Inc.: | |||
Series B1(d)(e) | 22,992 | 1,145,232 | |
Series E1(d)(e) | 17,916 | 892,396 | |
DNA Script: | |||
Series B(d)(e) | 4 | 3,060 | |
Series C(d)(e) | 2,060 | 1,575,703 | |
Omada Health, Inc. Series E (d)(e) | 435,062 | 2,608,284 | |
PrognomIQ, Inc.: | |||
Series A5(a)(d)(e) | 83,544 | 173,772 | |
Series B(a)(d)(e) | 198,721 | 413,340 | |
Series C(d)(e) | 66,506 | 138,332 | |
Wugen, Inc. Series B (d)(e) | 96,718 | 418,789 | |
7,368,908 | |||
Pharmaceuticals - 0.0% | |||
Castle Creek Pharmaceutical Holdings, Inc.: | |||
Series B(a)(d)(e) | 4,910 | 872,703 | |
Series C(a)(d)(e) | 2,570 | 456,792 | |
Galvanize Therapeutics Series B (d)(e) | 1,018,908 | 1,764,021 | |
Nohla Therapeutics, Inc. Series B (a)(d)(e) | 3,126,919 | 31 | |
3,093,547 | |||
TOTAL HEALTH CARE | 56,513,501 | ||
INDUSTRIALS - 0.3% | |||
Aerospace & Defense - 0.3% | |||
Space Exploration Technologies Corp. Series G (a)(d)(e) | 53,937 | 37,755,900 | |
Construction & Engineering - 0.0% | |||
Beta Technologies, Inc.: | |||
Series A(a)(d)(e) | 10,986 | 1,133,426 | |
Series B, 6.00%(d)(e) | 17,147 | 1,769,056 | |
2,902,482 | |||
TOTAL INDUSTRIALS | 40,658,382 | ||
INFORMATION TECHNOLOGY - 0.5% | |||
Communications Equipment - 0.1% | |||
Meesho Series F (d)(e) | 62,461 | 4,381,015 | |
Xsight Labs Ltd. Series D (a)(d)(e) | 167,386 | 1,252,047 | |
5,633,062 | |||
Electronic Equipment & Components - 0.0% | |||
Enevate Corp. Series E (a)(d)(e) | 814,561 | 903,091 | |
Menlo Micro, Inc. Series C (d)(e) | 959,784 | 1,010,173 | |
1,913,264 | |||
IT Services - 0.1% | |||
AppNexus, Inc. Series E (Escrow) (a)(d)(e) | 209,665 | 6,567 | |
ByteDance Ltd. Series E1 (a)(d)(e) | 84,766 | 11,354,406 | |
11,360,973 | |||
Semiconductors & Semiconductor Equipment - 0.1% | |||
Alif Semiconductor Series C (d)(e) | 43,548 | 883,961 | |
Astera Labs, Inc.: | |||
Series A(d)(e) | 85,993 | 874,506 | |
Series B(d)(e) | 14,642 | 148,902 | |
Series C(d)(e) | 371,500 | 3,777,969 | |
Series D(d)(e) | 291,891 | 2,968,386 | |
GaN Systems, Inc.: | |||
Series F1(d)(e) | 50,937 | 341,787 | |
Series F2(d)(e) | 26,897 | 180,479 | |
SiMa.ai: | |||
Series B(d)(e) | 338,113 | 2,397,525 | |
Series B1(d)(e) | 22,648 | 160,595 | |
11,734,110 | |||
Software - 0.2% | |||
Bolt Technology OU Series E (d)(e) | 13,569 | 3,350,410 | |
Databricks, Inc.: | |||
Series G(a)(d)(e) | 17,742 | 2,591,219 | |
Series H(d)(e) | 18,818 | 2,748,369 | |
Dataminr, Inc. Series D (a)(d)(e) | 442,241 | 9,304,751 | |
Evozyne LLC Series A (a)(d)(e) | 101,400 | 1,312,116 | |
Jet.Com, Inc. Series B1 (Escrow) (a)(d)(e) | 2,105,094 | 21 | |
Nuvia, Inc. Series B (a)(d) | 239,670 | 195,863 | |
Skyryse, Inc. Series B (d)(e) | 117,170 | 2,891,752 | |
Stripe, Inc. Series H (a)(d)(e) | 19,200 | 521,280 | |
Tenstorrent, Inc. Series C1 (a)(d)(e) | 21,000 | 1,181,880 | |
24,097,661 | |||
TOTAL INFORMATION TECHNOLOGY | 54,739,070 | ||
MATERIALS - 0.1% | |||
Chemicals - 0.0% | |||
Farmers Business Network, Inc. Series G (d)(e) | 36,990 | 1,850,240 | |
Metals & Mining - 0.1% | |||
Diamond Foundry, Inc. Series C (a)(d)(e) | 355,446 | 10,162,201 | |
TOTAL MATERIALS | 12,012,441 | ||
UTILITIES - 0.0% | |||
Independent Power and Renewable Electricity Producers - 0.0% | |||
Redwood Materials Series C (d)(e) | 16,253 | 770,449 | |
TOTAL CONVERTIBLE PREFERRED STOCKS | 202,143,228 | ||
Nonconvertible Preferred Stocks - 0.1% | |||
CONSUMER DISCRETIONARY - 0.1% | |||
Automobiles - 0.0% | |||
Neutron Holdings, Inc. Series 1D (a)(d)(e) | 5,678,726 | 164,115 | |
Waymo LLC Series A2 (a)(d)(e) | 10,731 | 984,269 | |
1,148,384 | |||
Internet & Direct Marketing Retail - 0.1% | |||
Circle Internet Financial Ltd. Series E (d) | 137,221 | 6,615,116 | |
TOTAL CONSUMER DISCRETIONARY | 7,763,500 | ||
HEALTH CARE - 0.0% | |||
Pharmaceuticals - 0.0% | |||
Castle Creek Pharmaceutical Holdings, Inc. Series A4 (a)(d)(e) | 13,511 | 2,345,915 | |
Faraday Pharmaceuticals, Inc. Series B (a)(d)(e) | 219,824 | 189,049 | |
2,534,964 | |||
TOTAL NONCONVERTIBLE PREFERRED STOCKS | 10,298,464 | ||
TOTAL PREFERRED STOCKS (Cost $187,183,790) | 212,441,692 | ||
Convertible Bonds - 0.0% | |||
Principal Amount (g) | Value ($) | ||
CONSUMER DISCRETIONARY - 0.0% | |||
Automobiles - 0.0% | |||
Neutron Holdings, Inc.: | |||
4% 10/27/25 (d)(e)(h) | 1,347,300 | 1,234,666 | |
4% 5/22/27 (d)(e) | 857,900 | 994,306 | |
4% 6/12/27 (d)(e) | 25,455 | 29,502 | |
2,258,474 | |||
FINANCIALS - 0.0% | |||
Diversified Financial Services - 0.0% | |||
Paragon Biosciences Emalex Capital, Inc. 0% (d)(e)(i) | 382,943 | 382,943 | |
TOTAL CONVERTIBLE BONDS (Cost $2,613,598) | 2,641,417 | ||
Preferred Securities - 0.0% | |||
Principal Amount (g) | Value ($) | ||
HEALTH CARE - 0.0% | |||
Biotechnology - 0.0% | |||
Intarcia Therapeutics, Inc. 6% 7/18/22 (d)(e) | 614,446 | 120,395 | |
Health Care Equipment & Supplies - 0.0% | |||
Kardium, Inc. 0% (d)(e)(i) | 1,612,660 | 1,612,660 | |
TOTAL HEALTH CARE | 1,733,055 | ||
INFORMATION TECHNOLOGY - 0.0% | |||
Electronic Equipment & Components - 0.0% | |||
Enevate Corp. 0% 1/29/23 (d)(e) | 346,804 | 346,804 | |
Semiconductors & Semiconductor Equipment - 0.0% | |||
GaN Systems, Inc. 0% (d)(e)(i) | 1,193,899 | 1,193,899 | |
Software - 0.0% | |||
Tenstorrent, Inc. 0% (d)(e)(i) | 1,170,000 | 1,170,000 | |
TOTAL INFORMATION TECHNOLOGY | 2,710,703 | ||
TOTAL PREFERRED SECURITIES (Cost $4,937,809) | 4,443,758 | ||
Money Market Funds - 3.6% | |||
Shares | Value ($) | ||
Fidelity Cash Central Fund 0.82% (j) | 223,806,552 | 223,851,313 | |
Fidelity Securities Lending Cash Central Fund 0.82% (j)(k) | 198,594,687 | 198,614,547 | |
TOTAL MONEY MARKET FUNDS (Cost $422,465,860) | 422,465,860 | ||
TOTAL INVESTMENT IN SECURITIES - 100.6% (Cost $6,677,614,520) | 12,008,066,107 |
NET OTHER ASSETS (LIABILITIES) - (0.6)% | (73,069,642) |
NET ASSETS - 100.0% | 11,934,996,465 |
Futures Contracts | |||||
Number of contracts | Expiration Date | Notional Amount ($) | Value ($) | Unrealized Appreciation/ (Depreciation) ($) | |
Purchased | |||||
Equity Index Contracts | |||||
CME E-mini S&P 500 Index Contracts (United States) | 1,382 | Jun 2022 | 285,469,375 | 5,450,571 | 5,450,571 |
The notional amount of futures purchased as a percentage of Net Assets is 2.4% |
(a) | Non-income producing |
(b) | Security or a portion of the security is on loan at period end. |
(c) | Security exempt from registration under Rule 144A of the Securities Act of 1933. These securities may be resold in transactions exempt from registration, normally to qualified institutional buyers. At the end of the period, the value of these securities amounted to $95,086,074 or 0.8% of net assets. |
(d) | Restricted securities (including private placements) - Investment in securities not registered under the Securities Act of 1933 (excluding 144A issues). At the end of the period, the value of restricted securities (excluding 144A issues) amounted to $414,759,164 or 3.5% of net assets. |
(e) | Level 3 security |
(f) | Investment is owned by a wholly-owned subsidiary (Subsidiary) that is treated as a corporation for U.S. tax purposes. |
(g) | Amount is stated in United States dollars unless otherwise noted. |
(h) | Security initially issued at one coupon which converts to a higher coupon at a specified date. The rate shown is the rate at period end. |
(i) | Security is perpetual in nature with no stated maturity date. |
(j) | Affiliated fund that is generally available only to investment companies and other accounts managed by Fidelity Investments. The rate quoted is the annualized seven-day yield of the fund at period end. A complete unaudited listing of the fund's holdings as of its most recent quarter end is available upon request. In addition, each Fidelity Central Fund's financial statements are available on the SEC's website or upon request. |
(k) | Investment made with cash collateral received from securities on loan. |
Additional information on each restricted holding is as follows: | ||
Security | Acquisition Date | Acquisition Cost ($) |
Adimab LLC | 9/17/14 - 6/05/15 | 11,583,995 |
AgBiome LLC Series C | 6/29/18 | 2,144,369 |
AgBiome LLC Series D | 9/03/21 | 749,101 |
Aledade, Inc. Series B1 | 5/07/21 | 880,380 |
Aledade, Inc. Series E1 | 5/20/22 | 892,475 |
Alif Semiconductor Series C | 3/08/22 | 883,961 |
Ankyra Therapeutics Series B | 8/26/21 | 1,449,327 |
Ant International Co. Ltd. Class C | 5/16/18 | 2,351,948 |
AppNexus, Inc. Series E (Escrow) | 8/01/14 | 0 |
Asimov, Inc. Series B | 10/29/21 | 1,462,779 |
Astera Labs, Inc. Series A | 5/17/22 | 874,506 |
Astera Labs, Inc. Series B | 5/17/22 | 148,902 |
Astera Labs, Inc. Series C | 8/24/21 | 1,248,909 |
Astera Labs, Inc. Series D | 5/17/22 | 2,968,386 |
Beta Technologies, Inc. Series A | 4/09/21 | 804,944 |
Beta Technologies, Inc. Series B, 6.00% | 4/04/22 | 1,769,056 |
Bird Global, Inc. | 5/11/21 | 2,283,390 |
Blink Health LLC Series A1 | 12/30/20 | 232,676 |
Blink Health LLC Series C | 11/07/19 - 7/14/21 | 7,523,268 |
Bolt Technology OU Series E | 1/03/22 | 3,525,179 |
Boundless Bio, Inc. Series B | 4/23/21 | 831,738 |
Bowery Farming, Inc. Series C1 | 5/18/21 | 1,634,925 |
Bright Peak Therapeutics AG Series B | 5/14/21 | 935,108 |
ByteDance Ltd. Series E1 | 11/18/20 | 9,288,165 |
Caris Life Sciences, Inc. Series D | 5/11/21 | 2,070,279 |
Castle Creek Biosciences, Inc. Series D1 | 4/19/22 | 959,034 |
Castle Creek Biosciences, Inc. Series D2 | 6/28/21 | 242,100 |
Castle Creek Pharmaceutical Holdings, Inc. Series A4 | 9/29/16 | 4,471,547 |
Castle Creek Pharmaceutical Holdings, Inc. Series B | 10/09/18 | 2,022,184 |
Castle Creek Pharmaceutical Holdings, Inc. Series C | 12/09/19 | 1,058,455 |
Cibus Corp. Series C | 2/16/18 | 2,400,000 |
Cibus Corp. Series D | 5/10/19 | 938,700 |
Cibus Corp. Series E | 6/23/21 | 217,694 |
Circle Internet Financial Ltd. Series E | 5/11/21 | 2,227,100 |
Conformal Medical, Inc. Series C | 7/24/20 | 882,846 |
Cyclerion Therapeutics, Inc. | 4/02/19 | 2,229,495 |
Databricks, Inc. Series G | 2/01/21 | 3,146,861 |
Databricks, Inc. Series H | 8/31/21 | 4,148,473 |
Dataminr, Inc. Series D | 2/18/15 - 3/06/15 | 5,638,573 |
Deep Genomics, Inc. Series C | 7/21/21 | 1,878,398 |
Delhivery Private Ltd. | 5/20/21 | 3,156,208 |
Diamond Foundry, Inc. Series C | 3/15/21 | 8,530,704 |
Dianthus Therapeutics, Inc. Series A | 4/06/22 | 1,251,762 |
Discord, Inc. Series I | 9/15/21 | 770,874 |
DNA Script | 12/17/21 | 327,504 |
DNA Script Series B | 12/17/21 | 3,203 |
DNA Script Series C | 10/01/21 | 1,791,891 |
Dragonfly Therapeutics, Inc. | 12/19/19 | 3,336,950 |
Element Biosciences, Inc. Series B | 12/13/19 | 1,315,160 |
Element Biosciences, Inc. Series C | 6/21/21 | 2,094,954 |
ElevateBio LLC Series C | 3/09/21 | 1,394,838 |
Enevate Corp. Series E | 1/29/21 | 903,092 |
Enevate Corp. 0% 1/29/23 | 1/29/21 | 346,804 |
Epic Games, Inc. | 7/13/20 - 7/30/20 | 6,785,000 |
Evozyne LLC Series A | 4/09/21 | 2,278,458 |
Fanatics, Inc. Class A | 8/13/20 - 12/15/21 | 3,989,927 |
Faraday Pharmaceuticals, Inc. Series B | 12/30/19 | 288,996 |
Farmers Business Network, Inc. Series G | 9/15/21 | 2,299,217 |
Freenome, Inc. Series C | 8/14/20 | 1,262,201 |
Freenome, Inc. Series D | 11/22/21 | 690,407 |
Galvanize Therapeutics Series B | 3/29/22 | 1,764,020 |
GaN Systems, Inc. Series F1 | 11/30/21 | 431,946 |
GaN Systems, Inc. Series F2 | 11/30/21 | 228,087 |
GaN Systems, Inc. 0% | 11/30/21 | 1,193,899 |
Generate Biomedicines Series B | 11/02/21 | 1,865,072 |
GoBrands, Inc. Series G | 3/02/21 | 6,700,664 |
GoBrands, Inc. Series H | 7/22/21 | 8,302,821 |
Inscripta, Inc. Series D | 11/13/20 | 1,411,367 |
Inscripta, Inc. Series E | 3/30/21 | 1,963,412 |
Instacart, Inc. Series H | 11/13/20 | 834,240 |
Instacart, Inc. Series I | 2/26/21 | 792,625 |
Intarcia Therapeutics, Inc. Series EE | 9/02/16 | 6,992,640 |
Intarcia Therapeutics, Inc. 6% 7/18/22 | 2/26/19 | 614,446 |
Jet.Com, Inc. Series B1 (Escrow) | 3/19/18 | 0 |
JUUL Labs, Inc. Class A | 7/06/18 | 392,042 |
JUUL Labs, Inc. Series E | 7/06/18 | 196,006 |
Kardium, Inc. Series D6 | 12/30/20 | 1,154,861 |
Kardium, Inc. 0% | 12/30/20 | 1,612,660 |
Korro Bio, Inc. Series B1 | 12/17/21 | 630,106 |
Korro Bio, Inc. Series B2 | 12/17/21 | 630,106 |
Laronde, Inc. Series B | 8/13/21 | 1,860,096 |
LifeMine Therapeutics, Inc. Series C | 2/15/22 | 3,626,739 |
Meesho Series F | 9/21/21 | 4,789,029 |
Menlo Micro, Inc. Series C | 2/09/22 | 1,272,194 |
MOD Super Fast Pizza Holdings LLC Series 3 | 11/03/16 | 2,225,976 |
MOD Super Fast Pizza Holdings LLC Series 4 | 12/14/17 | 207,516 |
MOD Super Fast Pizza Holdings LLC Series 5 | 5/15/19 | 848,707 |
National Resilience, Inc. Series B | 12/01/20 | 3,434,780 |
National Resilience, Inc. Series C | 6/28/21 | 1,991,789 |
Neutron Holdings, Inc. | 2/04/21 | 4,384 |
Neutron Holdings, Inc. Series 1D | 1/25/19 | 1,377,091 |
Neutron Holdings, Inc. 4% 10/27/25 | 10/29/21 | 1,347,300 |
Neutron Holdings, Inc. 4% 5/22/27 | 6/04/20 | 857,900 |
Neutron Holdings, Inc. 4% 6/12/27 | 6/12/20 | 25,455 |
Nohla Therapeutics, Inc. Series B | 5/01/18 | 1,096,231 |
Nuvia, Inc. Series B | 3/16/21 | 195,862 |
Oddity Tech Ltd. | 1/06/22 | 958,093 |
Omada Health, Inc. Series E | 12/22/21 | 2,608,284 |
Paragon Biosciences Emalex Capital, Inc. Series B | 9/18/19 | 2,020,004 |
Paragon Biosciences Emalex Capital, Inc. Series C | 2/26/21 | 1,238,974 |
Paragon Biosciences Emalex Capital, Inc. 0% | 5/18/22 | 382,943 |
PrognomIQ, Inc. Series A5 | 8/20/20 | 50,461 |
PrognomIQ, Inc. Series B | 9/11/20 | 454,100 |
PrognomIQ, Inc. Series C | 2/16/22 | 203,508 |
Quell Therapeutics Ltd. Series B | 11/24/21 | 1,438,224 |
Rad Power Bikes, Inc. | 1/21/21 | 1,202,019 |
Rad Power Bikes, Inc. Series A | 1/21/21 | 156,712 |
Rad Power Bikes, Inc. Series C | 1/21/21 | 616,636 |
Rad Power Bikes, Inc. Series D | 9/17/21 | 2,069,142 |
Reddit, Inc. Series B | 7/26/17 | 538,544 |
Reddit, Inc. Series E | 5/18/21 | 217,765 |
Reddit, Inc. Series F | 8/11/21 | 2,498,224 |
Redwood Materials Series C | 5/28/21 | 770,449 |
SalioGen Therapeutics, Inc. Series B | 12/10/21 | 928,004 |
Saluda Medical Pty Ltd. Series D | 1/20/22 | 1,402,995 |
Saluda Medical Pty Ltd. warrants | 1/20/22 | 0 |
Scorpion Therapeutics, Inc. Series B | 1/08/21 | 585,688 |
SiMa.ai Series B | 5/10/21 | 1,733,641 |
SiMa.ai Series B1 | 4/25/22 | 160,595 |
Skyhawk Therapeutics, Inc. | 5/21/21 | 2,069,954 |
Skyryse, Inc. Series B | 10/21/21 | 2,891,752 |
Sonoma Biotherapeutics, Inc. Series B | 7/26/21 | 951,243 |
Sonoma Biotherapeutics, Inc. Series B1 | 7/26/21 | 760,993 |
Space Exploration Technologies Corp. Class A | 10/16/15 - 4/06/17 | 12,876,729 |
Space Exploration Technologies Corp. Series G | 1/20/15 | 4,177,960 |
Stripe, Inc. Class B | 5/18/21 | 1,745,585 |
Stripe, Inc. Series H | 3/15/21 | 770,400 |
T-Knife Therapeutics, Inc. Series B | 6/30/21 | 1,150,045 |
Tenstorrent, Inc. Series C1 | 4/23/21 | 1,248,540 |
Tenstorrent, Inc. 0% | 4/23/21 | 1,170,000 |
The Beauty Health Co. | 12/08/20 | 5,538,280 |
The Oncology Institute, Inc. | 6/28/21 | 3,773,750 |
Tory Burch LLC | 5/14/15 | 17,704,966 |
Treeline Biosciences Series A | 7/30/21 | 1,958,441 |
Volta, Inc. | 1/25/21 - 2/07/21 | 47,381 |
Waymo LLC Series A2 | 5/08/20 | 921,441 |
Wugen, Inc. Series B | 7/09/21 | 750,038 |
Xsight Labs Ltd. Series D | 2/16/21 | 1,338,418 |
Zomato Ltd. | 12/09/20 - 2/10/21 | 4,714,002 |
Affiliate | Value, beginning of period ($) | Purchases ($) | Sales Proceeds ($) | Dividend Income ($) | Realized Gain (loss) ($) | Change in Unrealized appreciation (depreciation) ($) | Value, end of period ($) | %ownership, end of period |
Fidelity Cash Central Fund 0.82% | 76,613,355 | 3,816,806,062 | 3,669,568,104 | 214,296 | - | - | 223,851,313 | 0.4% |
Fidelity Securities Lending Cash Central Fund 0.82% | 317,559,429 | 524,961,038 | 643,905,920 | 695,314 | - | - | 198,614,547 | 0.5% |
Total | 394,172,784 | 4,341,767,100 | 4,313,474,024 | 909,610 | - | - | 422,465,860 |
Valuation Inputs at Reporting Date: | ||||
Description | Total ($) | Level 1 ($) | Level 2 ($) | Level 3 ($) |
Investments in Securities: | ||||
Equities: | ||||
Communication Services | 1,211,441,476 | 1,198,106,496 | 10,254,199 | 3,080,781 |
Consumer Discretionary | 2,292,221,629 | 2,230,869,940 | 14,909,070 | 46,442,619 |
Consumer Staples | 596,641,039 | 585,456,729 | - | 11,184,310 |
Energy | 437,462,489 | 437,462,489 | - | - |
Financials | 243,164,202 | 209,099,173 | - | 34,065,029 |
Health Care | 1,388,931,556 | 1,305,166,967 | 15,382,218 | 68,382,371 |
Industrials | 814,434,087 | 673,453,786 | 3,976,568 | 137,003,733 |
Information Technology | 4,252,075,683 | 4,185,371,828 | - | 66,703,855 |
Materials | 268,782,977 | 256,770,536 | - | 12,012,441 |
Real Estate | 61,014,228 | 61,014,228 | - | - |
Utilities | 12,345,706 | - | 11,575,257 | 770,449 |
Corporate Bonds | 2,641,417 | - | - | 2,641,417 |
Preferred Securities | 4,443,758 | - | - | 4,443,758 |
Money Market Funds | 422,465,860 | 422,465,860 | - | - |
Total Investments in Securities: | 12,008,066,107 | 11,565,238,032 | 56,097,312 | 386,730,763 |
Derivative Instruments: | ||||
Assets | ||||
Futures Contracts | 5,450,571 | 5,450,571 | - | - |
Total Assets | 5,450,571 | 5,450,571 | - | - |
Total Derivative Instruments: | 5,450,571 | 5,450,571 | - | - |
Investments in Securities: | |||
Equities - Industrials | |||
Beginning Balance | $ | 111,656,691 | |
Net Realized Gain (Loss) on Investment Securities | (22,690,756) | ||
Net Unrealized Gain (Loss) on Investment Securities | 49,401,778 | ||
Cost of Purchases | 1,769,056 | ||
Proceeds of Sales | (63,193) | ||
Amortization/Accretion | - | ||
Transfers into Level 3 | - | ||
Transfers out of Level 3 | (3,069,843) | ||
Ending Balance | $ | 137,003,733 | |
The change in unrealized gain (loss) for the period attributable to Level 3 securities held at May 31, 2022 | $ | 26,693,601 | |
Other Investments in Securities | |||
Beginning Balance | $ | 286,140,142 | |
Net Realized Gain (Loss) on Investment Securities | (1,567,956) | ||
Net Unrealized Gain (Loss) on Investment Securities | (64,342,530) | ||
Cost of Purchases | 28,204,755 | ||
Proceeds of Sales | (3,550) | ||
Amortization/Accretion | (242,100) | ||
Transfers into Level 3 | 1,538,269 | ||
Transfers out of Level 3 | - | ||
Ending Balance | $ | 249,727,030 | |
The change in unrealized gain (loss) for the period attributable to Level 3 securities held at May 31, 2022 | $ | (60,751,268) | |
Primary Risk Exposure / Derivative Type | Value | |
Asset ($) | Liability ($) | |
Equity Risk | ||
Futures Contracts (a) | 5,450,571 | 0 |
Total Equity Risk | 5,450,571 | 0 |
Total Value of Derivatives | 5,450,571 | 0 |
Statement of Assets and Liabilities | ||||
May 31, 2022 (Unaudited) | ||||
Assets | ||||
Investment in securities, at value (including securities loaned of $191,661,367) - See accompanying schedule: | $11,585,600,247 | |||
Unaffiliated issuers (cost $6,255,148,660) | ||||
Fidelity Central Funds (cost $422,465,860) | 422,465,860 | |||
Total Investment in Securities (cost $6,677,614,520) | $ | 12,008,066,107 | ||
Segregated cash with brokers for derivative instruments | 9,508,800 | |||
Cash | 243,426 | |||
Foreign currency held at value (cost $78,145) | 77,962 | |||
Receivable for investments sold | 9,715,843 | |||
Receivable for fund shares sold | 196,837,622 | |||
Dividends receivable | 6,194,435 | |||
Interest receivable | 76,048 | |||
Distributions receivable from Fidelity Central Funds | 225,352 | |||
Other receivables | 91,144 | |||
Total assets | 12,231,036,739 | |||
Liabilities | ||||
Payable for investments purchased | $93,444,069 | |||
Payable for fund shares redeemed | 168,434 | |||
Payable for daily variation margin on futures contracts | 1,494,597 | |||
Other payables and accrued expenses | 2,329,014 | |||
Collateral on securities loaned | 198,604,160 | |||
Total Liabilities | 296,040,274 | |||
Net Assets | $ | 11,934,996,465 | ||
Net Assets consist of: | ||||
Paid in capital | $ | 6,610,071,537 | ||
Total accumulated earnings (loss) | 5,324,924,928 | |||
Net Assets | $ | 11,934,996,465 | ||
Net Asset Value , offering price and redemption price per share ($11,934,996,465 ÷ 793,192,274 shares) | $ | 15.05 | ||
Statement of Operations | ||||
Six months ended May 31, 2022 (Unaudited) | ||||
Investment Income | ||||
Dividends | $ | 29,790,613 | ||
Interest | 22,819 | |||
Income from Fidelity Central Funds (including $695,314 from security lending) | 909,610 | |||
Total Income | 30,723,042 | |||
Expenses | ||||
Custodian fees and expenses | 147,091 | |||
Independent trustees' fees and expenses | 22,251 | |||
Interest | 8,406 | |||
Total Expenses | 177,748 | |||
Net Investment income (loss) | 30,545,294 | |||
Realized and Unrealized Gain (Loss) | ||||
Net realized gain (loss) on: | ||||
Investment Securities: | ||||
Unaffiliated issuers | 19,275,843 | |||
Foreign currency transactions | (34,300) | |||
Futures contracts | (13,233,161) | |||
Total net realized gain (loss) | 6,008,382 | |||
Change in net unrealized appreciation (depreciation) on: | ||||
Investment Securities: | ||||
Unaffiliated issuers (net of decrease in deferred foreign taxes of $612,022) | (4,181,892,753) | |||
Unfunded commitments | 462,888 | |||
Assets and liabilities in foreign currencies | 63,623 | |||
Futures contracts | 5,450,571 | |||
Total change in net unrealized appreciation (depreciation) | (4,175,915,671) | |||
Net gain (loss) | (4,169,907,289) | |||
Net increase (decrease) in net assets resulting from operations | $ | (4,139,361,995) |
Statement of Changes in Net Assets | ||||
Six months ended May 31, 2022 (Unaudited) | Year ended November 30, 2021 | |||
Increase (Decrease) in Net Assets | ||||
Operations | ||||
Net investment income (loss) | $ | 30,545,294 | $ | 54,065,811 |
Net realized gain (loss) | 6,008,382 | 3,574,332,861 | ||
Change in net unrealized appreciation (depreciation) | (4,175,915,671) | 390,342,151 | ||
Net increase (decrease) in net assets resulting from operations | (4,139,361,995) | 4,018,740,823 | ||
Distributions to shareholders | (3,620,786,672) | (3,221,895,370) | ||
Share transactions | ||||
Proceeds from sales of shares | 3,971,093,063 | 2,049,321,658 | ||
Reinvestment of distributions | 3,620,786,672 | 3,221,895,370 | ||
Cost of shares redeemed | (1,074,838,953) | (5,726,877,650) | ||
Net increase (decrease) in net assets resulting from share transactions | 6,517,040,782 | (455,660,622) | ||
Total increase (decrease) in net assets | (1,243,107,885) | 341,184,831 | ||
Net Assets | ||||
Beginning of period | 13,178,104,350 | 12,836,919,519 | ||
End of period | $ | 11,934,996,465 | $ | 13,178,104,350 |
Other Information | ||||
Shares | ||||
Sold | 225,968,114 | 82,597,344 | ||
Issued in reinvestment of distributions | 176,279,780 | 142,941,232 | ||
Redeemed | (59,513,175) | (217,576,432) | ||
Net increase (decrease) | 342,734,719 | 7,962,144 | ||
Fidelity® Series Growth Company Fund |
Six months ended (Unaudited) May 31, 2022 | Years ended November 30, 2021 | 2020 | 2019 | 2018 | 2017 | |||||||
Selected Per-Share Data | ||||||||||||
Net asset value, beginning of period | $ | 29.25 | $ | 29.01 | $ | 19.16 | $ | 17.61 | $ | 18.19 | $ | 13.49 |
Income from Investment Operations | ||||||||||||
Net investment income (loss) A,B | .04 | .10 C | .09 | .11 | .15 D | .07 | ||||||
Net realized and unrealized gain (loss) | (6.35) | 7.43 | 11.72 | 3.31 | 1.02 | 4.96 | ||||||
Total from investment operations | (6.31) | 7.53 | 11.81 | 3.42 | 1.17 | 5.03 | ||||||
Distributions from net investment income | (.12) | (.16) | (.13) | (.15) | (.09) | (.02) | ||||||
Distributions from net realized gain | (7.77) | (7.13) | (1.84) | (1.72) | (1.66) | (.31) | ||||||
Total distributions | (7.89) | (7.29) | (1.96) E | (1.87) | (1.75) | (.33) | ||||||
Net asset value, end of period | $ | 15.05 | $ | 29.25 | $ | 29.01 | $ | 19.16 | $ | 17.61 | $ | 18.19 |
Total Return F,G | (28.79)% | 33.42% | 68.41% | 23.24% | 6.96% | 38.10% | ||||||
Ratios to Average Net Assets B,H,I | ||||||||||||
Expenses before reductions | -% J,K | -% J | -% J | -% J | -% J | .38% | ||||||
Expenses net of fee waivers, if any | -% J,K | -% J | -% J | -% J | -% J | .38% | ||||||
Expenses net of all reductions | -% J,K | -% J | -% J | -% J | -% J | .37% | ||||||
Net investment income (loss) | .49% K | .40% C | .41% | .64% | .79% D | .43% | ||||||
Supplemental Data | ||||||||||||
Net assets, end of period (000 omitted) | $ | 11,934,996 | $ | 13,178,104 | $ | 12,836,920 | $ | 11,173,659 | $ | 11,276,470 | $ | 11,622,162 |
Portfolio turnover rate L | 29% K | 34% | 18% | 19% M | 23% | 15% |
Fidelity Central Fund | Investment Manager | Investment Objective | Investment Practices | Expense Ratio A |
Fidelity Money Market Central Funds | Fidelity Management & Research Company LLC (FMR) | Each fund seeks to obtain a high level of current income consistent with the preservation of capital and liquidity. | Short-term Investments | Less than .005% |
Asset Type | Fair Value | Valuation Technique(s) | Unobservable Input | Amount or Range/Weighted Average | Impact to Valuation from an Increase in Input A |
Equities | $379,645,588 | Market approach | Transaction price | $0.02 - $712.50 / $167.98 | Increase |
Discount rate | 5.3% - 58.3% / 32.9% | Decrease | |||
Liquidation value | $0.05 | Increase | |||
Recovery value | Transaction price | $12.76 | Increase | ||
Recovery value | $0.00 - $2.87 / $2.21 | Increase | |||
Discount for lack of marketability | 5.0% | Decrease | |||
Probability rate | 15.0% - 70.0% / 42.5% | Increase | |||
Market comparable | Enterprise value/Revenue multiple (EV/R) | 1.9 - 24.0 / 8.5 | Increase | ||
Enterprise value/Gross profit multiple (EV/GP) | 8.00 | Increase | |||
Liquidity preference | $204.67 - $232.61 / $219.38 | Increase | |||
Book value | Book value multiple | 1.8 | Increase | ||
Discounted cash flow | Weighted average cost of capital (WACC) | 33.0% - 41.0% / 38.1% | Decrease | ||
Discount rate | 12.3% - 13.0% / 12.6% | Decrease | |||
Growth rate | 3.5% | Increase | |||
Exit multiple | 2.3 - 5.0 / 4.0 | Increase | |||
Corporate Bonds | $2,641,417 | Market approach | Transaction price | $100.00 | Increase |
Market comparable | Enterprise value/Revenue multiple (EV/R) | 2.8 | Increase | ||
Term | 1.4 | Increase | |||
Volatility | 75.0% | Increase | |||
Preferred Securities | $4,443,758 | Market approach | Transaction price | $100.00 | Increase |
Recovery value | Recovery value | $0.00 | Increase |
Gross unrealized appreciation | $6,109,516,609 |
Gross unrealized depreciation | (863,019,637) |
Net unrealized appreciation (depreciation) | $5,246,496,972 |
Tax cost | $6,767,019,706 |
Investment to be Acquired | Commitment Amount | |
Fidelity Series Growth Company Fund | Twitter, Inc. | $2,263,609 |
$ Amount | % of Net Assets | |
Fidelity Series Growth Company Fund | 52,559,019 | .44 |
Equity Risk | Equity risk relates to the fluctuations in the value of financial instruments as a result of changes in market prices (other than those arising from interest rate risk or foreign exchange risk), whether caused by factors specific to an individual investment, its issuer, or all factors affecting all instruments traded in a market or market segment. |
Purchases ($) | Sales ($) | |
Fidelity Series Growth Company Fund | 4,418,772,933 | 1,825,488,608 |
Amount | |
Fidelity Series Growth Company Fund | $67,677 |
Borrower or Lender | Average Loan Balance | Weighted Average Interest Rate | Interest Expense | |
Fidelity Series Growth Company Fund | Borrower | $103,905,833 | .49% | $8,406 |
Purchases ($) | Sales ($) | Realized Gain (Loss) ($) | |
Fidelity Series Growth Company Fund | 779,473,073 | 122,358,409 | 6,958,508 |
Total Security Lending Fees Paid to NFS | Security Lending Income From Securities Loaned to NFS | Value of Securities Loaned to NFS at Period End | |
Fidelity Series Growth Company Fund | $74,778 | $26,834 | $1,049,305 |
The Example is based on an investment of $1,000 invested at the beginning of the period and held for the entire period (December 1, 2021 to May 31, 2022). |
Annualized Expense Ratio- A | Beginning Account Value December 1, 2021 | Ending Account Value May 31, 2022 | Expenses Paid During Period- C December 1, 2021 to May 31, 2022 | |||||||
Fidelity® Series Growth Company Fund | -%- D | |||||||||
Actual | $ 1,000 | $ 712.10 | $- E | |||||||
Hypothetical- B | $ 1,000 | $ 1,024.93 | $- E | |||||||
- Highly liquid investments - cash or convertible to cash within three business days or less
- Moderately liquid investments - convertible to cash in three to seven calendar days
- Less liquid investments - can be sold or disposed of, but not settled, within seven calendar days
- Illiquid investments - cannot be sold or disposed of within seven calendar days
Contents
Board Approval of Investment Advisory Contracts and Management Fees |
Top Holdings (% of Fund's net assets) | ||
Exxon Mobil Corp. | 3.8 | |
Bristol-Myers Squibb Co. | 2.7 | |
EQT Corp. | 2.6 | |
Hess Corp. | 2.4 | |
General Electric Co. | 2.3 | |
Wells Fargo & Co. | 2.1 | |
American International Group, Inc. | 2.1 | |
Eli Lilly & Co. | 2.0 | |
Bank of America Corp. | 1.9 | |
Comcast Corp. Class A | 1.8 | |
23.7 | ||
Market Sectors (% of Fund's net assets) | ||
Energy | 17.6 | |
Financials | 17.4 | |
Health Care | 15.0 | |
Industrials | 12.2 | |
Consumer Discretionary | 9.1 | |
Information Technology | 6.3 | |
Communication Services | 5.9 | |
Materials | 4.8 | |
Consumer Staples | 3.9 | |
Utilities | 3.2 | |
Real Estate | 2.8 | |
Asset Allocation (% of Fund's net assets) |
Foreign investments - 16.5% |
Geographic Diversification (% of Fund's net assets) |
* Includes Short-Term investments and Net Other Assets (Liabilities). Percentages are based on country or territory of incorporation and are adjusted for the effect of futures contracts, if applicable. |
Common Stocks - 95.6% | |||
Shares | Value ($) (000s) | ||
COMMUNICATION SERVICES - 5.9% | |||
Diversified Telecommunication Services - 1.1% | |||
Verizon Communications, Inc. | 557,500 | 28,594 | |
Entertainment - 0.7% | |||
Endeavor Group Holdings, Inc. (a) | 759,817 | 17,263 | |
Interactive Media & Services - 0.9% | |||
Alphabet, Inc. Class A (a) | 9,800 | 22,297 | |
Media - 3.2% | |||
Comcast Corp. Class A | 1,025,900 | 45,427 | |
Interpublic Group of Companies, Inc. | 604,900 | 19,496 | |
Omnicom Group, Inc. | 241,700 | 18,033 | |
82,956 | |||
TOTAL COMMUNICATION SERVICES | 151,110 | ||
CONSUMER DISCRETIONARY - 7.8% | |||
Auto Components - 0.7% | |||
American Axle & Manufacturing Holdings, Inc. (a) | 234,022 | 1,898 | |
Aptiv PLC (a) | 73,400 | 7,798 | |
Faurecia SA | 18,368 | 509 | |
Magna International, Inc. Class A (b) | 99,400 | 6,453 | |
16,658 | |||
Automobiles - 1.1% | |||
Aston Martin Lagonda Global Holdings PLC (a)(b)(c) | 487,479 | 4,410 | |
General Motors Co. (a) | 349,100 | 13,503 | |
Stellantis NV (b) | 664,300 | 10,031 | |
27,944 | |||
Hotels, Restaurants & Leisure - 1.2% | |||
Booking Holdings, Inc. (a) | 7,200 | 16,154 | |
Churchill Downs, Inc. | 56,800 | 11,498 | |
Elior SA (a)(c) | 334,000 | 997 | |
Sweetgreen, Inc. Class A | 87,300 | 1,596 | |
30,245 | |||
Household Durables - 1.4% | |||
D.R. Horton, Inc. | 166,800 | 12,535 | |
Mohawk Industries, Inc. (a) | 69,400 | 9,817 | |
NVR, Inc. (a) | 2,910 | 12,951 | |
35,303 | |||
Internet & Direct Marketing Retail - 0.6% | |||
Coupang, Inc. Class A (a) | 736,906 | 9,956 | |
eBay, Inc. | 133,600 | 6,502 | |
16,458 | |||
Leisure Products - 0.1% | |||
Peloton Interactive, Inc. Class A (a)(b) | 222,016 | 3,099 | |
Specialty Retail - 0.7% | |||
Best Buy Co., Inc. | 104,400 | 8,567 | |
Industria de Diseno Textil SA | 338,500 | 8,159 | |
16,726 | |||
Textiles, Apparel & Luxury Goods - 2.0% | |||
Brunello Cucinelli SpA | 545,800 | 27,317 | |
PVH Corp. | 106,100 | 7,519 | |
Ralph Lauren Corp. | 64,300 | 6,500 | |
Tapestry, Inc. | 318,400 | 10,985 | |
52,321 | |||
TOTAL CONSUMER DISCRETIONARY | 198,754 | ||
CONSUMER STAPLES - 3.7% | |||
Beverages - 1.7% | |||
Boston Beer Co., Inc. Class A (a) | 17,400 | 6,182 | |
Diageo PLC sponsored ADR | 63,900 | 11,947 | |
The Coca-Cola Co. | 414,700 | 26,284 | |
44,413 | |||
Food & Staples Retailing - 0.9% | |||
Kroger Co. | 423,100 | 22,412 | |
Food Products - 0.3% | |||
Greencore Group PLC (a) | 4,934,761 | 6,778 | |
Tobacco - 0.8% | |||
Altria Group, Inc. | 383,900 | 20,765 | |
TOTAL CONSUMER STAPLES | 94,368 | ||
ENERGY - 17.5% | |||
Energy Equipment & Services - 1.6% | |||
Noble Corp. (c) | 1,334 | 48 | |
Oceaneering International, Inc. (a) | 504,852 | 6,422 | |
Odfjell Drilling Ltd. (a) | 3,729,024 | 10,802 | |
Odfjell Technology Ltd. (a) | 621,504 | 1,830 | |
Schlumberger Ltd. | 399,200 | 18,347 | |
Technip Energies NV ADR | 58,160 | 759 | |
TechnipFMC PLC (a) | 291,100 | 2,399 | |
40,607 | |||
Oil, Gas & Consumable Fuels - 15.9% | |||
Canadian Natural Resources Ltd. | 626,400 | 41,456 | |
Cheniere Energy, Inc. | 328,400 | 44,915 | |
Energy Transfer LP | 699,300 | 8,154 | |
EQT Corp. (b) | 1,389,400 | 66,302 | |
Exxon Mobil Corp. | 1,005,100 | 96,493 | |
Golar LNG Ltd. (a) | 741,400 | 18,780 | |
Harbour Energy PLC | 558,916 | 2,706 | |
Hess Corp. | 494,500 | 60,858 | |
Range Resources Corp. (a) | 460,900 | 15,648 | |
The Williams Companies, Inc. | 853,397 | 31,627 | |
Valero Energy Corp. | 152,400 | 19,751 | |
406,690 | |||
TOTAL ENERGY | 447,297 | ||
FINANCIALS - 17.4% | |||
Banks - 6.3% | |||
Bank of America Corp. | 1,285,500 | 47,821 | |
Comerica, Inc. | 151,000 | 12,565 | |
HDFC Bank Ltd. sponsored ADR | 140,700 | 8,100 | |
PNC Financial Services Group, Inc. | 215,400 | 37,783 | |
Wells Fargo & Co. | 1,207,400 | 55,263 | |
161,532 | |||
Capital Markets - 3.1% | |||
Goldman Sachs Group, Inc. | 74,500 | 24,350 | |
Morgan Stanley | 282,200 | 24,309 | |
Sixth Street Specialty Lending, Inc. | 1,029,350 | 21,297 | |
TPG, Inc. (b) | 355,900 | 10,382 | |
80,338 | |||
Diversified Financial Services - 0.3% | |||
Equitable Holdings, Inc. | 249,100 | 7,575 | |
Insurance - 6.2% | |||
American International Group, Inc. | 895,800 | 52,566 | |
Arch Capital Group Ltd. (a) | 546,400 | 25,932 | |
Chubb Ltd. | 184,509 | 38,985 | |
First American Financial Corp. | 121,800 | 7,380 | |
Hiscox Ltd. | 639,207 | 7,446 | |
MetLife, Inc. | 317,300 | 21,383 | |
RenaissanceRe Holdings Ltd. | 33,000 | 5,066 | |
158,758 | |||
Thrifts & Mortgage Finance - 1.5% | |||
Housing Development Finance Corp. Ltd. | 299,068 | 8,890 | |
Radian Group, Inc. | 1,367,423 | 29,413 | |
38,303 | |||
TOTAL FINANCIALS | 446,506 | ||
HEALTH CARE - 14.4% | |||
Biotechnology - 0.8% | |||
Amgen, Inc. | 83,600 | 21,463 | |
Health Care Equipment & Supplies - 2.1% | |||
Becton, Dickinson & Co. | 68,200 | 17,446 | |
Boston Scientific Corp. (a) | 395,700 | 16,228 | |
Butterfly Network, Inc. (a)(d) | 557,178 | 1,699 | |
Butterfly Network, Inc. Class A (a)(b) | 2,061,648 | 6,288 | |
Embecta Corp. (a) | 13,640 | 338 | |
Hologic, Inc. (a) | 155,100 | 11,674 | |
53,673 | |||
Health Care Providers & Services - 4.5% | |||
Centene Corp. (a) | 262,200 | 21,354 | |
Cigna Corp. | 93,300 | 25,031 | |
Guardant Health, Inc. (a) | 116,600 | 4,778 | |
LifeStance Health Group, Inc. | 586,000 | 4,366 | |
Oak Street Health, Inc. (a)(b) | 359,633 | 6,790 | |
UnitedHealth Group, Inc. | 88,200 | 43,816 | |
Universal Health Services, Inc. Class B | 67,100 | 8,361 | |
114,496 | |||
Pharmaceuticals - 7.0% | |||
Bristol-Myers Squibb Co. | 929,200 | 70,108 | |
Eli Lilly & Co. | 160,100 | 50,182 | |
Euroapi SASU (a) | 5,313 | 77 | |
Roche Holding AG (participation certificate) | 52,080 | 17,748 | |
Sanofi SA | 122,200 | 13,037 | |
UCB SA | 64,200 | 5,663 | |
Viatris, Inc. | 1,785,900 | 21,913 | |
178,728 | |||
TOTAL HEALTH CARE | 368,360 | ||
INDUSTRIALS - 11.8% | |||
Aerospace & Defense - 5.4% | |||
BWX Technologies, Inc. | 202,700 | 10,378 | |
General Dynamics Corp. | 133,600 | 30,048 | |
Huntington Ingalls Industries, Inc. | 136,200 | 28,665 | |
Northrop Grumman Corp. | 59,300 | 27,751 | |
Space Exploration Technologies Corp.: | |||
Class A (a)(d)(e) | 585,890 | 41,012 | |
Class C (a)(d)(e) | 8,180 | 573 | |
138,427 | |||
Air Freight & Logistics - 0.2% | |||
GXO Logistics, Inc. (a) | 101,400 | 5,503 | |
Building Products - 0.5% | |||
Fortune Brands Home & Security, Inc. | 118,500 | 8,218 | |
Jeld-Wen Holding, Inc. (a) | 237,600 | 4,474 | |
12,692 | |||
Construction & Engineering - 0.6% | |||
AECOM | 118,500 | 8,277 | |
Argan, Inc. | 164,600 | 6,582 | |
14,859 | |||
Electrical Equipment - 0.4% | |||
Sensata Technologies, Inc. PLC | 206,900 | 9,937 | |
Industrial Conglomerates - 2.3% | |||
General Electric Co. | 752,712 | 58,930 | |
Machinery - 0.5% | |||
Donaldson Co., Inc. | 121,700 | 6,362 | |
Pentair PLC | 138,900 | 6,969 | |
13,331 | |||
Marine - 0.3% | |||
Goodbulk Ltd. (a)(e) | 959,290 | 6,496 | |
Professional Services - 0.6% | |||
Leidos Holdings, Inc. | 92,700 | 9,687 | |
Science Applications International Corp. | 72,000 | 6,232 | |
15,919 | |||
Road & Rail - 1.0% | |||
Hertz Global Holdings, Inc. (b) | 226,900 | 4,554 | |
Knight-Swift Transportation Holdings, Inc. Class A | 327,386 | 15,924 | |
XPO Logistics, Inc. (a) | 104,800 | 5,601 | |
26,079 | |||
TOTAL INDUSTRIALS | 302,173 | ||
INFORMATION TECHNOLOGY - 6.3% | |||
Communications Equipment - 1.5% | |||
Cisco Systems, Inc. | 663,000 | 29,868 | |
Ericsson (B Shares) | 1,170,800 | 9,508 | |
39,376 | |||
Electronic Equipment & Components - 0.6% | |||
Keysight Technologies, Inc. (a) | 106,600 | 15,521 | |
IT Services - 2.6% | |||
Akamai Technologies, Inc. (a) | 117,200 | 11,842 | |
Euronet Worldwide, Inc. (a) | 58,700 | 7,112 | |
Fidelity National Information Services, Inc. | 113,800 | 11,892 | |
Fiserv, Inc. (a) | 1 | 0 | |
Global Payments, Inc. | 48,300 | 6,329 | |
Visa, Inc. Class A | 134,900 | 28,622 | |
65,797 | |||
Semiconductors & Semiconductor Equipment - 1.6% | |||
Analog Devices, Inc. | 82,500 | 13,893 | |
Intel Corp. | 466,200 | 20,709 | |
Skyworks Solutions, Inc. | 55,300 | 6,021 | |
40,623 | |||
TOTAL INFORMATION TECHNOLOGY | 161,317 | ||
MATERIALS - 4.8% | |||
Chemicals - 1.3% | |||
Cabot Corp. | 115,000 | 8,695 | |
LG Chemical Ltd. | 20,230 | 9,525 | |
Nutrien Ltd. | 154,120 | 15,062 | |
33,282 | |||
Containers & Packaging - 1.1% | |||
Avery Dennison Corp. | 54,900 | 9,474 | |
O-I Glass, Inc. (a) | 1,174,500 | 19,321 | |
28,795 | |||
Metals & Mining - 2.4% | |||
Franco-Nevada Corp. | 133,400 | 18,871 | |
Freeport-McMoRan, Inc. | 703,600 | 27,497 | |
Newcrest Mining Ltd. | 408,709 | 7,167 | |
Novagold Resources, Inc. (a) | 1,383,780 | 7,757 | |
61,292 | |||
TOTAL MATERIALS | 123,369 | ||
REAL ESTATE - 2.8% | |||
Equity Real Estate Investment Trusts (REITs) - 2.6% | |||
Cousins Properties, Inc. | 186,288 | 6,436 | |
Gaming & Leisure Properties | 262,183 | 12,275 | |
Healthcare Trust of America, Inc. | 235,700 | 7,083 | |
Orion Office (REIT), Inc. | 10,680 | 142 | |
Realty Income Corp. (b) | 106,807 | 7,286 | |
Simon Property Group, Inc. | 74,100 | 8,496 | |
Spirit Realty Capital, Inc. | 260,560 | 10,941 | |
VICI Properties, Inc. | 428,600 | 13,222 | |
65,881 | |||
Real Estate Management & Development - 0.2% | |||
WeWork, Inc. (a)(b) | 673,800 | 4,912 | |
TOTAL REAL ESTATE | 70,793 | ||
UTILITIES - 3.2% | |||
Electric Utilities - 2.2% | |||
Duke Energy Corp. | 230,300 | 25,913 | |
FirstEnergy Corp. | 219,500 | 9,430 | |
Southern Co. | 259,200 | 19,611 | |
54,954 | |||
Independent Power and Renewable Electricity Producers - 1.0% | |||
The AES Corp. | 591,800 | 13,043 | |
Vistra Corp. | 521,400 | 13,749 | |
26,792 | |||
TOTAL UTILITIES | 81,746 | ||
TOTAL COMMON STOCKS (Cost $1,757,091) | 2,445,793 | ||
Preferred Stocks - 2.5% | |||
Shares | Value ($) (000s) | ||
Convertible Preferred Stocks - 1.8% | |||
CONSUMER DISCRETIONARY - 0.6% | |||
Textiles, Apparel & Luxury Goods - 0.6% | |||
Bolt Threads, Inc.: | |||
Series D(a)(d)(e) | 390,327 | 6,741 | |
Series E(d)(e) | 522,488 | 9,023 | |
15,764 | |||
CONSUMER STAPLES - 0.2% | |||
Food Products - 0.2% | |||
Bowery Farming, Inc. Series C1 (d)(e) | 161,754 | 5,750 | |
HEALTH CARE - 0.6% | |||
Biotechnology - 0.6% | |||
National Resilience, Inc. Series B (a)(d)(e) | 243,347 | 14,795 | |
INDUSTRIALS - 0.4% | |||
Aerospace & Defense - 0.2% | |||
Space Exploration Technologies Corp. Series H (a)(d)(e) | 7,570 | 5,299 | |
Construction & Engineering - 0.2% | |||
Beta Technologies, Inc. Series B, 6.00% (d)(e) | 49,853 | 5,143 | |
TOTAL INDUSTRIALS | 10,442 | ||
TOTAL CONVERTIBLE PREFERRED STOCKS | 46,751 | ||
Nonconvertible Preferred Stocks - 0.7% | |||
CONSUMER DISCRETIONARY - 0.7% | |||
Automobiles - 0.7% | |||
Porsche Automobil Holding SE (Germany) | 211,000 | 17,282 | |
TOTAL PREFERRED STOCKS (Cost $50,561) | 64,033 | ||
Other - 0.1% | |||
Shares | Value ($) (000s) | ||
Energy - Oil, Gas & Consumable Fuels - 0.1% | |||
Utica Shale Drilling Program (non-operating revenue interest) (d)(e)(f) (Cost $8,368) | 8,367,654 | 2,751 | |
Money Market Funds - 3.4% | |||
Shares | Value ($) (000s) | ||
Fidelity Cash Central Fund 0.82% (g) | 44,390,327 | 44,399 | |
Fidelity Securities Lending Cash Central Fund 0.82% (g)(h) | 41,695,673 | 41,700 | |
TOTAL MONEY MARKET FUNDS (Cost $86,099) | 86,099 | ||
TOTAL INVESTMENT IN SECURITIES - 101.6% (Cost $1,902,119) | 2,598,676 |
NET OTHER ASSETS (LIABILITIES) - (1.6)% | (41,240) |
NET ASSETS - 100.0% | 2,557,436 |
(a) | Non-income producing |
(b) | Security or a portion of the security is on loan at period end. |
(c) | Security exempt from registration under Rule 144A of the Securities Act of 1933. These securities may be resold in transactions exempt from registration, normally to qualified institutional buyers. At the end of the period, the value of these securities amounted to $5,455,000 or 0.2% of net assets. |
(d) | Restricted securities (including private placements) - Investment in securities not registered under the Securities Act of 1933 (excluding 144A issues). At the end of the period, the value of restricted securities (excluding 144A issues) amounted to $92,786,000 or 3.6% of net assets. |
(e) | Level 3 security |
(f) | Investment is owned by a wholly-owned subsidiary (Subsidiary) that is treated as a corporation for U.S. tax purposes. |
(g) | Affiliated fund that is generally available only to investment companies and other accounts managed by Fidelity Investments. The rate quoted is the annualized seven-day yield of the fund at period end. A complete unaudited listing of the fund's holdings as of its most recent quarter end is available upon request. In addition, each Fidelity Central Fund's financial statements are available on the SEC's website or upon request. |
(h) | Investment made with cash collateral received from securities on loan. |
Additional information on each restricted holding is as follows: | ||
Security | Acquisition Date | Acquisition Cost ($) (000s) |
Beta Technologies, Inc. Series B, 6.00% | 4/04/22 | 5,143 |
Bolt Threads, Inc. Series D | 12/13/17 | 6,261 |
Bolt Threads, Inc. Series E | 2/07/20 - 9/02/21 | 9,224 |
Bowery Farming, Inc. Series C1 | 5/18/21 | 9,746 |
Butterfly Network, Inc. | 2/12/21 | 5,572 |
National Resilience, Inc. Series B | 12/01/20 | 3,324 |
Space Exploration Technologies Corp. Class A | 4/08/16 - 9/11/17 | 5,980 |
Space Exploration Technologies Corp. Class C | 9/11/17 | 110 |
Space Exploration Technologies Corp. Series H | 8/04/17 | 1,022 |
Utica Shale Drilling Program (non-operating revenue interest) | 10/05/16 - 9/01/17 | 8,368 |
Affiliate (Amounts in thousands) | Value, beginning of period ($) | Purchases ($) | Sales Proceeds ($) | Dividend Income ($) | Realized Gain (loss) ($) | Change in Unrealized appreciation (depreciation) ($) | Value, end of period ($) | %ownership, end of period |
Fidelity Cash Central Fund 0.82% | 23,004 | 225,073 | 203,678 | 54 | - | - | 44,399 | 0.1% |
Fidelity Securities Lending Cash Central Fund 0.82% | 36,767 | 262,078 | 257,145 | 118 | - | - | 41,700 | 0.1% |
Total | 59,771 | 487,151 | 460,823 | 172 | - | - | 86,099 |
Valuation Inputs at Reporting Date: | ||||
Description (Amounts in thousands) | Total ($) | Level 1 ($) | Level 2 ($) | Level 3 ($) |
Investments in Securities: | ||||
Equities: | ||||
Communication Services | 151,110 | 151,110 | - | - |
Consumer Discretionary | 231,800 | 190,595 | 25,441 | 15,764 |
Consumer Staples | 100,118 | 94,368 | - | 5,750 |
Energy | 447,297 | 447,297 | - | - |
Financials | 446,506 | 446,506 | - | - |
Health Care | 383,155 | 350,612 | 17,748 | 14,795 |
Industrials | 312,615 | 254,092 | - | 58,523 |
Information Technology | 161,317 | 151,809 | 9,508 | - |
Materials | 123,369 | 116,202 | 7,167 | - |
Real Estate | 70,793 | 70,793 | - | - |
Utilities | 81,746 | 81,746 | - | - |
Other | 2,751 | - | - | 2,751 |
Money Market Funds | 86,099 | 86,099 | - | - |
Total Investments in Securities: | 2,598,676 | 2,441,229 | 59,864 | 97,583 |
(Amounts in thousands) | |||
Investments in Securities: | |||
Equities - Industrials | |||
Beginning Balance | $ | 45,462 | |
Net Realized Gain (Loss) on Investment Securities | - | ||
Net Unrealized Gain (Loss) on Investment Securities | 7,918 | ||
Cost of Purchases | 5,143 | ||
Proceeds of Sales | - | ||
Amortization/Accretion | - | ||
Transfers into Level 3 | - | ||
Transfers out of Level 3 | - | ||
Ending Balance | $ | 58,523 | |
The change in unrealized gain (loss) for the period attributable to Level 3 securities held at May 31, 2022 | $ | 7,918 | |
Other Investments in Securities | |||
Beginning Balance | $ | 40,555 | |
Net Realized Gain (Loss) on Investment Securities | - | ||
Net Unrealized Gain (Loss) on Investment Securities | (1,495) | ||
Cost of Purchases | - | ||
Proceeds of Sales | - | ||
Amortization/Accretion | - | ||
Transfers into Level 3 | - | ||
Transfers out of Level 3 | - | ||
Ending Balance | $ | 39,060 | |
The change in unrealized gain (loss) for the period attributable to Level 3 securities held at May 31, 2022 | $ | (1,495) | |
Statement of Assets and Liabilities | ||||
Amounts in thousands (except per-share amount) | May 31, 2022 (Unaudited) | |||
Assets | ||||
Investment in securities, at value (including securities loaned of $39,655) - See accompanying schedule: | $2,512,577 | |||
Unaffiliated issuers (cost $1,816,020) | ||||
Fidelity Central Funds (cost $86,099) | 86,099 | |||
Total Investment in Securities (cost $1,902,119) | $ | 2,598,676 | ||
Restricted cash | 118 | |||
Receivable for investments sold | 544 | |||
Receivable for fund shares sold | 448 | |||
Dividends receivable | 5,191 | |||
Distributions receivable from Fidelity Central Funds | 53 | |||
Other receivables | 20 | |||
Total assets | 2,605,050 | |||
Liabilities | ||||
Payable for investments purchased | $3,937 | |||
Payable for fund shares redeemed | 942 | |||
Accrued management fee | 675 | |||
Other affiliated payables | 327 | |||
Other payables and accrued expenses | 43 | |||
Collateral on securities loaned | 41,690 | |||
Total Liabilities | 47,614 | |||
Net Assets | $ | 2,557,436 | ||
Net Assets consist of: | ||||
Paid in capital | $ | 1,754,249 | ||
Total accumulated earnings (loss) | 803,187 | |||
Net Assets | $ | 2,557,436 | ||
Net Asset Value , offering price and redemption price per share ($2,557,436 ÷ 61,032 shares) | $ | 41.90 | ||
Statement of Operations | ||||
Amounts in thousands | Six months ended May 31, 2022 (Unaudited) | |||
Investment Income | ||||
Dividends | $ | 27,955 | ||
Income from Fidelity Central Funds (including $118 from security lending) | 172 | |||
Total Income | 28,127 | |||
Expenses | ||||
Management fee | ||||
Basic fee | $ | 6,841 | ||
Performance adjustment | (2,622) | |||
Transfer agent fees | 1,598 | |||
Accounting fees | 387 | |||
Custodian fees and expenses | 20 | |||
Independent trustees' fees and expenses | 5 | |||
Registration fees | 18 | |||
Audit | 99 | |||
Legal | 2 | |||
Miscellaneous | 4 | |||
Total expenses before reductions | 6,352 | |||
Expense reductions | (39) | |||
Total expenses after reductions | 6,313 | |||
Net Investment income (loss) | 21,814 | |||
Realized and Unrealized Gain (Loss) | ||||
Net realized gain (loss) on: | ||||
Investment Securities: | ||||
Unaffiliated issuers | 96,296 | |||
Foreign currency transactions | (31) | |||
Total net realized gain (loss) | 96,265 | |||
Change in net unrealized appreciation (depreciation) on: | ||||
Investment Securities: | ||||
Unaffiliated issuers | 25,966 | |||
Assets and liabilities in foreign currencies | (43) | |||
Total change in net unrealized appreciation (depreciation) | 25,923 | |||
Net gain (loss) | 122,188 | |||
Net increase (decrease) in net assets resulting from operations | $ | 144,002 |
Statement of Changes in Net Assets | ||||
Amounts in thousands | Six months ended May 31, 2022 (Unaudited) | Year ended November 30, 2021 | ||
Increase (Decrease) in Net Assets | ||||
Operations | ||||
Net investment income (loss) | $ | 21,814 | $ | 39,349 |
Net realized gain (loss) | 96,265 | 178,290 | ||
Change in net unrealized appreciation (depreciation) | 25,923 | 318,305 | ||
Net increase (decrease) in net assets resulting from operations | 144,002 | 535,944 | ||
Distributions to shareholders | (209,958) | (190,997) | ||
Share transactions | ||||
Proceeds from sales of shares | 71,306 | 265,604 | ||
Reinvestment of distributions | 199,038 | 181,627 | ||
Cost of shares redeemed | (276,708) | (493,222) | ||
Net increase (decrease) in net assets resulting from share transactions | (6,364) | (45,991) | ||
Total increase (decrease) in net assets | (72,320) | 298,956 | ||
Net Assets | ||||
Beginning of period | 2,629,756 | 2,330,800 | ||
End of period | $ | 2,557,436 | $ | 2,629,756 |
Other Information | ||||
Shares | ||||
Sold | 1,752 | 6,486 | ||
Issued in reinvestment of distributions | 4,756 | 5,013 | ||
Redeemed | (6,715) | (11,970) | ||
Net increase (decrease) | (207) | (471) | ||
Fidelity® New Millennium Fund® |
Six months ended (Unaudited) May 31, 2022 | Years ended November 30, 2021 | 2020 | 2019 | 2018 | 2017 | |||||||
Selected Per-Share Data | ||||||||||||
Net asset value, beginning of period | $ | 42.94 | $ | 37.77 | $ | 38.43 | $ | 40.52 | $ | 42.70 | $ | 37.56 |
Income from Investment Operations | ||||||||||||
Net investment income (loss) A,B | .35 | .62 | .54 | .62 | .43 | .38 | ||||||
Net realized and unrealized gain (loss) | 2.07 | 7.70 | .45 | 3.11 | .87 | 7.01 | ||||||
Total from investment operations | 2.42 | 8.32 | .99 | 3.73 | 1.30 | 7.39 | ||||||
Distributions from net investment income | (.85) | (.58) | (.36) | (.39) | (.36) | (.43) | ||||||
Distributions from net realized gain | (2.60) | (2.56) | (1.29) | (5.43) | (3.12) | (1.82) | ||||||
Total distributions | (3.46) C | (3.15) C | (1.65) | (5.82) | (3.48) | (2.25) | ||||||
Net asset value, end of period | $ | 41.90 | $ | 42.94 | $ | 37.77 | $ | 38.43 | $ | 40.52 | $ | 42.70 |
Total Return D,E | 5.64% | 23.56% | 2.60% | 12.82% | 3.19% | 20.69% | ||||||
Ratios to Average Net Assets B,F,G | ||||||||||||
Expenses before reductions | .49% H | .49% | .46% | .61% | .64% | .54% | ||||||
Expenses net of fee waivers, if any | .48% H | .48% | .46% | .61% | .64% | .54% | ||||||
Expenses net of all reductions | .48% H | .48% | .45% | .61% | .63% | .54% | ||||||
Net investment income (loss) | 1.67% H | 1.46% | 1.61% | 1.72% | 1.03% | .98% | ||||||
Supplemental Data | ||||||||||||
Net assets, end of period (in millions) | $ | 2,557 | $ | 2,630 | $ | 2,331 | $ | 2,991 | $ | 3,206 | $ | 3,288 |
Portfolio turnover rate I | 10% H | 19% | 22% | 34% | 37% | 31% |
Fidelity Central Fund | Investment Manager | Investment Objective | Investment Practices | Expense Ratio A |
Fidelity Money Market Central Funds | Fidelity Management & Research Company LLC (FMR) | Each fund seeks to obtain a high level of current income consistent with the preservation of capital and liquidity. | Short-term Investments | Less than .005% |
Asset Type | Fair Value | Valuation Technique(s) | Unobservable Input | Amount or Range/Weighted Average | Impact to Valuation from an Increase in Input A |
Equities | $ 94,832 | Market approach | Transaction price | $60.80 - $700.00 / $120.47 | Increase |
Premium rate | 2.8% | Increase | |||
Market comparable | Enterprise value/Revenue multiple (EV/R) | 15.8 - 16.0 / 15.8 | Increase | ||
Other | $ 2,751 | Discounted cash flow | Discount rate | 11.5% | Decrease |
Gross unrealized appreciation | $846,899 |
Gross unrealized depreciation | (160,245) |
Net unrealized appreciation (depreciation) | $686,654 |
Tax cost | $1,912,022 |
$ Amount | % of Net Assets | |
Fidelity New Millennium Fund | 2,869 | .11 |
Purchases ($) | Sales ($) | |
Fidelity New Millennium Fund | 132,395 | 354,377 |
% of Average Net Assets | |
Fidelity New Millennium Fund | .03 |
Amount | |
Fidelity New Millennium Fund | $5 |
Purchases ($) | Sales ($) | Realized Gain (Loss) ($) | |
Fidelity New Millennium Fund | 1,053 | 38,368 | 17,413 |
Amount | |
Fidelity New Millennium Fund | $2 |
Total Security Lending Fees Paid to NFS | Security Lending Income From Securities Loaned to NFS | Value of Securities Loaned to NFS at Period End | |
Fidelity New Millennium Fund | $13 | $11 | $2,305 |
The Example is based on an investment of $1,000 invested at the beginning of the period and held for the entire period (December 1, 2021 to May 31, 2022). |
Annualized Expense Ratio- A | Beginning Account Value December 1, 2021 | Ending Account Value May 31, 2022 | Expenses Paid During Period- C December 1, 2021 to May 31, 2022 | |||||||
Fidelity® New Millennium Fund® | .48% | |||||||||
Actual | $ 1,000 | $ 1,056.40 | $ 2.46 | |||||||
Hypothetical- B | $ 1,000 | $ 1,022.54 | $ 2.42 | |||||||
- Highly liquid investments - cash or convertible to cash within three business days or less
- Moderately liquid investments - convertible to cash in three to seven calendar days
- Less liquid investments - can be sold or disposed of, but not settled, within seven calendar days
- Illiquid investments - cannot be sold or disposed of within seven calendar days
Contents
Board Approval of Investment Advisory Contracts and Management Fees |
Top Holdings (% of Fund's net assets) | ||
Cadence Design Systems, Inc. | 3.2 | |
Fortinet, Inc. | 2.9 | |
Mettler-Toledo International, Inc. | 2.7 | |
Synopsys, Inc. | 2.5 | |
ResMed, Inc. | 2.5 | |
Entegris, Inc. | 2.4 | |
MSCI, Inc. | 2.4 | |
EPAM Systems, Inc. | 2.1 | |
onsemi | 2.1 | |
West Pharmaceutical Services, Inc. | 2.1 | |
24.9 | ||
Market Sectors (% of Fund's net assets) | ||
Information Technology | 31.2 | |
Health Care | 16.7 | |
Consumer Discretionary | 15.7 | |
Industrials | 15.1 | |
Financials | 8.6 | |
Energy | 3.5 | |
Materials | 3.0 | |
Consumer Staples | 2.4 | |
Real Estate | 0.3 | |
Asset Allocation (% of Fund's net assets) |
Foreign investments - 3.4% |
Common Stocks - 96.5% | |||
Shares | Value ($) | ||
CONSUMER DISCRETIONARY - 15.7% | |||
Distributors - 1.7% | |||
LKQ Corp. | 4,127 | 212,087 | |
Pool Corp. | 5,199 | 2,072,425 | |
2,284,512 | |||
Hotels, Restaurants & Leisure - 6.7% | |||
Chipotle Mexican Grill, Inc. (a) | 1,000 | 1,402,550 | |
Churchill Downs, Inc. | 6,927 | 1,402,233 | |
Domino's Pizza, Inc. | 2,445 | 887,951 | |
Expedia, Inc. (a) | 14,900 | 1,927,017 | |
Hilton Worldwide Holdings, Inc. | 15,300 | 2,155,158 | |
Wyndham Hotels & Resorts, Inc. | 12,400 | 993,612 | |
8,768,521 | |||
Household Durables - 1.4% | |||
NVR, Inc. (a) | 102 | 453,963 | |
Tempur Sealy International, Inc. | 54,653 | 1,441,200 | |
1,895,163 | |||
Internet & Direct Marketing Retail - 0.3% | |||
eBay, Inc. | 9,200 | 447,764 | |
Multiline Retail - 0.5% | |||
Dollar General Corp. | 3,259 | 718,088 | |
Specialty Retail - 5.0% | |||
AutoZone, Inc. (a) | 1,200 | 2,471,580 | |
Five Below, Inc. (a) | 3,600 | 470,124 | |
O'Reilly Automotive, Inc. (a) | 2,650 | 1,688,501 | |
Tractor Supply Co. | 8,660 | 1,622,538 | |
Williams-Sonoma, Inc. | 2,026 | 259,166 | |
6,511,909 | |||
Textiles, Apparel & Luxury Goods - 0.1% | |||
Deckers Outdoor Corp. (a) | 300 | 80,568 | |
TOTAL CONSUMER DISCRETIONARY | 20,706,525 | ||
CONSUMER STAPLES - 2.4% | |||
Beverages - 0.5% | |||
Brown-Forman Corp. Class B (non-vtg.) | 10,197 | 674,226 | |
Food Products - 1.7% | |||
Bunge Ltd. | 7,847 | 928,457 | |
Darling Ingredients, Inc. (a) | 16,702 | 1,337,329 | |
2,265,786 | |||
Personal Products - 0.2% | |||
Estee Lauder Companies, Inc. Class A | 1,020 | 259,743 | |
TOTAL CONSUMER STAPLES | 3,199,755 | ||
ENERGY - 3.5% | |||
Energy Equipment & Services - 1.0% | |||
Halliburton Co. | 31,500 | 1,275,750 | |
Oil, Gas & Consumable Fuels - 2.5% | |||
Coterra Energy, Inc. | 7,610 | 261,251 | |
Occidental Petroleum Corp. | 17,400 | 1,205,994 | |
PDC Energy, Inc. | 23,804 | 1,883,849 | |
3,351,094 | |||
TOTAL ENERGY | 4,626,844 | ||
FINANCIALS - 8.6% | |||
Capital Markets - 6.9% | |||
Ameriprise Financial, Inc. | 6,100 | 1,685,247 | |
LPL Financial | 3,770 | 739,636 | |
MarketAxess Holdings, Inc. | 3,300 | 929,544 | |
Moody's Corp. | 1,325 | 399,580 | |
MSCI, Inc. | 7,000 | 3,096,450 | |
Nordnet AB | 18,881 | 307,016 | |
Raymond James Financial, Inc. | 13,100 | 1,290,219 | |
S&P Global, Inc. | 1,325 | 463,061 | |
Tradeweb Markets, Inc. Class A | 1,736 | 117,371 | |
9,028,124 | |||
Consumer Finance - 0.8% | |||
Discover Financial Services | 9,800 | 1,112,202 | |
Insurance - 0.9% | |||
Arthur J. Gallagher & Co. | 7,000 | 1,133,580 | |
TOTAL FINANCIALS | 11,273,906 | ||
HEALTH CARE - 16.7% | |||
Biotechnology - 0.9% | |||
Horizon Therapeutics PLC (a) | 13,745 | 1,232,789 | |
Health Care Equipment & Supplies - 4.7% | |||
DexCom, Inc. (a) | 6,623 | 1,973,257 | |
Edwards Lifesciences Corp. (a) | 4,276 | 431,235 | |
Intuitive Surgical, Inc. (a) | 916 | 208,518 | |
Masimo Corp. (a) | 2,000 | 280,860 | |
ResMed, Inc. | 16,302 | 3,316,805 | |
6,210,675 | |||
Health Care Providers & Services - 2.8% | |||
Laboratory Corp. of America Holdings | 3,160 | 779,635 | |
McKesson Corp. | 4,400 | 1,446,236 | |
Tenet Healthcare Corp. (a) | 21,599 | 1,397,671 | |
3,623,542 | |||
Health Care Technology - 1.5% | |||
Doximity, Inc. (b) | 14,416 | 504,416 | |
Veeva Systems, Inc. Class A (a) | 8,500 | 1,447,210 | |
1,951,626 | |||
Life Sciences Tools & Services - 6.8% | |||
Charles River Laboratories International, Inc. (a) | 10,085 | 2,360,697 | |
Mettler-Toledo International, Inc. (a) | 2,752 | 3,539,402 | |
Waters Corp. (a) | 963 | 315,816 | |
West Pharmaceutical Services, Inc. | 8,666 | 2,689,753 | |
8,905,668 | |||
TOTAL HEALTH CARE | 21,924,300 | ||
INDUSTRIALS - 15.1% | |||
Aerospace & Defense - 1.1% | |||
TransDigm Group, Inc. (a) | 2,348 | 1,421,409 | |
Building Products - 3.2% | |||
Builders FirstSource, Inc. (a) | 20,400 | 1,327,836 | |
Carlisle Companies, Inc. | 5,600 | 1,424,808 | |
Carrier Global Corp. | 36,285 | 1,426,363 | |
4,179,007 | |||
Commercial Services & Supplies - 3.5% | |||
Cintas Corp. | 5,810 | 2,314,297 | |
Copart, Inc. (a) | 18,563 | 2,126,020 | |
Tetra Tech, Inc. | 1,123 | 151,571 | |
4,591,888 | |||
Construction & Engineering - 0.9% | |||
Quanta Services, Inc. | 9,369 | 1,114,911 | |
Electrical Equipment - 2.0% | |||
AMETEK, Inc. | 7,858 | 954,511 | |
Atkore, Inc. (a) | 10,089 | 1,098,894 | |
Generac Holdings, Inc. (a) | 2,300 | 568,284 | |
2,621,689 | |||
Machinery - 2.0% | |||
Cummins, Inc. | 296 | 61,900 | |
IDEX Corp. | 3,869 | 741,107 | |
Otis Worldwide Corp. | 10,813 | 804,487 | |
Toro Co. | 13,141 | 1,084,001 | |
2,691,495 | |||
Professional Services - 0.6% | |||
Booz Allen Hamilton Holding Corp. Class A | 4,079 | 350,223 | |
CoStar Group, Inc. (a) | 8,148 | 496,539 | |
846,762 | |||
Road & Rail - 1.8% | |||
Old Dominion Freight Lines, Inc. | 9,171 | 2,368,319 | |
TOTAL INDUSTRIALS | 19,835,480 | ||
INFORMATION TECHNOLOGY - 31.2% | |||
Electronic Equipment & Components - 3.1% | |||
Amphenol Corp. Class A | 22,522 | 1,595,909 | |
Keysight Technologies, Inc. (a) | 8,188 | 1,192,173 | |
Zebra Technologies Corp. Class A (a) | 3,600 | 1,217,484 | |
4,005,566 | |||
IT Services - 2.1% | |||
Adyen BV (a)(c) | 7 | 10,841 | |
EPAM Systems, Inc. (a) | 8,255 | 2,794,483 | |
2,805,324 | |||
Semiconductors & Semiconductor Equipment - 8.6% | |||
ASM International NV (Netherlands) | 409 | 127,048 | |
Broadcom, Inc. | 611 | 354,459 | |
Entegris, Inc. | 28,235 | 3,132,956 | |
KLA Corp. | 6,114 | 2,230,693 | |
Lam Research Corp. | 714 | 371,301 | |
Marvell Technology, Inc. | 7,419 | 438,834 | |
Monolithic Power Systems, Inc. | 200 | 90,078 | |
NXP Semiconductors NV | 2,900 | 550,304 | |
onsemi (a) | 44,900 | 2,724,532 | |
SolarEdge Technologies, Inc. (a) | 4,680 | 1,276,657 | |
11,296,862 | |||
Software - 17.4% | |||
Adobe, Inc. (a) | 715 | 297,783 | |
ANSYS, Inc. (a) | 5,602 | 1,458,537 | |
Atlassian Corp. PLC (a) | 2,041 | 361,910 | |
Cadence Design Systems, Inc. (a) | 27,300 | 4,196,828 | |
Citrix Systems, Inc. | 8,800 | 886,072 | |
Datadog, Inc. Class A (a) | 12,800 | 1,220,992 | |
Fortinet, Inc. (a) | 13,144 | 3,866,176 | |
HubSpot, Inc. (a) | 2,700 | 911,763 | |
Intuit, Inc. | 913 | 378,402 | |
Palo Alto Networks, Inc. (a) | 2,700 | 1,357,506 | |
Paycom Software, Inc. (a) | 5,300 | 1,507,002 | |
Qualtrics International, Inc. (a) | 28,420 | 403,564 | |
Roper Technologies, Inc. | 919 | 406,602 | |
Synopsys, Inc. (a) | 10,394 | 3,317,765 | |
The Trade Desk, Inc. (a) | 44,000 | 2,290,200 | |
22,861,102 | |||
TOTAL INFORMATION TECHNOLOGY | 40,968,854 | ||
MATERIALS - 3.0% | |||
Chemicals - 1.0% | |||
LyondellBasell Industries NV Class A | 9,500 | 1,085,375 | |
Sherwin-Williams Co. | 1,123 | 301,009 | |
1,386,384 | |||
Metals & Mining - 1.4% | |||
Steel Dynamics, Inc. | 21,085 | 1,800,237 | |
Paper & Forest Products - 0.6% | |||
Louisiana-Pacific Corp. | 11,860 | 819,052 | |
TOTAL MATERIALS | 4,005,673 | ||
REAL ESTATE - 0.3% | |||
Equity Real Estate Investment Trusts (REITs) - 0.3% | |||
SBA Communications Corp. Class A | 1,018 | 342,669 | |
TOTAL COMMON STOCKS (Cost $90,466,542) | 126,884,006 | ||
Money Market Funds - 3.7% | |||
Shares | Value ($) | ||
Fidelity Cash Central Fund 0.82% (d) | 4,345,155 | 4,346,024 | |
Fidelity Securities Lending Cash Central Fund 0.82% (d)(e) | 521,948 | 522,000 | |
TOTAL MONEY MARKET FUNDS (Cost $4,868,024) | 4,868,024 | ||
TOTAL INVESTMENT IN SECURITIES - 100.2% (Cost $95,334,566) | 131,752,030 |
NET OTHER ASSETS (LIABILITIES) - (0.2)% | (224,883) |
NET ASSETS - 100.0% | 131,527,147 |
(a) | Non-income producing |
(b) | Security or a portion of the security is on loan at period end. |
(c) | Security exempt from registration under Rule 144A of the Securities Act of 1933. These securities may be resold in transactions exempt from registration, normally to qualified institutional buyers. At the end of the period, the value of these securities amounted to $10,841 or 0.0% of net assets. |
(d) | Affiliated fund that is generally available only to investment companies and other accounts managed by Fidelity Investments. The rate quoted is the annualized seven-day yield of the fund at period end. A complete unaudited listing of the fund's holdings as of its most recent quarter end is available upon request. In addition, each Fidelity Central Fund's financial statements are available on the SEC's website or upon request. |
(e) | Investment made with cash collateral received from securities on loan. |
Affiliate | Value, beginning of period ($) | Purchases ($) | Sales Proceeds ($) | Dividend Income ($) | Realized Gain (loss) ($) | Change in Unrealized appreciation (depreciation) ($) | Value, end of period ($) | %ownership, end of period |
Fidelity Cash Central Fund 0.82% | 2,812,135 | 39,903,773 | 38,369,884 | 4,138 | - | - | 4,346,024 | 0.0% |
Fidelity Securities Lending Cash Central Fund 0.82% | - | 6,443,628 | 5,921,628 | 176 | - | - | 522,000 | 0.0% |
Total | 2,812,135 | 46,347,401 | 44,291,512 | 4,314 | - | - | 4,868,024 |
Valuation Inputs at Reporting Date: | ||||
Description | Total ($) | Level 1 ($) | Level 2 ($) | Level 3 ($) |
Investments in Securities: | ||||
Equities: | ||||
Consumer Discretionary | 20,706,525 | 20,706,525 | - | - |
Consumer Staples | 3,199,755 | 3,199,755 | - | - |
Energy | 4,626,844 | 4,626,844 | - | - |
Financials | 11,273,906 | 11,273,906 | - | - |
Health Care | 21,924,300 | 21,924,300 | - | - |
Industrials | 19,835,480 | 19,835,480 | - | - |
Information Technology | 40,968,854 | 40,958,013 | 10,841 | - |
Materials | 4,005,673 | 4,005,673 | - | - |
Real Estate | 342,669 | 342,669 | - | - |
Money Market Funds | 4,868,024 | 4,868,024 | - | - |
Total Investments in Securities: | 131,752,030 | 131,741,189 | 10,841 | - |
Statement of Assets and Liabilities | ||||
May 31, 2022 (Unaudited) | ||||
Assets | ||||
Investment in securities, at value (including securities loaned of $503,856) - See accompanying schedule: | $126,884,006 | |||
Unaffiliated issuers (cost $90,466,542) | ||||
Fidelity Central Funds (cost $4,868,024) | 4,868,024 | |||
Total Investment in Securities (cost $95,334,566) | $ | 131,752,030 | ||
Receivable for investments sold | 749,373 | |||
Receivable for fund shares sold | 92,568 | |||
Dividends receivable | 63,538 | |||
Distributions receivable from Fidelity Central Funds | 2,101 | |||
Other receivables | 1,065 | |||
Total assets | 132,660,675 | |||
Liabilities | ||||
Payable for investments purchased | $382,392 | |||
Payable for fund shares redeemed | 181,185 | |||
Accrued management fee | 47,951 | |||
Collateral on securities loaned | 522,000 | |||
Total Liabilities | 1,133,528 | |||
Net Assets | $ | 131,527,147 | ||
Net Assets consist of: | ||||
Paid in capital | $ | 100,546,675 | ||
Total accumulated earnings (loss) | 30,980,472 | |||
Net Assets | $ | 131,527,147 | ||
Net Asset Value , offering price and redemption price per share ($131,527,147 ÷ 10,404,495 shares) | $ | 12.64 | ||
Statement of Operations | ||||
Six months ended May 31, 2022 (Unaudited) | ||||
Investment Income | ||||
Dividends | $ | 356,828 | ||
Income from Fidelity Central Funds (including $176 from security lending) | 4,314 | |||
Total Income | 361,142 | |||
Expenses | ||||
Management fee | $ | 325,502 | ||
Independent trustees' fees and expenses | 258 | |||
Total expenses before reductions | 325,760 | |||
Expense reductions | (2) | |||
Total expenses after reductions | 325,758 | |||
Net Investment income (loss) | 35,384 | |||
Realized and Unrealized Gain (Loss) | ||||
Net realized gain (loss) on: | ||||
Investment Securities: | ||||
Unaffiliated issuers | (5,447,059) | |||
Foreign currency transactions | 2 | |||
Total net realized gain (loss) | (5,447,057) | |||
Change in net unrealized appreciation (depreciation) on: | ||||
Investment Securities: | ||||
Unaffiliated issuers | (33,887,825) | |||
Assets and liabilities in foreign currencies | (78) | |||
Total change in net unrealized appreciation (depreciation) | (33,887,903) | |||
Net gain (loss) | (39,334,960) | |||
Net increase (decrease) in net assets resulting from operations | $ | (39,299,576) |
Statement of Changes in Net Assets | ||||
Six months ended May 31, 2022 (Unaudited) | Year ended November 30, 2021 | |||
Increase (Decrease) in Net Assets | ||||
Operations | ||||
Net investment income (loss) | $ | 35,384 | $ | (84,269) |
Net realized gain (loss) | (5,447,057) | 34,883,614 | ||
Change in net unrealized appreciation (depreciation) | (33,887,903) | 1,007,412 | ||
Net increase (decrease) in net assets resulting from operations | (39,299,576) | 35,806,757 | ||
Distributions to shareholders | (34,673,946) | (4,603,993) | ||
Share transactions | ||||
Proceeds from sales of shares | 26,630,189 | 23,657,289 | ||
Reinvestment of distributions | 34,673,946 | 4,603,993 | ||
Cost of shares redeemed | (13,171,376) | (84,288,088) | ||
Net increase (decrease) in net assets resulting from share transactions | 48,132,759 | (56,026,806) | ||
Total increase (decrease) in net assets | (25,840,763) | (24,824,042) | ||
Net Assets | ||||
Beginning of period | 157,367,910 | 182,191,952 | ||
End of period | $ | 131,527,147 | $ | 157,367,910 |
Other Information | ||||
Shares | ||||
Sold | 1,697,870 | 1,254,833 | ||
Issued in reinvestment of distributions | 2,051,713 | 265,973 | ||
Redeemed | (876,153) | (4,670,567) | ||
Net increase (decrease) | 2,873,430 | (3,149,761) | ||
Fidelity® Growth Strategies K6 Fund |
Six months ended (Unaudited) May 31, 2022 | Years ended November 30, 2021 | 2020 | 2019 | 2018 | 2017 A | |||||||
Selected Per-Share Data | ||||||||||||
Net asset value, beginning of period | $ | 20.90 | $ | 17.06 | $ | 13.69 | $ | 11.21 | $ | 10.95 | $ | 10.00 |
Income from Investment Operations | ||||||||||||
Net investment income (loss) B,C | - D | (.01) | .04 E | .06 F | .09 G | .04 | ||||||
Net realized and unrealized gain (loss) | (3.86) | 4.29 | 3.40 | 2.51 | .20 | .91 | ||||||
Total from investment operations | (3.86) | 4.28 | 3.44 | 2.57 | .29 | .95 | ||||||
Distributions from net investment income | - | (.02) | (.07) | (.09) | (.03) | - | ||||||
Distributions from net realized gain | (4.40) | (.42) | - | - | - | - | ||||||
Total distributions | (4.40) | (.44) | (.07) | (.09) | (.03) | - | ||||||
Net asset value, end of period | $ | 12.64 | $ | 20.90 | $ | 17.06 | $ | 13.69 | $ | 11.21 | $ | 10.95 |
Total Return H,I | (23.77)% | 25.64% | 25.24% | 23.18% | 2.68% | 9.50% | ||||||
Ratios to Average Net Assets C,J,K | ||||||||||||
Expenses before reductions | .45% L | .45% | .45% | .45% | .45% | .45% L | ||||||
Expenses net of fee waivers, if any | .45% L | .45% | .45% | .45% | .45% | .45% L | ||||||
Expenses net of all reductions | .45% L | .45% | .45% | .45% | .45% | .45% L | ||||||
Net investment income (loss) | .05% L | (.06)% | .25% E | .49% F | .76% G | .81% L | ||||||
Supplemental Data | ||||||||||||
Net assets, end of period (000 omitted) | $ | 131,527 | $ | 157,368 | $ | 182,192 | $ | 165,691 | $ | 132,993 | $ | 80,512 |
Portfolio turnover rate M | 65% L,N | 51% | 73% | 66% N | 51% N | 56% L,N |
Fidelity Central Fund | Investment Manager | Investment Objective | Investment Practices | Expense Ratio A |
Fidelity Money Market Central Funds | Fidelity Management & Research Company LLC (FMR) | Each fund seeks to obtain a high level of current income consistent with the preservation of capital and liquidity. | Short-term Investments | Less than .005% |
Gross unrealized appreciation | $41,493,078 |
Gross unrealized depreciation | (5,092,459) |
Net unrealized appreciation (depreciation) | $36,400,619 |
Tax cost | $95,351,411 |
Purchases ($) | Sales ($) | |
Fidelity Growth Strategies K6 Fund | 54,564,010 | 46,100,596 |
Shares | Total Proceeds ($) | |
Fidelity Growth Strategies K6 Fund | 194,488 | 2,722,836 |
Amount | |
Fidelity Growth Strategies K6 Fund | $613 |
Purchases ($) | Sales ($) | Realized Gain (Loss) ($) | |
Fidelity Growth Strategies K6 Fund | 1,694,301 | 801,784 | (96,734) |
Total Security Lending Fees Paid to NFS | Security Lending Income From Securities Loaned to NFS | Value of Securities Loaned to NFS at Period End | |
Fidelity Growth Strategies K6 Fund | $18 | $- | $- |
The Example is based on an investment of $1,000 invested at the beginning of the period and held for the entire period (December 1, 2021 to May 31, 2022). |
Annualized Expense Ratio- A | Beginning Account Value December 1, 2021 | Ending Account Value May 31, 2022 | Expenses Paid During Period- C December 1, 2021 to May 31, 2022 | |||||||
Fidelity® Growth Strategies K6 Fund | .45% | |||||||||
Actual | $ 1,000 | $ 762.30 | $ 1.98 | |||||||
Hypothetical- B | $ 1,000 | $ 1,022.69 | $ 2.27 | |||||||
- Highly liquid investments - cash or convertible to cash within three business days or less
- Moderately liquid investments - convertible to cash in three to seven calendar days
- Less liquid investments - can be sold or disposed of, but not settled, within seven calendar days
- Illiquid investments - cannot be sold or disposed of within seven calendar days
Contents
Board Approval of Investment Advisory Contracts and Management Fees |
Top Holdings (% of Fund's net assets) | ||
Cadence Design Systems, Inc. | 3.2 | |
Fortinet, Inc. | 3.0 | |
Mettler-Toledo International, Inc. | 2.8 | |
ResMed, Inc. | 2.6 | |
Synopsys, Inc. | 2.5 | |
Entegris, Inc. | 2.5 | |
MSCI, Inc. | 2.3 | |
EPAM Systems, Inc. | 2.1 | |
West Pharmaceutical Services, Inc. | 2.1 | |
onsemi | 2.1 | |
25.2 | ||
Market Sectors (% of Fund's net assets) | ||
Information Technology | 31.3 | |
Health Care | 16.8 | |
Consumer Discretionary | 15.4 | |
Industrials | 15.3 | |
Financials | 8.6 | |
Energy | 3.5 | |
Materials | 3.1 | |
Consumer Staples | 2.5 | |
Real Estate | 0.2 | |
Asset Allocation (% of Fund's net assets) |
Foreign investments - 3.5% |
Common Stocks - 96.7% | |||
Shares | Value ($) (000s) | ||
CONSUMER DISCRETIONARY - 15.4% | |||
Distributors - 1.7% | |||
LKQ Corp. | 71,573 | 3,678 | |
Pool Corp. (a) | 105,000 | 41,855 | |
45,533 | |||
Hotels, Restaurants & Leisure - 6.6% | |||
Chipotle Mexican Grill, Inc. (b) | 18,800 | 26,368 | |
Churchill Downs, Inc. | 139,073 | 28,153 | |
Domino's Pizza, Inc. | 49,455 | 17,961 | |
Expedia, Inc. (b) | 295,000 | 38,152 | |
Hilton Worldwide Holdings, Inc. | 305,800 | 43,075 | |
Wyndham Hotels & Resorts, Inc. | 248,000 | 19,872 | |
173,581 | |||
Household Durables - 1.3% | |||
NVR, Inc. (b) | 1,648 | 7,335 | |
Tempur Sealy International, Inc. | 1,041,519 | 27,465 | |
34,800 | |||
Internet & Direct Marketing Retail - 0.3% | |||
eBay, Inc. | 183,000 | 8,907 | |
Multiline Retail - 0.6% | |||
Dollar General Corp. | 64,941 | 14,309 | |
Specialty Retail - 4.8% | |||
AutoZone, Inc. (b) | 23,500 | 48,402 | |
Five Below, Inc. (b) | 70,000 | 9,141 | |
O'Reilly Automotive, Inc. (b) | 52,000 | 33,133 | |
Tractor Supply Co. | 171,034 | 32,045 | |
Williams-Sonoma, Inc. | 28,974 | 3,706 | |
126,427 | |||
Textiles, Apparel & Luxury Goods - 0.1% | |||
Deckers Outdoor Corp. (b) | 4,891 | 1,314 | |
TOTAL CONSUMER DISCRETIONARY | 404,871 | ||
CONSUMER STAPLES - 2.5% | |||
Beverages - 0.6% | |||
Brown-Forman Corp. Class B (non-vtg.) | 214,803 | 14,203 | |
Food Products - 1.7% | |||
Bunge Ltd. (a) | 160,853 | 19,032 | |
Darling Ingredients, Inc. (b) | 329,298 | 26,367 | |
45,399 | |||
Personal Products - 0.2% | |||
Estee Lauder Companies, Inc. Class A | 21,680 | 5,521 | |
TOTAL CONSUMER STAPLES | 65,123 | ||
ENERGY - 3.5% | |||
Energy Equipment & Services - 1.0% | |||
Halliburton Co. | 627,000 | 25,394 | |
Oil, Gas & Consumable Fuels - 2.5% | |||
Coterra Energy, Inc. | 135,500 | 4,652 | |
Occidental Petroleum Corp. (a) | 344,300 | 23,863 | |
PDC Energy, Inc. | 476,127 | 37,681 | |
66,196 | |||
TOTAL ENERGY | 91,590 | ||
FINANCIALS - 8.6% | |||
Capital Markets - 6.9% | |||
Ameriprise Financial, Inc. | 120,700 | 33,346 | |
LPL Financial | 75,930 | 14,897 | |
MarketAxess Holdings, Inc. | 66,000 | 18,591 | |
Moody's Corp. | 27,375 | 8,255 | |
MSCI, Inc. | 140,000 | 61,929 | |
Nordnet AB | 415,619 | 6,758 | |
Raymond James Financial, Inc. | 262,900 | 25,893 | |
S&P Global, Inc. | 27,175 | 9,497 | |
Tradeweb Markets, Inc. Class A | 38,864 | 2,628 | |
181,794 | |||
Consumer Finance - 0.9% | |||
Discover Financial Services | 204,097 | 23,163 | |
Insurance - 0.8% | |||
Arthur J. Gallagher & Co. | 137,700 | 22,299 | |
TOTAL FINANCIALS | 227,256 | ||
HEALTH CARE - 16.8% | |||
Biotechnology - 0.9% | |||
Horizon Therapeutics PLC (b) | 267,755 | 24,015 | |
Health Care Equipment & Supplies - 4.8% | |||
DexCom, Inc. (b) | 134,108 | 39,956 | |
Edwards Lifesciences Corp. (b) | 82,924 | 8,363 | |
Intuitive Surgical, Inc. (b) | 17,984 | 4,094 | |
Masimo Corp. (b) | 40,000 | 5,617 | |
ResMed, Inc. | 329,698 | 67,080 | |
125,110 | |||
Health Care Providers & Services - 2.7% | |||
Laboratory Corp. of America Holdings | 64,940 | 16,022 | |
McKesson Corp. | 87,100 | 28,629 | |
Tenet Healthcare Corp. (b) | 429,000 | 27,761 | |
72,412 | |||
Health Care Technology - 1.5% | |||
Doximity, Inc. (a) | 282,236 | 9,875 | |
Veeva Systems, Inc. Class A (b) | 168,000 | 28,604 | |
38,479 | |||
Life Sciences Tools & Services - 6.9% | |||
Charles River Laboratories International, Inc. (b) | 201,615 | 47,194 | |
Mettler-Toledo International, Inc. (b) | 56,948 | 73,242 | |
Waters Corp. (b) | 19,182 | 6,291 | |
West Pharmaceutical Services, Inc. | 176,000 | 54,627 | |
181,354 | |||
TOTAL HEALTH CARE | 441,370 | ||
INDUSTRIALS - 15.3% | |||
Aerospace & Defense - 1.1% | |||
TransDigm Group, Inc. (b) | 47,000 | 28,452 | |
Building Products - 3.1% | |||
Builders FirstSource, Inc. (b) | 397,600 | 25,880 | |
Carlisle Companies, Inc. | 108,900 | 27,707 | |
Carrier Global Corp. | 720,000 | 28,303 | |
81,890 | |||
Commercial Services & Supplies - 3.7% | |||
Cintas Corp. | 119,890 | 47,756 | |
Copart, Inc. (b) | 396,261 | 45,384 | |
Tetra Tech, Inc. | 24,977 | 3,371 | |
96,511 | |||
Construction & Engineering - 0.9% | |||
Quanta Services, Inc. | 189,826 | 22,589 | |
Electrical Equipment - 2.1% | |||
AMETEK, Inc. | 172,042 | 20,898 | |
Atkore, Inc. (b) | 206,271 | 22,467 | |
Generac Holdings, Inc. (b) | 45,900 | 11,341 | |
54,706 | |||
Machinery - 2.0% | |||
Cummins, Inc. | 4,666 | 976 | |
IDEX Corp. | 74,931 | 14,353 | |
Otis Worldwide Corp. | 212,787 | 15,831 | |
Toro Co. | 263,259 | 21,716 | |
52,876 | |||
Professional Services - 0.6% | |||
Booz Allen Hamilton Holding Corp. Class A | 85,921 | 7,377 | |
CoStar Group, Inc. (b) | 161,647 | 9,851 | |
17,228 | |||
Road & Rail - 1.8% | |||
Old Dominion Freight Lines, Inc. | 183,000 | 47,258 | |
TOTAL INDUSTRIALS | 401,510 | ||
INFORMATION TECHNOLOGY - 31.3% | |||
Electronic Equipment & Components - 3.1% | |||
Amphenol Corp. Class A | 460,778 | 32,651 | |
Keysight Technologies, Inc. (b) | 165,000 | 24,024 | |
Zebra Technologies Corp. Class A (b) | 72,000 | 24,350 | |
81,025 | |||
IT Services - 2.2% | |||
Adyen BV (b)(c) | 1,393 | 2,157 | |
EPAM Systems, Inc. (b) | 165,000 | 55,856 | |
58,013 | |||
Semiconductors & Semiconductor Equipment - 8.6% | |||
ASM International NV (Netherlands) | 9,297 | 2,888 | |
Broadcom, Inc. | 12,089 | 7,013 | |
Entegris, Inc. | 583,465 | 64,741 | |
KLA Corp. | 123,886 | 45,200 | |
Lam Research Corp. | 15,586 | 8,105 | |
Marvell Technology, Inc. | 129,881 | 7,682 | |
Monolithic Power Systems, Inc. | 1,700 | 766 | |
NXP Semiconductors NV | 58,100 | 11,025 | |
onsemi (b) | 891,200 | 54,078 | |
SolarEdge Technologies, Inc. (b) | 90,000 | 24,551 | |
226,049 | |||
Software - 17.4% | |||
Adobe, Inc. (b) | 15,000 | 6,247 | |
ANSYS, Inc. (b) | 110,953 | 28,888 | |
Atlassian Corp. PLC (b) | 44,659 | 7,919 | |
Cadence Design Systems, Inc. (b) | 546,000 | 83,933 | |
Citrix Systems, Inc. | 160,500 | 16,161 | |
Datadog, Inc. Class A (b) | 253,200 | 24,153 | |
Fortinet, Inc. (b) | 266,556 | 78,405 | |
HubSpot, Inc. (b) | 53,000 | 17,898 | |
Intuit, Inc. | 19,982 | 8,282 | |
Palo Alto Networks, Inc. (b) | 54,000 | 27,150 | |
Paycom Software, Inc. (b) | 105,600 | 30,026 | |
Qualtrics International, Inc. (b) | 575,609 | 8,174 | |
Roper Technologies, Inc. | 19,682 | 8,708 | |
Synopsys, Inc. (b) | 208,200 | 66,457 | |
The Trade Desk, Inc. (b) | 881,572 | 45,886 | |
458,287 | |||
TOTAL INFORMATION TECHNOLOGY | 823,374 | ||
MATERIALS - 3.1% | |||
Chemicals - 1.1% | |||
LyondellBasell Industries NV Class A | 189,826 | 21,688 | |
Sherwin-Williams Co. | 25,477 | 6,829 | |
28,517 | |||
Metals & Mining - 1.4% | |||
Steel Dynamics, Inc. | 420,430 | 35,896 | |
Paper & Forest Products - 0.6% | |||
Louisiana-Pacific Corp. (a) | 228,145 | 15,756 | |
TOTAL MATERIALS | 80,169 | ||
REAL ESTATE - 0.2% | |||
Equity Real Estate Investment Trusts (REITs) - 0.2% | |||
SBA Communications Corp. Class A | 19,482 | 6,558 | |
TOTAL COMMON STOCKS (Cost $1,655,567) | 2,541,821 | ||
Money Market Funds - 5.5% | |||
Shares | Value ($) (000s) | ||
Fidelity Cash Central Fund 0.82% (d) | 82,378,207 | 82,395 | |
Fidelity Securities Lending Cash Central Fund 0.82% (d)(e) | 61,003,287 | 61,009 | |
TOTAL MONEY MARKET FUNDS (Cost $143,402) | 143,404 | ||
TOTAL INVESTMENT IN SECURITIES - 102.2% (Cost $1,798,969) | 2,685,225 |
NET OTHER ASSETS (LIABILITIES) - (2.2)% | (56,976) |
NET ASSETS - 100.0% | 2,628,249 |
(a) | Security or a portion of the security is on loan at period end. |
(b) | Non-income producing |
(c) | Security exempt from registration under Rule 144A of the Securities Act of 1933. These securities may be resold in transactions exempt from registration, normally to qualified institutional buyers. At the end of the period, the value of these securities amounted to $2,157,000 or 0.1% of net assets. |
(d) | Affiliated fund that is generally available only to investment companies and other accounts managed by Fidelity Investments. The rate quoted is the annualized seven-day yield of the fund at period end. A complete unaudited listing of the fund's holdings as of its most recent quarter end is available upon request. In addition, each Fidelity Central Fund's financial statements are available on the SEC's website or upon request. |
(e) | Investment made with cash collateral received from securities on loan. |
Affiliate (Amounts in thousands) | Value, beginning of period ($) | Purchases ($) | Sales Proceeds ($) | Dividend Income ($) | Realized Gain (loss) ($) | Change in Unrealized appreciation (depreciation) ($) | Value, end of period ($) | %ownership, end of period |
Fidelity Cash Central Fund 0.82% | 59,492 | 633,233 | 610,330 | 70 | - | - | 82,395 | 0.2% |
Fidelity Securities Lending Cash Central Fund 0.82% | 14,439 | 521,879 | 475,309 | 12 | - | - | 61,009 | 0.2% |
Total | 73,931 | 1,155,112 | 1,085,639 | 82 | - | - | 143,404 |
Valuation Inputs at Reporting Date: | ||||
Description (Amounts in thousands) | Total ($) | Level 1 ($) | Level 2 ($) | Level 3 ($) |
Investments in Securities: | ||||
Equities: | ||||
Consumer Discretionary | 404,871 | 404,871 | - | - |
Consumer Staples | 65,123 | 65,123 | - | - |
Energy | 91,590 | 91,590 | - | - |
Financials | 227,256 | 227,256 | - | - |
Health Care | 441,370 | 441,370 | - | - |
Industrials | 401,510 | 401,510 | - | - |
Information Technology | 823,374 | 821,217 | 2,157 | - |
Materials | 80,169 | 80,169 | - | - |
Real Estate | 6,558 | 6,558 | - | - |
Money Market Funds | 143,404 | 143,404 | - | - |
Total Investments in Securities: | 2,685,225 | 2,683,068 | 2,157 | - |
Statement of Assets and Liabilities | ||||
Amounts in thousands (except per-share amounts) | May 31, 2022 (Unaudited) | |||
Assets | ||||
Investment in securities, at value (including securities loaned of $58,645) - See accompanying schedule: | $2,541,821 | |||
Unaffiliated issuers (cost $1,655,567) | ||||
Fidelity Central Funds (cost $143,402) | 143,404 | |||
Total Investment in Securities (cost $1,798,969) | $ | 2,685,225 | ||
Receivable for investments sold | 12,391 | |||
Receivable for fund shares sold | 772 | |||
Dividends receivable | 1,279 | |||
Distributions receivable from Fidelity Central Funds | 40 | |||
Prepaid expenses | 1 | |||
Other receivables | 37 | |||
Total assets | 2,699,745 | |||
Liabilities | ||||
Payable for investments purchased | $7,424 | |||
Payable for fund shares redeemed | 1,135 | |||
Accrued management fee | 1,461 | |||
Other affiliated payables | 421 | |||
Other payables and accrued expenses | 47 | |||
Collateral on securities loaned | 61,008 | |||
Total Liabilities | 71,496 | |||
Net Assets | $ | 2,628,249 | ||
Net Assets consist of: | ||||
Paid in capital | $ | 1,824,853 | ||
Total accumulated earnings (loss) | 803,396 | |||
Net Assets | $ | 2,628,249 | ||
Net Asset Value and Maximum Offering Price | ||||
Growth Strategies : | ||||
Net Asset Value , offering price and redemption price per share ($2,446,208 ÷ 51,579 shares) | $ | 47.43 | ||
Class K : | ||||
Net Asset Value , offering price and redemption price per share ($182,041 ÷ 3,793 shares) (a) | $ | 48.00 | ||
(a)Corresponding Net Asset Value does not calculate due to rounding of fractional net assets and/or shares |
Statement of Operations | ||||
Amounts in thousands | Six months ended May 31, 2022 (Unaudited) | |||
Investment Income | ||||
Dividends | $ | 7,539 | ||
Income from Fidelity Central Funds (including $12 from security lending) | 82 | |||
Total Income | 7,621 | |||
Expenses | ||||
Management fee | ||||
Basic fee | $ | 8,031 | ||
Performance adjustment | 1,944 | |||
Transfer agent fees | 2,218 | |||
Accounting fees | 448 | |||
Custodian fees and expenses | 16 | |||
Independent trustees' fees and expenses | 6 | |||
Registration fees | 46 | |||
Audit | 29 | |||
Legal | 2 | |||
Miscellaneous | 5 | |||
Total expenses before reductions | 12,745 | |||
Expense reductions | (49) | |||
Total expenses after reductions | 12,696 | |||
Net Investment income (loss) | (5,075) | |||
Realized and Unrealized Gain (Loss) | ||||
Net realized gain (loss) on: | ||||
Investment Securities: | ||||
Unaffiliated issuers | (69,588) | |||
Foreign currency transactions | (1) | |||
Total net realized gain (loss) | (69,589) | |||
Change in net unrealized appreciation (depreciation) on: | ||||
Investment Securities: | ||||
Unaffiliated issuers | (778,413) | |||
Assets and liabilities in foreign currencies | (2) | |||
Total change in net unrealized appreciation (depreciation) | (778,415) | |||
Net gain (loss) | (848,004) | |||
Net increase (decrease) in net assets resulting from operations | $ | (853,079) |
Statement of Changes in Net Assets | ||||
Amounts in thousands | Six months ended May 31, 2022 (Unaudited) | Year ended November 30, 2021 | ||
Increase (Decrease) in Net Assets | ||||
Operations | ||||
Net investment income (loss) | $ | (5,075) | $ | (7,595) |
Net realized gain (loss) | (69,589) | 458,725 | ||
Change in net unrealized appreciation (depreciation) | (778,415) | 305,051 | ||
Net increase (decrease) in net assets resulting from operations | (853,079) | 756,181 | ||
Distributions to shareholders | (458,304) | (254,989) | ||
Share transactions - net increase (decrease) | 307,372 | (115,670) | ||
Total increase (decrease) in net assets | (1,004,011) | 385,522 | ||
Net Assets | ||||
Beginning of period | 3,632,260 | 3,246,738 | ||
End of period | $ | 2,628,249 | $ | 3,632,260 |
Fidelity® Growth Strategies Fund |
Six months ended (Unaudited) May 31, 2022 | Years ended November 30, 2021 | 2020 | 2019 | 2018 | 2017 | |||||||
Selected Per-Share Data | ||||||||||||
Net asset value, beginning of period | $ | 71.14 | $ | 61.57 | $ | 50.98 | $ | 41.90 | $ | 40.96 | $ | 33.87 |
Income from Investment Operations | ||||||||||||
Net investment income (loss) A,B | (.09) | (.15) | .04 C | .30 | .25 D | .16 E | ||||||
Net realized and unrealized gain (loss) | (14.63) | 14.72 | 12.31 | 9.13 | .87 | 7.13 | ||||||
Total from investment operations | (14.72) | 14.57 | 12.35 | 9.43 | 1.12 | 7.29 | ||||||
Distributions from net investment income | - | - | (.22) | (.28) | (.16) | (.18) | ||||||
Distributions from net realized gain | (8.99) | (5.00) | (1.55) | (.06) | (.02) | (.02) | ||||||
Total distributions | (8.99) | (5.00) | (1.76) F | (.35) F | (.18) | (.20) | ||||||
Redemption fees added to paid in capital A | - | - | - | - | - | - G | ||||||
Net asset value, end of period | $ | 47.43 | $ | 71.14 | $ | 61.57 | $ | 50.98 | $ | 41.90 | $ | 40.96 |
Total Return H,I | (23.90)% | 25.31% | 25.02% | 22.76% | 2.74% | 21.63% | ||||||
Ratios to Average Net Assets B,J,K | ||||||||||||
Expenses before reductions | .84% L | .63% | .63% | .56% | .59% | .78% | ||||||
Expenses net of fee waivers, if any | .84% L | .63% | .63% | .56% | .59% | .78% | ||||||
Expenses net of all reductions | .84% L | .63% | .63% | .55% | .59% | .78% | ||||||
Net investment income (loss) | (.34)% L | (.23)% | .07% C | .67% | .59% D | .43% E | ||||||
Supplemental Data | ||||||||||||
Net assets, end of period (in millions) | $ | 2,446 | $ | 3,381 | $ | 3,011 | $ | 2,860 | $ | 2,349 | $ | 2,455 |
Portfolio turnover rate M | 60% L,N | 49% | 67% | 66% N | 43% N | 73% N |
Fidelity® Growth Strategies Fund Class K |
Six months ended (Unaudited) May 31, 2022 | Years ended November 30, 2021 | 2020 | 2019 | 2018 | 2017 | |||||||
Selected Per-Share Data | ||||||||||||
Net asset value, beginning of period | $ | 71.85 | $ | 62.08 | $ | 51.38 | $ | 42.23 | $ | 41.29 | $ | 34.14 |
Income from Investment Operations | ||||||||||||
Net investment income (loss) A,B | (.06) | (.08) | .10 C | .36 | .31 D | .21 E | ||||||
Net realized and unrealized gain (loss) | (14.80) | 14.85 | 12.42 | 9.20 | .86 | 7.19 | ||||||
Total from investment operations | (14.86) | 14.77 | 12.52 | 9.56 | 1.17 | 7.40 | ||||||
Distributions from net investment income | - | - | (.27) | (.34) | (.21) | (.23) | ||||||
Distributions from net realized gain | (8.99) | (5.00) | (1.55) | (.06) | (.02) | (.02) | ||||||
Total distributions | (8.99) | (5.00) | (1.82) | (.41) F | (.23) | (.25) | ||||||
Redemption fees added to paid in capital A | - | - | - | - | - | - G | ||||||
Net asset value, end of period | $ | 48.00 | $ | 71.85 | $ | 62.08 | $ | 51.38 | $ | 42.23 | $ | 41.29 |
Total Return H,I | (23.85)% | 25.44% | 25.17% | 22.94% | 2.84% | 21.81% | ||||||
Ratios to Average Net Assets B,J,K | ||||||||||||
Expenses before reductions | .73% L | .52% | .52% | .43% | .46% | .63% | ||||||
Expenses net of fee waivers, if any | .72% L | .52% | .52% | .43% | .46% | .63% | ||||||
Expenses net of all reductions | .72% L | .52% | .51% | .43% | .46% | .63% | ||||||
Net investment income (loss) | (.23)% L | (.13)% | .19% C | .79% | .72% D | .57% E | ||||||
Supplemental Data | ||||||||||||
Net assets, end of period (in millions) | $ | 182 | $ | 251 | $ | 236 | $ | 236 | $ | 205 | $ | 272 |
Portfolio turnover rate M | 60% L,N | 49% | 67% | 66% N | 43% N | 73% N |
Fidelity Central Fund | Investment Manager | Investment Objective | Investment Practices | Expense Ratio A |
Fidelity Money Market Central Funds | Fidelity Management & Research Company LLC (FMR) | Each fund seeks to obtain a high level of current income consistent with the preservation of capital and liquidity. | Short-term Investments | Less than .005% |
Fidelity Growth Strategies Fund | $15 |
Gross unrealized appreciation | $960,211 |
Gross unrealized depreciation | (74,015) |
Net unrealized appreciation (depreciation) | $886,196 |
Tax cost | $1,799,029 |
Purchases ($) | Sales ($) | |
Fidelity Growth Strategies Fund | 919,652 | 1,075,818 |
Shares | Total net realized gain or loss ($) | Total Proceeds ($) | Participating classes | |
Fidelity Growth Strategies Fund | 343 | 14,540 | 23,513 | Growth Strategies, Class K |
Amount | % of Class-Level Average Net Assets A | |
Growth Strategies | $2,176 | .15 |
Class K | 42 | .04 |
$2,218 |
% of Average Net Assets | |
Fidelity Growth Strategies Fund | .03 |
Amount | |
Fidelity Growth Strategies Fund | $13 |
Purchases ($) | Sales ($) | Realized Gain (Loss) ($) | |
Fidelity Growth Strategies Fund | 33,489 | 28,559 | (2,791) |
Amount | |
Fidelity Growth Strategies Fund | $3 |
Total Security Lending Fees Paid to NFS | Security Lending Income From Securities Loaned to NFS | Value of Securities Loaned to NFS at Period End | |
Fidelity Growth Strategies Fund | $1 | $- A | $- |
Six months ended May 31, 2022 | Year ended November 30, 2021 | |
Fidelity Growth Strategies Fund | ||
Distributions to shareholders | ||
Growth Strategies | $426,994 | $236,172 |
Class K | 31,310 | 18,817 |
Total | $458,304 | $254,989 |
Shares | Shares | Dollars | Dollars | |
Six months ended May 31, 2022 | Year ended November 30, 2021 | Six months ended May 31, 2022 | Year ended November 30, 2021 | |
Fidelity Growth Strategies Fund | ||||
Growth Strategies | ||||
Shares sold | 2,433 | 3,959 | $143,737 | $259,220 |
Reinvestment of distributions | 6,391 | 3,814 | 406,035 | 225,526 |
Shares redeemed | (4,769) | (9,146) | (263,891) | (581,726) |
Net increase (decrease) | 4,055 | (1,373) | $285,881 | $(96,980) |
Class K | ||||
Shares sold | 279 | 525 | $16,271 | $34,729 |
Reinvestment of distributions | 487 | 315 | 31,310 | 18,817 |
Shares redeemed | (472) | (1,145) | (26,090) | (72,236) |
Net increase (decrease) | 294 | (305) | $21,491 | $(18,690) |
The Example is based on an investment of $1,000 invested at the beginning of the period and held for the entire period (December 1, 2021 to May 31, 2022). |
Annualized Expense Ratio- A | Beginning Account Value December 1, 2021 | Ending Account Value May 31, 2022 | Expenses Paid During Period- C December 1, 2021 to May 31, 2022 | |||||||
Fidelity® Growth Strategies Fund | ||||||||||
Growth Strategies Fund | .84% | |||||||||
Actual | $ 1,000 | $ 761.00 | $ 3.69 | |||||||
Hypothetical- B | $ 1,000 | $ 1,020.74 | $ 4.23 | |||||||
Class K | .72% | |||||||||
Actual | $ 1,000 | $ 761.50 | $ 3.16 | |||||||
Hypothetical- B | $ 1,000 | $ 1,021.34 | $ 3.63 | |||||||
- Highly liquid investments - cash or convertible to cash within three business days or less
- Moderately liquid investments - convertible to cash in three to seven calendar days
- Less liquid investments - can be sold or disposed of, but not settled, within seven calendar days
- Illiquid investments - cannot be sold or disposed of within seven calendar days
Contents
Board Approval of Investment Advisory Contracts and Management Fees |
Top Holdings (% of Fund's net assets) | ||
Apple, Inc. | 8.9 | |
NVIDIA Corp. | 7.8 | |
Microsoft Corp. | 5.9 | |
Amazon.com, Inc. | 5.3 | |
Alphabet, Inc. Class A | 3.9 | |
lululemon athletica, Inc. | 3.4 | |
Tesla, Inc. | 2.3 | |
Salesforce.com, Inc. | 2.0 | |
Alphabet, Inc. Class C | 1.7 | |
Meta Platforms, Inc. Class A | 1.6 | |
42.8 | ||
Market Sectors (% of Fund's net assets) | ||
Information Technology | 38.4 | |
Consumer Discretionary | 19.8 | |
Health Care | 12.4 | |
Communication Services | 9.0 | |
Industrials | 6.0 | |
Consumer Staples | 5.2 | |
Energy | 3.7 | |
Materials | 2.3 | |
Financials | 1.9 | |
Real Estate | 0.5 | |
Utilities | 0.1 | |
Asset Allocation (% of Fund's net assets) |
Foreign investments - 6% |
Common Stocks - 97.7% | |||
Shares | Value ($) | ||
COMMUNICATION SERVICES - 9.0% | |||
Diversified Telecommunication Services - 0.1% | |||
IHS Holding Ltd. | 72,753 | 851,938 | |
Starry Group Holdings, Inc. (a) | 544,953 | 4,840,545 | |
Starry, Inc. | 793,836 | 6,680,130 | |
Verizon Communications, Inc. | 9,147 | 469,150 | |
12,841,763 | |||
Entertainment - 0.9% | |||
Live Nation Entertainment, Inc. (b) | 52,303 | 4,971,400 | |
Netflix, Inc. (b) | 194,961 | 38,493,100 | |
Roblox Corp. (b)(c) | 297,687 | 8,912,749 | |
Roku, Inc. Class A (b) | 388,748 | 36,892,185 | |
The Walt Disney Co. (b) | 46,768 | 5,165,058 | |
94,434,492 | |||
Interactive Media & Services - 7.4% | |||
Alphabet, Inc.: | |||
Class A (b) | 182,320 | 414,821,757 | |
Class C (b) | 79,353 | 180,986,735 | |
IAC (b) | 13,205 | 1,126,387 | |
Kuaishou Technology Class B (b)(d) | 121,962 | 1,181,200 | |
Match Group, Inc. (b) | 504 | 39,705 | |
Meta Platforms, Inc. Class A (b) | 848,589 | 164,320,774 | |
Snap, Inc. Class A (b) | 393,055 | 5,546,006 | |
Taboola.com Ltd. (b) | 93,092 | 301,618 | |
Twitter, Inc. (b) | 52,000 | 2,059,200 | |
Vimeo, Inc. (b) | 1,270,627 | 11,041,749 | |
781,425,131 | |||
Media - 0.0% | |||
Comcast Corp. Class A | 125,048 | 5,537,125 | |
Wireless Telecommunication Services - 0.6% | |||
T-Mobile U.S., Inc. (b) | 452,229 | 60,277,603 | |
TOTAL COMMUNICATION SERVICES | 954,516,114 | ||
CONSUMER DISCRETIONARY - 19.6% | |||
Automobiles - 2.8% | |||
Rad Power Bikes, Inc. (a)(b)(e) | 171,416 | 949,645 | |
Rivian Automotive, Inc. (d) | 156,725 | 4,921,165 | |
Rivian Automotive, Inc. (c) | 1,310,602 | 41,152,903 | |
Tesla, Inc. (b) | 318,072 | 241,181,275 | |
XPeng, Inc. ADR (b) | 265,523 | 6,239,791 | |
294,444,779 | |||
Hotels, Restaurants & Leisure - 2.1% | |||
Airbnb, Inc. Class A (b) | 30,181 | 3,647,977 | |
Booking Holdings, Inc. (b) | 29,515 | 66,218,673 | |
Chipotle Mexican Grill, Inc. (b) | 11,023 | 15,460,309 | |
Dutch Bros, Inc. (c) | 51,891 | 1,948,507 | |
Expedia, Inc. (b) | 135,498 | 17,523,956 | |
F45 Training Holdings, Inc. | 207,474 | 1,319,535 | |
Hyatt Hotels Corp. Class A (b) | 41,626 | 3,679,322 | |
Marriott International, Inc. Class A | 359,984 | 61,766,055 | |
McDonald's Corp. | 779 | 196,472 | |
Penn National Gaming, Inc. (b) | 654,366 | 20,913,537 | |
Shake Shack, Inc. Class A (b)(c) | 16,622 | 808,660 | |
Sonder Holdings, Inc. (b) | 515,046 | 1,158,854 | |
Sonder Holdings, Inc. | 247,433 | 528,888 | |
Sonder Holdings, Inc.: | |||
rights (b)(e) | 5,104 | 4,440 | |
rights (b)(e) | 5,104 | 3,981 | |
rights (b)(e) | 5,104 | 3,573 | |
rights (b)(e) | 5,104 | 3,267 | |
rights (b)(e) | 5,103 | 2,960 | |
rights (b)(e) | 5,102 | 2,755 | |
Starbucks Corp. | 261,271 | 20,509,774 | |
Sweetgreen, Inc. Class A | 163,837 | 2,994,940 | |
Yum China Holdings, Inc. (c) | 162,299 | 7,378,113 | |
226,074,548 | |||
Household Durables - 0.3% | |||
Lennar Corp. Class A | 341,386 | 27,396,227 | |
PulteGroup, Inc. | 51,818 | 2,345,283 | |
Purple Innovation, Inc. (b)(c) | 909,420 | 4,710,796 | |
Vizio Holding Corp. (b) | 144,993 | 1,286,088 | |
35,738,394 | |||
Internet & Direct Marketing Retail - 6.4% | |||
Amazon.com, Inc. (b) | 235,327 | 565,770,820 | |
Etsy, Inc. (b) | 28,874 | 2,342,259 | |
JD.com, Inc. sponsored ADR | 43,081 | 2,417,706 | |
Lyft, Inc. (b) | 280,889 | 4,966,118 | |
Ozon Holdings PLC ADR (b)(c)(e) | 6,381 | 13,404 | |
Pinduoduo, Inc. ADR (b) | 39,907 | 2,009,317 | |
Revolve Group, Inc. (b)(c) | 500,986 | 14,718,969 | |
RumbleON, Inc. Class B (b)(c) | 90,444 | 1,438,964 | |
The RealReal, Inc. (b) | 13,258 | 43,486 | |
thredUP, Inc. (b)(c) | 399,827 | 1,671,277 | |
Uber Technologies, Inc. (b) | 1,108,129 | 25,708,593 | |
Wayfair LLC Class A (b)(c) | 852,037 | 50,602,477 | |
Zomato Ltd. (a)(b) | 4,462,200 | 4,078,044 | |
675,781,434 | |||
Leisure Products - 0.0% | |||
Peloton Interactive, Inc. Class A (b)(c) | 82,304 | 1,148,964 | |
Multiline Retail - 0.5% | |||
Dollar General Corp. | 45,333 | 9,988,673 | |
Dollar Tree, Inc. (b) | 68,001 | 10,902,600 | |
Ollie's Bargain Outlet Holdings, Inc. (b) | 459,496 | 21,582,527 | |
Target Corp. | 25,579 | 4,140,729 | |
46,614,529 | |||
Specialty Retail - 2.4% | |||
Carvana Co. Class A (b)(c) | 42,400 | 1,248,256 | |
Fanatics, Inc. Class A (a)(e) | 192,713 | 13,073,650 | |
Five Below, Inc. (b) | 63,523 | 8,295,469 | |
Floor & Decor Holdings, Inc. Class A (b) | 117,950 | 8,898,148 | |
Lowe's Companies, Inc. | 326,927 | 63,848,843 | |
RH (b) | 45,145 | 13,095,662 | |
The Home Depot, Inc. | 274,582 | 83,129,701 | |
TJX Companies, Inc. | 956,786 | 60,822,886 | |
252,412,615 | |||
Textiles, Apparel & Luxury Goods - 5.1% | |||
Canada Goose Holdings, Inc. (b) | 230,417 | 4,627,103 | |
Deckers Outdoor Corp. (b) | 168,335 | 45,208,048 | |
lululemon athletica, Inc. (b) | 1,216,584 | 356,081,971 | |
NIKE, Inc. Class B | 337,765 | 40,143,370 | |
On Holding AG (c) | 1,133,070 | 23,397,896 | |
Skechers U.S.A., Inc. Class A (sub. vtg.) (b) | 1,799,886 | 70,915,508 | |
540,373,896 | |||
TOTAL CONSUMER DISCRETIONARY | 2,072,589,159 | ||
CONSUMER STAPLES - 5.1% | |||
Beverages - 1.8% | |||
Constellation Brands, Inc. Class A (sub. vtg.) | 32,153 | 7,892,597 | |
Fever-Tree Drinks PLC | 186,434 | 3,613,154 | |
Keurig Dr. Pepper, Inc. | 689,737 | 23,961,463 | |
Monster Beverage Corp. (b) | 611,095 | 54,460,786 | |
PepsiCo, Inc. | 131,313 | 22,027,756 | |
The Coca-Cola Co. | 1,201,829 | 76,171,922 | |
188,127,678 | |||
Food & Staples Retailing - 1.2% | |||
Albertsons Companies, Inc. | 133,016 | 4,063,639 | |
Blink Health LLC Series A1 (a)(b)(e) | 65,933 | 2,113,812 | |
Costco Wholesale Corp. | 122,088 | 56,919,867 | |
Grocery Outlet Holding Corp. (b)(c) | 111,490 | 4,264,493 | |
Kroger Co. | 417,548 | 22,117,518 | |
Performance Food Group Co. (b) | 389,957 | 16,900,736 | |
Sysco Corp. | 270,163 | 22,742,321 | |
The Real Good Food Co. LLC Class B (e) | 149,688 | 2 | |
129,122,388 | |||
Food Products - 0.6% | |||
Archer Daniels Midland Co. | 96,890 | 8,799,550 | |
Bunge Ltd. | 207,339 | 24,532,350 | |
Darling Ingredients, Inc. (b) | 156,713 | 12,548,010 | |
Kellogg Co. (c) | 52,993 | 3,695,732 | |
Laird Superfood, Inc. (b)(c) | 75,528 | 180,512 | |
Mondelez International, Inc. | 81,253 | 5,164,441 | |
Oatly Group AB ADR (b)(c) | 640,923 | 2,647,012 | |
The Hershey Co. | 32,842 | 6,952,980 | |
The Real Good Food Co. LLC Class B unit (d) | 149,688 | 1,008,897 | |
The Real Good Food Co., Inc. | 12,799 | 86,265 | |
65,615,749 | |||
Household Products - 0.4% | |||
Church & Dwight Co., Inc. | 68,035 | 6,127,232 | |
Colgate-Palmolive Co. | 117,770 | 9,281,454 | |
Procter & Gamble Co. | 150,762 | 22,294,685 | |
37,703,371 | |||
Personal Products - 0.2% | |||
Olaplex Holdings, Inc. (c) | 883,365 | 14,239,844 | |
The Beauty Health Co. (a)(b) | 428,643 | 6,116,736 | |
The Beauty Health Co. (b)(c) | 472,211 | 6,738,451 | |
27,095,031 | |||
Tobacco - 0.9% | |||
Altria Group, Inc. | 661,530 | 35,782,158 | |
Philip Morris International, Inc. | 532,989 | 56,630,081 | |
92,412,239 | |||
TOTAL CONSUMER STAPLES | 540,076,456 | ||
ENERGY - 3.7% | |||
Energy Equipment & Services - 0.8% | |||
Baker Hughes Co. Class A | 425,238 | 15,300,063 | |
Halliburton Co. | 941,720 | 38,139,660 | |
Schlumberger Ltd. | 611,331 | 28,096,773 | |
81,536,496 | |||
Oil, Gas & Consumable Fuels - 2.9% | |||
Cameco Corp. (c) | 407,589 | 9,973,703 | |
Devon Energy Corp. | 123,038 | 9,215,546 | |
EOG Resources, Inc. | 215,893 | 29,568,705 | |
Hess Corp. | 928,037 | 114,213,514 | |
Occidental Petroleum Corp. | 227,800 | 15,788,818 | |
Phillips 66 Co. | 58,200 | 5,867,142 | |
Pioneer Natural Resources Co. | 120,544 | 33,503,999 | |
Range Resources Corp. (b) | 888,733 | 30,172,485 | |
Reliance Industries Ltd. | 1,066,946 | 36,198,038 | |
Valero Energy Corp. | 175,190 | 22,704,624 | |
307,206,574 | |||
TOTAL ENERGY | 388,743,070 | ||
FINANCIALS - 1.9% | |||
Banks - 0.8% | |||
Bank of America Corp. | 772,102 | 28,722,194 | |
First Republic Bank | 93,194 | 14,447,866 | |
HDFC Bank Ltd. sponsored ADR | 370,432 | 21,325,770 | |
JPMorgan Chase & Co. | 117,048 | 15,477,257 | |
Wells Fargo & Co. | 115,484 | 5,285,703 | |
85,258,790 | |||
Capital Markets - 0.8% | |||
B3 SA - Brasil Bolsa Balcao | 1,459,000 | 3,920,302 | |
BlackRock, Inc. Class A | 39,366 | 26,339,003 | |
Charles Schwab Corp. | 722,549 | 50,650,685 | |
80,909,990 | |||
Consumer Finance - 0.3% | |||
American Express Co. | 170,532 | 28,789,212 | |
Discover Financial Services | 28,405 | 3,223,683 | |
32,012,895 | |||
TOTAL FINANCIALS | 198,181,675 | ||
HEALTH CARE - 11.9% | |||
Biotechnology - 6.1% | |||
4D Molecular Therapeutics, Inc. (b) | 25,059 | 190,198 | |
AbbVie, Inc. | 122,312 | 18,025,119 | |
ACADIA Pharmaceuticals, Inc. (b) | 1,217,027 | 19,654,986 | |
Adagio Therapeutics, Inc. (c) | 1,313,629 | 3,888,342 | |
ADC Therapeutics SA (b) | 198,695 | 1,359,074 | |
Akouos, Inc. (b)(d) | 54,474 | 169,959 | |
Akouos, Inc. (b) | 270,926 | 845,289 | |
Alector, Inc. (b) | 476,737 | 4,223,890 | |
Allovir, Inc. (b)(c) | 633,912 | 2,453,239 | |
Alnylam Pharmaceuticals, Inc. (b) | 597,546 | 75,171,287 | |
Ambrx Biopharma, Inc. ADR | 78,842 | 309,849 | |
Amgen, Inc. | 109,041 | 27,995,186 | |
Arcutis Biotherapeutics, Inc. (b) | 128,247 | 2,677,797 | |
Argenx SE ADR (b) | 174,347 | 53,925,527 | |
Arrowhead Pharmaceuticals, Inc. (b) | 45,770 | 1,526,887 | |
Ascendis Pharma A/S sponsored ADR (b) | 12,872 | 1,087,813 | |
aTyr Pharma, Inc. (b) | 358,958 | 1,008,672 | |
Avidity Biosciences, Inc. (b)(c) | 349,608 | 4,870,039 | |
Axcella Health, Inc. (b) | 621,882 | 1,318,390 | |
Beam Therapeutics, Inc. (b)(c) | 50,724 | 1,784,470 | |
BeiGene Ltd. ADR (b) | 251,651 | 34,531,550 | |
BioNTech SE ADR (b) | 12 | 1,960 | |
BioXcel Therapeutics, Inc. (b)(c) | 396,253 | 4,636,160 | |
Calyxt, Inc. (b) | 30,990 | 10,072 | |
Century Therapeutics, Inc. | 643,321 | 5,590,459 | |
Cerevel Therapeutics Holdings (b) | 1,432,028 | 37,418,892 | |
ChemoCentryx, Inc. (b) | 545,167 | 12,140,869 | |
Cibus Corp. Series E (a)(b)(e)(f) | 2,065,675 | 5,060,904 | |
Codiak Biosciences, Inc. (b) | 207,492 | 578,903 | |
Connect Biopharma Holdings Ltd. ADR (b)(c) | 20 | 16 | |
CRISPR Therapeutics AG (b)(c) | 122,425 | 7,106,771 | |
Cyclerion Therapeutics, Inc. (b) | 49,491 | 30,813 | |
Day One Biopharmaceuticals, Inc. (b) | 49,618 | 308,624 | |
Denali Therapeutics, Inc. (b) | 90,881 | 2,207,499 | |
EQRx, Inc. (b)(c) | 1,656,049 | 9,207,632 | |
EQRx, Inc.: | |||
rights (b)(e) | 65,872 | 175,878 | |
rights (b)(e) | 28,231 | 59,567 | |
Erasca, Inc. | 86,619 | 469,475 | |
Evelo Biosciences, Inc. (b)(c) | 1,258,637 | 2,643,138 | |
Exelixis, Inc. (b) | 66,944 | 1,227,084 | |
Foghorn Therapeutics, Inc. (b) | 232,534 | 2,999,689 | |
Gemini Therapeutics, Inc. (b)(c) | 47,951 | 61,377 | |
Generation Bio Co. (b) | 476,619 | 2,678,599 | |
Graphite Bio, Inc. | 60,717 | 142,685 | |
Icosavax, Inc. (b) | 76,739 | 521,058 | |
Imago BioSciences, Inc. | 41,016 | 662,819 | |
Immunocore Holdings PLC ADR (b) | 41,446 | 1,174,994 | |
Inhibrx, Inc. (b)(c) | 127,281 | 1,663,563 | |
Instil Bio, Inc. (b) | 118,554 | 711,917 | |
Ionis Pharmaceuticals, Inc. (b) | 1,805,835 | 65,949,094 | |
iTeos Therapeutics, Inc. (b) | 22,517 | 394,048 | |
Janux Therapeutics, Inc. | 126,228 | 1,404,918 | |
Karuna Therapeutics, Inc. (b) | 319,993 | 33,381,670 | |
Kinnate Biopharma, Inc. (b) | 61,608 | 489,168 | |
Kronos Bio, Inc. (b)(c) | 20,314 | 75,568 | |
Lexicon Pharmaceuticals, Inc. (b)(c) | 380,837 | 674,081 | |
Lyell Immunopharma, Inc. (c) | 227,441 | 941,606 | |
Moderna, Inc. (b) | 161,712 | 23,501,605 | |
Monte Rosa Therapeutics, Inc. | 271,103 | 2,098,337 | |
Morphic Holding, Inc. (b) | 240,902 | 5,646,743 | |
Nuvalent, Inc. Class A (b) | 333,844 | 2,957,858 | |
Omega Therapeutics, Inc. (b)(c) | 406,174 | 922,015 | |
ORIC Pharmaceuticals, Inc. (b) | 222,226 | 742,235 | |
Poseida Therapeutics, Inc. (b) | 370,431 | 840,878 | |
Praxis Precision Medicines, Inc. (b) | 393,336 | 3,264,689 | |
Protagonist Therapeutics, Inc. (b) | 167,417 | 1,466,573 | |
Prothena Corp. PLC (b) | 179,645 | 4,891,733 | |
PTC Therapeutics, Inc. (b) | 298,301 | 8,761,100 | |
Recursion Pharmaceuticals, Inc. (b)(c) | 335,381 | 2,052,532 | |
Regeneron Pharmaceuticals, Inc. (b) | 73,259 | 48,698,188 | |
Relay Therapeutics, Inc. (b) | 185,779 | 3,024,482 | |
Rigel Pharmaceuticals, Inc. (b) | 2,298,442 | 4,160,180 | |
Rubius Therapeutics, Inc. (b)(c) | 1,193,911 | 1,313,302 | |
Sage Therapeutics, Inc. (b) | 475,102 | 14,856,440 | |
Saluda Medical Pty Ltd. warrants (a)(b)(e) | 46,461 | 133,343 | |
Sana Biotechnology, Inc. (b)(c) | 122,629 | 629,087 | |
Scholar Rock Holding Corp. (b)(c) | 211,176 | 1,060,104 | |
Seagen, Inc. (b) | 16,968 | 2,302,218 | |
Seres Therapeutics, Inc. (b) | 1,238,973 | 3,840,816 | |
Shattuck Labs, Inc. (b) | 256,477 | 733,524 | |
Sigilon Therapeutics, Inc. (b)(c) | 96,766 | 73,349 | |
Silverback Therapeutics, Inc. (b)(c) | 337,511 | 1,177,913 | |
Springworks Therapeutics, Inc. (b)(c) | 615,812 | 11,663,479 | |
Synlogic, Inc. (b) | 550,228 | 599,749 | |
Syros Pharmaceuticals, Inc. warrants 10/10/22 (b) | 11,545 | 0 | |
Tango Therapeutics, Inc. (b) | 217,510 | 1,455,142 | |
Taysha Gene Therapies, Inc. (b) | 183,192 | 467,140 | |
Tenaya Therapeutics, Inc. (b) | 62,846 | 421,068 | |
TG Therapeutics, Inc. (b) | 418,268 | 1,848,745 | |
Twist Bioscience Corp. (b) | 260,414 | 8,864,493 | |
Tyra Biosciences, Inc. | 39,195 | 267,702 | |
Ultragenyx Pharmaceutical, Inc. (b) | 19,167 | 898,932 | |
uniQure B.V. (b) | 117,998 | 1,694,451 | |
UNITY Biotechnology, Inc. (b) | 140,347 | 110,888 | |
Vaxcyte, Inc. (b) | 266,385 | 6,390,576 | |
Vera Therapeutics, Inc. (b) | 119,887 | 1,743,157 | |
Vertex Pharmaceuticals, Inc. (b) | 24,683 | 6,631,088 | |
Verve Therapeutics, Inc. | 73,310 | 1,111,380 | |
Vor Biopharma, Inc. (b) | 99,790 | 420,116 | |
Yumanity Therapeutics, Inc. (b)(c) | 125,356 | 134,131 | |
Zai Lab Ltd. ADR (b) | 148,073 | 4,308,924 | |
Zentalis Pharmaceuticals, Inc. (b) | 166,363 | 4,011,012 | |
652,010,550 | |||
Health Care Equipment & Supplies - 2.7% | |||
Abbott Laboratories | 80,737 | 9,483,368 | |
DexCom, Inc. (b) | 82,764 | 24,658,706 | |
Insulet Corp. (b) | 399,711 | 85,330,304 | |
Intuitive Surgical, Inc. (b) | 197,195 | 44,889,470 | |
Novocure Ltd. (b)(c) | 1,020,792 | 82,051,261 | |
Oddity Tech Ltd. (a)(e) | 3,704 | 1,594,239 | |
Outset Medical, Inc. (b) | 346,911 | 7,562,660 | |
Penumbra, Inc. (b) | 6,456 | 948,516 | |
Presbia PLC (b)(e) | 96,997 | 1,455 | |
PROCEPT BioRobotics Corp. | 142,285 | 5,566,189 | |
PROCEPT BioRobotics Corp. (d) | 109,638 | 4,289,039 | |
Shockwave Medical, Inc. (b) | 151,068 | 24,806,876 | |
291,182,083 | |||
Health Care Providers & Services - 0.9% | |||
1Life Healthcare, Inc. (b) | 274,352 | 2,323,761 | |
Alignment Healthcare, Inc. (b) | 304,192 | 3,248,771 | |
AmerisourceBergen Corp. | 31,830 | 4,926,966 | |
Centene Corp. (b) | 236,454 | 19,256,814 | |
Guardant Health, Inc. (b) | 71,098 | 2,913,596 | |
Humana, Inc. | 29,375 | 13,343,006 | |
McKesson Corp. | 27,868 | 9,159,933 | |
Privia Health Group, Inc. (b)(c) | 27,233 | 652,503 | |
Progyny, Inc. (b)(c) | 73,456 | 2,321,944 | |
The Oncology Institute, Inc. (a) | 446,788 | 4,025,560 | |
UnitedHealth Group, Inc. | 65,398 | 32,488,418 | |
94,661,272 | |||
Health Care Technology - 0.0% | |||
DNA Script (a)(e) | 115 | 87,964 | |
DNA Script (a)(e) | 439 | 335,793 | |
423,757 | |||
Life Sciences Tools & Services - 0.9% | |||
10X Genomics, Inc. (b)(c) | 596,451 | 30,532,327 | |
Absci Corp. (c) | 1,203,757 | 4,393,713 | |
Akoya Biosciences, Inc. (b)(c) | 14,787 | 172,269 | |
Danaher Corp. | 12,929 | 3,410,929 | |
ICON PLC (b) | 8,445 | 1,889,907 | |
Nanostring Technologies, Inc. (b) | 41,295 | 645,854 | |
Olink Holding AB ADR (b) | 356,920 | 4,197,379 | |
Seer, Inc. (b) | 227,318 | 2,018,584 | |
Thermo Fisher Scientific, Inc. | 41,573 | 23,595,588 | |
WuXi AppTec Co. Ltd. (H Shares) (d) | 286,645 | 3,537,767 | |
Wuxi Biologics (Cayman), Inc. (b)(d) | 2,165,047 | 16,009,684 | |
90,404,001 | |||
Pharmaceuticals - 1.3% | |||
4D Pharma PLC (b)(c) | 928,396 | 384,393 | |
Adimab LLC (a)(b)(e)(f) | 196,899 | 8,124,230 | |
Arvinas Holding Co. LLC (b) | 50,660 | 2,112,015 | |
Atea Pharmaceuticals, Inc. (b)(c) | 1,118,084 | 8,810,502 | |
Bristol-Myers Squibb Co. | 114,923 | 8,670,940 | |
Dragonfly Therapeutics, Inc. (a)(b)(e) | 31,376 | 359,255 | |
Eli Lilly & Co. | 33,800 | 10,594,272 | |
Fulcrum Therapeutics, Inc. (b) | 323,686 | 2,304,644 | |
GH Research PLC | 315,246 | 3,158,765 | |
Hansoh Pharmaceutical Group Co. Ltd. (d) | 440,394 | 793,553 | |
Harmony Biosciences Holdings, Inc. (b)(c) | 484,317 | 21,116,221 | |
Intra-Cellular Therapies, Inc. (b) | 814,988 | 46,780,311 | |
Jiangsu Hengrui Medicine Co. Ltd. (A Shares) | 6,216 | 28,248 | |
Nuvation Bio, Inc. (b)(c) | 946,179 | 3,340,012 | |
OptiNose, Inc. (b)(c) | 1,217,444 | 2,501,847 | |
Pfizer, Inc. | 161,223 | 8,551,268 | |
Pharvaris BV (b) | 34,839 | 617,347 | |
Pliant Therapeutics, Inc. (b) | 106,220 | 598,019 | |
Sienna Biopharmaceuticals, Inc. (b) | 289,339 | 0 | |
Skyhawk Therapeutics, Inc. (a)(e) | 127,580 | 1,236,250 | |
Theravance Biopharma, Inc. (b) | 197,507 | 1,734,111 | |
Theseus Pharmaceuticals, Inc. (c) | 56,760 | 383,130 | |
UCB SA | 34,668 | 3,057,817 | |
135,257,150 | |||
TOTAL HEALTH CARE | 1,263,938,813 | ||
INDUSTRIALS - 5.8% | |||
Aerospace & Defense - 0.5% | |||
AeroVironment, Inc. (b) | 8,400 | 772,464 | |
Lockheed Martin Corp. | 34,358 | 15,121,299 | |
Raytheon Technologies Corp. | 110,395 | 10,500,772 | |
Space Exploration Technologies Corp. Class A (a)(b)(e) | 324,714 | 22,729,980 | |
The Boeing Co. (b) | 39,890 | 5,241,546 | |
54,366,061 | |||
Air Freight & Logistics - 0.2% | |||
Delhivery Private Ltd. (a) | 486,000 | 2,988,883 | |
FedEx Corp. | 33,785 | 7,587,435 | |
United Parcel Service, Inc. Class B | 78,957 | 14,389,913 | |
24,966,231 | |||
Airlines - 1.8% | |||
Delta Air Lines, Inc. (b) | 985,080 | 41,067,985 | |
JetBlue Airways Corp. (b) | 2,593,535 | 27,854,566 | |
Ryanair Holdings PLC sponsored ADR (b) | 6,095 | 531,484 | |
Southwest Airlines Co. (b) | 1,255,891 | 57,595,161 | |
Spirit Airlines, Inc. (b) | 526,709 | 11,034,554 | |
United Airlines Holdings, Inc. (b) | 552,828 | 26,331,198 | |
Wheels Up Experience, Inc. (a)(b) | 961,536 | 2,432,686 | |
Wheels Up Experience, Inc. Class A (b) | 1,229,205 | 3,109,889 | |
Wizz Air Holdings PLC (b)(d) | 621,401 | 22,864,400 | |
192,821,923 | |||
Building Products - 0.0% | |||
Trane Technologies PLC | 14,391 | 1,986,821 | |
Construction & Engineering - 0.1% | |||
Fluor Corp. (b) | 82,494 | 2,328,806 | |
MasTec, Inc. (b) | 27,048 | 2,260,942 | |
Quanta Services, Inc. | 26,509 | 3,154,571 | |
7,744,319 | |||
Electrical Equipment - 0.4% | |||
AMETEK, Inc. | 8,052 | 978,076 | |
Eaton Corp. PLC | 50,126 | 6,947,464 | |
Emerson Electric Co. | 101,368 | 8,987,287 | |
Fluence Energy, Inc. (c) | 47,136 | 461,933 | |
Generac Holdings, Inc. (b) | 51,665 | 12,765,388 | |
Rockwell Automation, Inc. | 31,805 | 6,780,826 | |
36,920,974 | |||
Industrial Conglomerates - 0.1% | |||
Honeywell International, Inc. | 41,307 | 7,997,861 | |
Machinery - 0.8% | |||
Caterpillar, Inc. | 104,693 | 22,597,984 | |
Deere & Co. | 86,669 | 31,008,435 | |
Illinois Tool Works, Inc. | 51,266 | 10,666,917 | |
Ingersoll Rand, Inc. | 71,339 | 3,363,634 | |
Xylem, Inc. (c) | 206,315 | 17,382,039 | |
85,019,009 | |||
Professional Services - 0.0% | |||
Clarivate Analytics PLC (b) | 23,581 | 348,291 | |
LegalZoom.com, Inc. (c) | 125,741 | 1,647,207 | |
Sterling Check Corp. (c) | 61,193 | 1,136,966 | |
3,132,464 | |||
Road & Rail - 1.9% | |||
Avis Budget Group, Inc. (b)(c) | 549,394 | 104,538,690 | |
Bird Global, Inc. (a) | 156,425 | 118,461 | |
Bird Global, Inc.: | |||
rights (b)(e) | 27,377 | 1,643 | |
rights (b)(e) | 27,377 | 821 | |
rights (b)(e) | 27,377 | 274 | |
Class A (b) | 765,426 | 579,657 | |
Canadian Pacific Railway Ltd. | 109,809 | 7,844,755 | |
CSX Corp. | 470,445 | 14,955,447 | |
Hertz Global Holdings, Inc. (c) | 812,070 | 16,298,245 | |
Union Pacific Corp. (c) | 261,183 | 57,402,800 | |
201,740,793 | |||
TOTAL INDUSTRIALS | 616,696,456 | ||
INFORMATION TECHNOLOGY - 37.9% | |||
Communications Equipment - 0.6% | |||
Arista Networks, Inc. (b) | 94,516 | 9,667,096 | |
Ciena Corp. (b) | 779,554 | 39,616,934 | |
Infinera Corp. (b)(c) | 3,337,418 | 19,123,405 | |
68,407,435 | |||
Electronic Equipment & Components - 0.2% | |||
Arlo Technologies, Inc. (b) | 195,556 | 1,384,536 | |
II-VI, Inc. (b)(c) | 170,359 | 10,647,438 | |
TE Connectivity Ltd. | 2,930 | 379,113 | |
Trimble, Inc. (b) | 163,758 | 11,143,732 | |
23,554,819 | |||
IT Services - 3.9% | |||
Accenture PLC Class A | 59,444 | 17,741,656 | |
Actua Corp. (b)(e) | 230,718 | 2,307 | |
Block, Inc. Class A (b)(c) | 198,455 | 17,366,797 | |
CI&T, Inc. Class A (c) | 61,292 | 885,669 | |
Cloudflare, Inc. (b) | 1,012,778 | 56,715,568 | |
IBM Corp. | 3,322 | 461,226 | |
MasterCard, Inc. Class A | 344,604 | 123,323,433 | |
MongoDB, Inc. Class A (b) | 7,797 | 1,849,059 | |
Okta, Inc. (b) | 59,268 | 4,922,207 | |
PayPal Holdings, Inc. (b) | 413,796 | 35,259,557 | |
Shopify, Inc. Class A (b) | 53,406 | 20,049,681 | |
Snowflake, Inc. (b) | 20,544 | 2,622,442 | |
Thoughtworks Holding, Inc. | 57,065 | 987,795 | |
Toast, Inc. | 7,161 | 116,295 | |
Twilio, Inc. Class A (b) | 17,520 | 1,842,578 | |
Visa, Inc. Class A | 611,209 | 129,680,214 | |
413,826,484 | |||
Semiconductors & Semiconductor Equipment - 12.4% | |||
Advanced Micro Devices, Inc. (b) | 865,250 | 88,134,365 | |
Applied Materials, Inc. | 398,641 | 46,756,603 | |
ASML Holding NV | 47,663 | 27,467,710 | |
Broadcom, Inc. | 37,219 | 21,591,858 | |
Cirrus Logic, Inc. (b) | 370,859 | 30,239,843 | |
Enphase Energy, Inc. (b) | 55,580 | 10,348,440 | |
First Solar, Inc. (b)(c) | 165,958 | 11,718,294 | |
GlobalFoundries, Inc. | 135,618 | 8,095,038 | |
Intel Corp. | 110,334 | 4,901,036 | |
KLA Corp. | 56,529 | 20,624,606 | |
Lam Research Corp. | 13,228 | 6,878,957 | |
Marvell Technology, Inc. | 600,589 | 35,524,839 | |
Micron Technology, Inc. | 47,777 | 3,527,854 | |
NVIDIA Corp. | 4,431,864 | 827,517,646 | |
onsemi (b) | 68,662 | 4,166,410 | |
Qualcomm, Inc. | 149,947 | 21,475,409 | |
Silicon Laboratories, Inc. (b) | 516,093 | 76,980,432 | |
SiTime Corp. (b) | 97,490 | 20,765,370 | |
Taiwan Semiconductor Manufacturing Co. Ltd. sponsored ADR | 110,143 | 10,496,628 | |
Teradyne, Inc. | 75,866 | 8,289,119 | |
Texas Instruments, Inc. | 127,594 | 22,553,515 | |
Wolfspeed, Inc. (b)(c) | 89,861 | 6,760,243 | |
1,314,814,215 | |||
Software - 11.2% | |||
Adobe, Inc. (b) | 164,063 | 68,328,958 | |
Atlassian Corp. PLC (b) | 10,630 | 1,884,912 | |
Autodesk, Inc. (b) | 111,935 | 23,254,496 | |
Avalara, Inc. (b) | 33,125 | 2,804,694 | |
AvidXchange Holdings, Inc. | 960 | 8,429 | |
Bill.Com Holdings, Inc. (b) | 3,782 | 447,184 | |
Black Knight, Inc. (b) | 74,937 | 5,088,972 | |
C3.Ai, Inc. (b)(c) | 153,826 | 2,910,388 | |
Clear Secure, Inc. | 526 | 14,433 | |
Clearwater Analytics Holdings, Inc. (c) | 42,953 | 606,067 | |
Coupa Software, Inc. (b) | 18,408 | 1,266,286 | |
Crowdstrike Holdings, Inc. (b) | 81,349 | 13,015,027 | |
Datadog, Inc. Class A (b) | 33,847 | 3,228,665 | |
Elastic NV (b) | 39,828 | 2,455,396 | |
Epic Games, Inc. (a)(b)(e) | 5,000 | 4,650,000 | |
ForgeRock, Inc. (c) | 41,620 | 797,439 | |
HubSpot, Inc. (b) | 26,349 | 8,897,794 | |
Informatica, Inc. (c) | 70,254 | 1,433,182 | |
Intuit, Inc. | 48,243 | 19,994,794 | |
Microsoft Corp. | 2,311,171 | 628,338,060 | |
Nutanix, Inc. Class A (b) | 3,016,441 | 48,866,344 | |
Oracle Corp. | 852,288 | 61,296,553 | |
Paycom Software, Inc. (b) | 14,064 | 3,998,958 | |
Paylocity Holding Corp. (b) | 20,838 | 3,643,733 | |
RingCentral, Inc. (b) | 6,883 | 434,593 | |
Riskified Ltd. (b)(c) | 271,863 | 1,413,688 | |
Riskified Ltd.: | |||
Class A (d) | 4,200 | 21,840 | |
Class B | 69,050 | 359,060 | |
Salesforce.com, Inc. (b) | 1,327,973 | 212,794,394 | |
Samsara, Inc. | 61,971 | 697,174 | |
SentinelOne, Inc. | 69,158 | 1,645,269 | |
ServiceNow, Inc. (b) | 54,427 | 25,442,990 | |
Stripe, Inc. Class B (a)(b)(e) | 38,500 | 1,045,275 | |
The Trade Desk, Inc. (b) | 23,465 | 1,221,353 | |
UiPath, Inc. Class A (b)(c) | 649,165 | 11,081,247 | |
Workday, Inc. Class A (b) | 31,911 | 4,987,689 | |
Zoom Video Communications, Inc. Class A (b) | 43,759 | 4,701,905 | |
Zscaler, Inc. (b) | 72,939 | 11,166,232 | |
1,184,243,473 | |||
Technology Hardware, Storage & Peripherals - 9.6% | |||
Apple, Inc. | 6,359,996 | 946,621,799 | |
Pure Storage, Inc. Class A (b) | 2,770,646 | 65,747,430 | |
Samsung Electronics Co. Ltd. | 102,855 | 5,579,800 | |
1,017,949,029 | |||
TOTAL INFORMATION TECHNOLOGY | 4,022,795,455 | ||
MATERIALS - 2.2% | |||
Chemicals - 1.2% | |||
Albemarle Corp. U.S. | 32,740 | 8,526,151 | |
CF Industries Holdings, Inc. | 262,863 | 25,962,979 | |
Corteva, Inc. | 674,317 | 42,225,731 | |
DuPont de Nemours, Inc. | 205,290 | 13,928,927 | |
Nutrien Ltd. | 154,955 | 15,143,288 | |
The Mosaic Co. | 287,759 | 18,028,101 | |
123,815,177 | |||
Containers & Packaging - 0.0% | |||
Sealed Air Corp. | 60,230 | 3,745,101 | |
Metals & Mining - 1.0% | |||
Barrick Gold Corp. (Canada) | 691,498 | 14,165,089 | |
Freeport-McMoRan, Inc. | 1,676,244 | 65,507,616 | |
Newmont Corp. | 267,130 | 18,124,771 | |
Rio Tinto PLC sponsored ADR | 175,927 | 12,920,079 | |
110,717,555 | |||
TOTAL MATERIALS | 238,277,833 | ||
REAL ESTATE - 0.5% | |||
Equity Real Estate Investment Trusts (REITs) - 0.3% | |||
American Tower Corp. | 79,295 | 20,309,828 | |
Equinix, Inc. | 6,835 | 4,696,260 | |
Simon Property Group, Inc. | 94,423 | 10,825,597 | |
35,831,685 | |||
Real Estate Management & Development - 0.2% | |||
CBRE Group, Inc. (b) | 123,686 | 10,246,148 | |
WeWork, Inc. (b) | 1,650,400 | 12,031,416 | |
22,277,564 | |||
TOTAL REAL ESTATE | 58,109,249 | ||
UTILITIES - 0.1% | |||
Electric Utilities - 0.1% | |||
ORSTED A/S (d) | 106,100 | 11,958,469 | |
TOTAL COMMON STOCKS (Cost $9,429,555,931) | 10,365,882,749 | ||
Preferred Stocks - 1.5% | |||
Shares | Value ($) | ||
Convertible Preferred Stocks - 1.4% | |||
COMMUNICATION SERVICES - 0.0% | |||
Interactive Media & Services - 0.0% | |||
Reddit, Inc.: | |||
Series E(a)(e) | 4,501 | 166,087 | |
Series F(a)(e) | 88,486 | 3,265,133 | |
3,431,220 | |||
CONSUMER DISCRETIONARY - 0.1% | |||
Automobiles - 0.0% | |||
Rad Power Bikes, Inc.: | |||
Series A(a)(b)(e) | 22,348 | 123,808 | |
Series C(a)(b)(e) | 87,936 | 487,165 | |
Series D(a)(e) | 219,600 | 1,216,584 | |
1,827,557 | |||
Hotels, Restaurants & Leisure - 0.0% | |||
Discord, Inc. Series I (a)(e) | 1,400 | 770,874 | |
Internet & Direct Marketing Retail - 0.1% | |||
GoBrands, Inc.: | |||
Series G(a)(b)(e) | 19,907 | 4,012,256 | |
Series H(a)(e) | 20,720 | 4,176,116 | |
Instacart, Inc.: | |||
Series H(a)(b)(e) | 12,458 | 603,341 | |
Series I(a)(b)(e) | 6,009 | 291,016 | |
9,082,729 | |||
Textiles, Apparel & Luxury Goods - 0.0% | |||
Freenome, Inc.: | |||
Series C(a)(b)(e) | 141,369 | 1,294,940 | |
Series D(a)(e) | 125,665 | 1,151,091 | |
Laronde, Inc. Series B (a)(e) | 81,282 | 1,364,725 | |
3,810,756 | |||
TOTAL CONSUMER DISCRETIONARY | 15,491,916 | ||
CONSUMER STAPLES - 0.1% | |||
Food & Staples Retailing - 0.1% | |||
Blink Health LLC Series C (a)(b)(e) | 145,007 | 4,648,924 | |
Food Products - 0.0% | |||
AgBiome LLC Series D (a)(e) | 511,821 | 3,086,281 | |
Bowery Farming, Inc. Series C1 (a)(e) | 27,155 | 965,360 | |
4,051,641 | |||
TOTAL CONSUMER STAPLES | 8,700,565 | ||
FINANCIALS - 0.0% | |||
Diversified Financial Services - 0.0% | |||
Paragon Biosciences Emalex Capital, Inc. Series C (a)(b)(e) | 109,967 | 494,852 | |
HEALTH CARE - 0.5% | |||
Biotechnology - 0.4% | |||
Ankyra Therapeutics Series B (a)(e) | 329,325 | 1,080,186 | |
Asimov, Inc. Series B (a)(e) | 19,920 | 1,217,909 | |
Bright Peak Therapeutics AG Series B (a)(e) | 282,257 | 649,191 | |
Caris Life Sciences, Inc. Series D (a)(e) | 258,638 | 1,432,855 | |
Castle Creek Biosciences, Inc.: | |||
Series D1(a)(e) | 4,476 | 731,692 | |
Series D2(a)(e) | 1,254 | 204,991 | |
Deep Genomics, Inc. Series C (a)(e) | 155,443 | 1,293,286 | |
Dianthus Therapeutics, Inc. Series A (a)(e) | 333,765 | 999,626 | |
Element Biosciences, Inc.: | |||
Series B(a)(b)(e) | 125,057 | 1,708,279 | |
Series C(a)(e) | 114,255 | 1,560,723 | |
ElevateBio LLC Series C (a)(b)(e) | 247,600 | 1,132,275 | |
Generate Biomedicines Series B (a)(e) | 191,856 | 1,293,109 | |
Inscripta, Inc.: | |||
Series D(a)(b)(e) | 277,957 | 1,689,979 | |
Series E(a)(b)(e) | 215,182 | 1,308,307 | |
Korro Bio, Inc.: | |||
Series B1(a)(e) | 379,289 | 580,312 | |
Series B2(a)(e) | 356,095 | 544,825 | |
LifeMine Therapeutics, Inc. Series C (a)(e) | 1,759,782 | 2,410,901 | |
National Resilience, Inc.: | |||
Series B(a)(b)(e) | 182,315 | 11,084,752 | |
Series C(a)(e) | 74,748 | 4,544,678 | |
Quell Therapeutics Ltd. Series B (a)(e) | 822,639 | 806,186 | |
SalioGen Therapeutics, Inc. Series B (a)(e) | 14,028 | 839,295 | |
Saluda Medical Pty Ltd. Series D (a)(e) | 154,870 | 1,556,186 | |
Sonoma Biotherapeutics, Inc.: | |||
Series B(a)(e) | 587,934 | 823,108 | |
Series B1(a)(e) | 313,559 | 438,983 | |
T-Knife Therapeutics, Inc. Series B (a)(e) | 241,456 | 767,830 | |
Treeline Biosciences Series A (a)(e) | 242,200 | 1,148,028 | |
41,847,492 | |||
Health Care Equipment & Supplies - 0.0% | |||
Kardium, Inc. Series D6 (a)(b)(e) | 1,087,032 | 809,056 | |
Health Care Providers & Services - 0.0% | |||
Boundless Bio, Inc. Series B (a)(b)(e) | 756,226 | 567,170 | |
Conformal Medical, Inc. Series C (a)(b)(e) | 140,186 | 461,212 | |
Scorpion Therapeutics, Inc. Series B (a)(b)(e) | 260,848 | 263,456 | |
1,291,838 | |||
Health Care Technology - 0.1% | |||
Aledade, Inc.: | |||
Series B1(a)(e) | 26,096 | 1,299,842 | |
Series E1(a)(e) | 21,357 | 1,063,792 | |
DNA Script: | |||
Series B(a)(e) | 6 | 4,589 | |
Series C(a)(e) | 2,549 | 1,949,741 | |
Omada Health, Inc. Series E (a)(e) | 636,551 | 3,816,251 | |
PrognomIQ, Inc.: | |||
Series A5(a)(b)(e) | 37,950 | 78,936 | |
Series B(a)(b)(e) | 196,968 | 409,693 | |
Series C(a)(e) | 65,704 | 136,664 | |
Wugen, Inc. Series B (a)(e) | 121,894 | 527,801 | |
9,287,309 | |||
Pharmaceuticals - 0.0% | |||
Castle Creek Pharmaceutical Holdings, Inc. Series C (a)(b)(e) | 582 | 103,445 | |
Galvanize Therapeutics Series B (a)(e) | 1,125,997 | 1,949,423 | |
2,052,868 | |||
TOTAL HEALTH CARE | 55,288,563 | ||
INDUSTRIALS - 0.2% | |||
Aerospace & Defense - 0.2% | |||
Space Exploration Technologies Corp. Series N (a)(b)(e) | 19,900 | 13,930,000 | |
Construction & Engineering - 0.0% | |||
Beta Technologies, Inc.: | |||
Series A(a)(b)(e) | 10,545 | 1,087,928 | |
Series B, 6.00%(a)(e) | 20,919 | 2,158,213 | |
3,246,141 | |||
TOTAL INDUSTRIALS | 17,176,141 | ||
INFORMATION TECHNOLOGY - 0.4% | |||
Communications Equipment - 0.1% | |||
Meesho Series F (a)(e) | 66,982 | 4,698,117 | |
Xsight Labs Ltd. Series D (a)(b)(e) | 122,201 | 914,063 | |
5,612,180 | |||
Electronic Equipment & Components - 0.0% | |||
Enevate Corp. Series E (a)(b)(e) | 754,820 | 836,857 | |
Menlo Micro, Inc. Series C (a)(e) | 993,699 | 1,045,868 | |
1,882,725 | |||
IT Services - 0.1% | |||
ByteDance Ltd. Series E1 (a)(b)(e) | 49,039 | 6,568,774 | |
Semiconductors & Semiconductor Equipment - 0.1% | |||
Alif Semiconductor Series C (a)(e) | 43,034 | 873,527 | |
Astera Labs, Inc.: | |||
Series A(a)(e) | 80,597 | 819,631 | |
Series B(a)(e) | 13,723 | 139,556 | |
Series C(a)(e) | 372,400 | 3,787,122 | |
Series D(a)(e) | 273,573 | 2,782,101 | |
GaN Systems, Inc.: | |||
Series F1(a)(e) | 63,044 | 423,025 | |
Series F2(a)(e) | 33,289 | 223,369 | |
SiMa.ai: | |||
Series B(a)(e) | 299,482 | 2,123,597 | |
Series B1(a)(e) | 20,061 | 142,251 | |
11,314,179 | |||
Software - 0.1% | |||
Bolt Technology OU Series E (a)(e) | 17,815 | 4,398,817 | |
Databricks, Inc.: | |||
Series G(a)(b)(e) | 12,605 | 1,840,960 | |
Series H(a)(e) | 18,695 | 2,730,405 | |
Evozyne LLC Series A (a)(b)(e) | 78,000 | 1,009,320 | |
Nuvia, Inc. Series B (a)(b) | 212,200 | 173,414 | |
Skyryse, Inc. Series B (a)(e) | 117,653 | 2,903,673 | |
Stripe, Inc. Series H (a)(b)(e) | 14,400 | 390,960 | |
Tenstorrent, Inc. Series C1 (a)(b)(e) | 16,900 | 951,132 | |
14,398,681 | |||
TOTAL INFORMATION TECHNOLOGY | 39,776,539 | ||
MATERIALS - 0.1% | |||
Chemicals - 0.0% | |||
Farmers Business Network, Inc. Series G (a)(e) | 42,859 | 2,143,807 | |
Metals & Mining - 0.1% | |||
Diamond Foundry, Inc. Series C (a)(b)(e) | 301,038 | 8,606,676 | |
TOTAL MATERIALS | 10,750,483 | ||
UTILITIES - 0.0% | |||
Independent Power and Renewable Electricity Producers - 0.0% | |||
Redwood Materials Series C (a)(e) | 20,469 | 970,302 | |
TOTAL CONVERTIBLE PREFERRED STOCKS | 152,080,581 | ||
Nonconvertible Preferred Stocks - 0.1% | |||
CONSUMER DISCRETIONARY - 0.1% | |||
Automobiles - 0.0% | |||
Waymo LLC Series A2 (a)(b)(e) | 6,592 | 604,631 | |
Internet & Direct Marketing Retail - 0.1% | |||
Circle Internet Financial Ltd. Series E (a) | 127,757 | 6,158,878 | |
TOTAL CONSUMER DISCRETIONARY | 6,763,509 | ||
TOTAL PREFERRED STOCKS (Cost $158,545,816) | 158,844,090 | ||
Convertible Bonds - 0.0% | |||
Principal Amount (g) | Value ($) | ||
CONSUMER DISCRETIONARY - 0.0% | |||
Automobiles - 0.0% | |||
Neutron Holdings, Inc.: | |||
4% 10/27/25 (a)(e)(h) | 1,957,700 | 1,794,036 | |
4% 5/22/27 (a)(e) | 310,600 | 359,985 | |
4% 6/12/27 (a)(e) | 82,200 | 95,270 | |
2,249,291 | |||
FINANCIALS - 0.0% | |||
Diversified Financial Services - 0.0% | |||
Paragon Biosciences Emalex Capital, Inc. 0% (a)(e)(i) | 134,101 | 134,101 | |
TOTAL CONVERTIBLE BONDS (Cost $2,484,601) | 2,383,392 | ||
Preferred Securities - 0.1% | |||
Principal Amount (g) | Value ($) | ||
HEALTH CARE - 0.0% | |||
Health Care Equipment & Supplies - 0.0% | |||
Kardium, Inc. 0% (a)(e)(i) | 1,541,987 | 1,541,987 | |
INFORMATION TECHNOLOGY - 0.1% | |||
Electronic Equipment & Components - 0.0% | |||
Enevate Corp. 0% 1/29/23 (a)(e) | 321,369 | 321,369 | |
Semiconductors & Semiconductor Equipment - 0.1% | |||
GaN Systems, Inc. 0% (a)(e)(i) | 1,477,665 | 1,477,665 | |
Software - 0.0% | |||
Tenstorrent, Inc. 0% (a)(e)(i) | 940,000 | 940,000 | |
TOTAL INFORMATION TECHNOLOGY | 2,739,034 | ||
TOTAL PREFERRED SECURITIES (Cost $4,281,021) | 4,281,021 | ||
Money Market Funds - 4.7% | |||
Shares | Value ($) | ||
Fidelity Cash Central Fund 0.82% (j) | 86,617,413 | 86,634,736 | |
Fidelity Securities Lending Cash Central Fund 0.82% (j)(k) | 410,615,719 | 410,656,781 | |
TOTAL MONEY MARKET FUNDS (Cost $497,291,517) | 497,291,517 | ||
TOTAL INVESTMENT IN SECURITIES - 104.0% (Cost $10,092,158,886) | 11,028,682,769 |
NET OTHER ASSETS (LIABILITIES) - (4.0)% | (422,694,664) |
NET ASSETS - 100.0% | 10,605,988,105 |
(a) | Restricted securities (including private placements) - Investment in securities not registered under the Securities Act of 1933 (excluding 144A issues). At the end of the period, the value of restricted securities (excluding 144A issues) amounted to $251,603,758 or 2.4% of net assets. |
(b) | Non-income producing |
(c) | Security or a portion of the security is on loan at period end. |
(d) | Security exempt from registration under Rule 144A of the Securities Act of 1933. These securities may be resold in transactions exempt from registration, normally to qualified institutional buyers. At the end of the period, the value of these securities amounted to $66,755,973 or 0.6% of net assets. |
(e) | Level 3 security |
(f) | Investment is owned by a wholly-owned subsidiary (Subsidiary) that is treated as a corporation for U.S. tax purposes. |
(g) | Amount is stated in United States dollars unless otherwise noted. |
(h) | Security initially issued at one coupon which converts to a higher coupon at a specified date. The rate shown is the rate at period end. |
(i) | Security is perpetual in nature with no stated maturity date. |
(j) | Affiliated fund that is generally available only to investment companies and other accounts managed by Fidelity Investments. The rate quoted is the annualized seven-day yield of the fund at period end. A complete unaudited listing of the fund's holdings as of its most recent quarter end is available upon request. In addition, each Fidelity Central Fund's financial statements are available on the SEC's website or upon request. |
(k) | Investment made with cash collateral received from securities on loan. |
Additional information on each restricted holding is as follows: | ||
Security | Acquisition Date | Acquisition Cost ($) |
Adimab LLC | 1/19/21 | 10,000,008 |
AgBiome LLC Series D | 9/03/21 | 3,033,967 |
Aledade, Inc. Series B1 | 5/07/21 | 999,234 |
Aledade, Inc. Series E1 | 5/20/22 | 1,063,886 |
Alif Semiconductor Series C | 3/08/22 | 873,527 |
Ankyra Therapeutics Series B | 8/26/21 | 1,854,693 |
Asimov, Inc. Series B | 10/29/21 | 1,846,200 |
Astera Labs, Inc. Series A | 5/17/22 | 819,631 |
Astera Labs, Inc. Series B | 5/17/22 | 139,556 |
Astera Labs, Inc. Series C | 8/24/21 | 1,251,934 |
Astera Labs, Inc. Series D | 5/17/22 | 2,782,101 |
Beta Technologies, Inc. Series A | 4/09/21 | 772,632 |
Beta Technologies, Inc. Series B, 6.00% | 4/04/22 | 2,158,213 |
Bird Global, Inc. | 5/11/21 | 1,564,250 |
Blink Health LLC Series A1 | 12/30/20 | 1,786,125 |
Blink Health LLC Series C | 11/07/19 - 7/14/21 | 5,535,788 |
Bolt Technology OU Series E | 1/03/22 | 4,628,275 |
Boundless Bio, Inc. Series B | 4/23/21 | 1,020,905 |
Bowery Farming, Inc. Series C1 | 5/18/21 | 1,636,070 |
Bright Peak Therapeutics AG Series B | 5/14/21 | 1,102,496 |
ByteDance Ltd. Series E1 | 11/18/20 | 5,373,408 |
Caris Life Sciences, Inc. Series D | 5/11/21 | 2,094,968 |
Castle Creek Biosciences, Inc. Series D1 | 4/19/22 | 962,474 |
Castle Creek Biosciences, Inc. Series D2 | 6/28/21 | 215,100 |
Castle Creek Pharmaceutical Holdings, Inc. Series C | 12/09/19 | 239,697 |
Cibus Corp. Series E | 6/23/21 | 3,635,588 |
Circle Internet Financial Ltd. Series E | 5/11/21 | 2,073,500 |
Conformal Medical, Inc. Series C | 7/24/20 | 514,071 |
Databricks, Inc. Series G | 2/01/21 | 2,235,722 |
Databricks, Inc. Series H | 8/31/21 | 4,121,358 |
Deep Genomics, Inc. Series C | 7/21/21 | 2,254,110 |
Delhivery Private Ltd. | 5/20/21 | 2,372,281 |
Diamond Foundry, Inc. Series C | 3/15/21 | 7,224,912 |
Dianthus Therapeutics, Inc. Series A | 4/06/22 | 1,450,710 |
Discord, Inc. Series I | 9/15/21 | 770,874 |
DNA Script | 12/17/21 | 443,611 |
DNA Script Series B | 12/17/21 | 4,804 |
DNA Script Series C | 10/01/21 | 2,217,248 |
Dragonfly Therapeutics, Inc. | 12/19/19 | 830,209 |
Element Biosciences, Inc. Series B | 12/13/19 | 655,374 |
Element Biosciences, Inc. Series C | 6/21/21 | 2,348,706 |
ElevateBio LLC Series C | 3/09/21 | 1,038,682 |
Enevate Corp. Series E | 1/29/21 | 836,858 |
Enevate Corp. 0% 1/29/23 | 1/29/21 | 321,369 |
Epic Games, Inc. | 7/13/20 - 7/30/20 | 2,875,000 |
Evozyne LLC Series A | 4/09/21 | 1,752,660 |
Fanatics, Inc. Class A | 8/13/20 - 12/15/21 | 6,379,647 |
Farmers Business Network, Inc. Series G | 9/15/21 | 2,664,021 |
Freenome, Inc. Series C | 8/14/20 | 934,916 |
Freenome, Inc. Series D | 11/22/21 | 947,803 |
Galvanize Therapeutics Series B | 3/29/22 | 1,949,422 |
GaN Systems, Inc. Series F1 | 11/30/21 | 534,613 |
GaN Systems, Inc. Series F2 | 11/30/21 | 282,291 |
GaN Systems, Inc. 0% | 11/30/21 | 1,477,665 |
Generate Biomedicines Series B | 11/02/21 | 2,273,494 |
GoBrands, Inc. Series G | 3/02/21 | 4,971,122 |
GoBrands, Inc. Series H | 7/22/21 | 8,049,525 |
Inscripta, Inc. Series D | 11/13/20 | 1,270,263 |
Inscripta, Inc. Series E | 3/30/21 | 1,900,057 |
Instacart, Inc. Series H | 11/13/20 | 747,480 |
Instacart, Inc. Series I | 2/26/21 | 751,125 |
Kardium, Inc. Series D6 | 12/30/20 | 1,104,251 |
Kardium, Inc. 0% | 12/30/20 | 1,541,987 |
Korro Bio, Inc. Series B1 | 12/17/21 | 989,944 |
Korro Bio, Inc. Series B2 | 12/17/21 | 989,944 |
Laronde, Inc. Series B | 8/13/21 | 2,275,896 |
LifeMine Therapeutics, Inc. Series C | 2/15/22 | 3,583,954 |
Meesho Series F | 9/21/21 | 5,135,664 |
Menlo Micro, Inc. Series C | 2/09/22 | 1,317,148 |
National Resilience, Inc. Series B | 12/01/20 | 2,490,423 |
National Resilience, Inc. Series C | 6/28/21 | 3,319,559 |
Neutron Holdings, Inc. 4% 10/27/25 | 10/29/21 | 1,957,700 |
Neutron Holdings, Inc. 4% 5/22/27 | 6/04/20 | 310,600 |
Neutron Holdings, Inc. 4% 6/12/27 | 6/12/20 | 82,200 |
Nuvia, Inc. Series B | 3/16/21 | 173,413 |
Oddity Tech Ltd. | 1/06/22 | 1,594,239 |
Omada Health, Inc. Series E | 12/22/21 | 3,816,251 |
Paragon Biosciences Emalex Capital, Inc. Series C | 2/26/21 | 1,176,647 |
Paragon Biosciences Emalex Capital, Inc. 0% | 5/18/22 | 134,101 |
PrognomIQ, Inc. Series A5 | 8/20/20 | 22,922 |
PrognomIQ, Inc. Series B | 9/11/20 | 450,094 |
PrognomIQ, Inc. Series C | 2/16/22 | 201,054 |
Quell Therapeutics Ltd. Series B | 11/24/21 | 1,554,788 |
Rad Power Bikes, Inc. | 1/21/21 | 826,883 |
Rad Power Bikes, Inc. Series A | 1/21/21 | 107,803 |
Rad Power Bikes, Inc. Series C | 1/21/21 | 424,189 |
Rad Power Bikes, Inc. Series D | 9/17/21 | 2,104,602 |
Reddit, Inc. Series E | 5/18/21 | 191,176 |
Reddit, Inc. Series F | 8/11/21 | 5,467,939 |
Redwood Materials Series C | 5/28/21 | 970,302 |
SalioGen Therapeutics, Inc. Series B | 12/10/21 | 1,485,060 |
Saluda Medical Pty Ltd. Series D | 1/20/22 | 1,975,505 |
Saluda Medical Pty Ltd. warrants | 1/20/22 | 0 |
Scorpion Therapeutics, Inc. Series B | 1/08/21 | 631,103 |
SiMa.ai Series B | 5/10/21 | 1,535,564 |
SiMa.ai Series B1 | 4/25/22 | 142,251 |
Skyhawk Therapeutics, Inc. | 5/21/21 | 2,094,864 |
Skyryse, Inc. Series B | 10/21/21 | 2,903,673 |
Sonoma Biotherapeutics, Inc. Series B | 7/26/21 | 1,161,934 |
Sonoma Biotherapeutics, Inc. Series B1 | 7/26/21 | 929,546 |
Space Exploration Technologies Corp. Class A | 2/16/21 - 5/24/22 | 21,637,941 |
Space Exploration Technologies Corp. Series N | 8/04/20 | 5,373,000 |
Starry Group Holdings, Inc. | 10/06/21 | 4,087,148 |
Stripe, Inc. Class B | 5/18/21 | 1,544,943 |
Stripe, Inc. Series H | 3/15/21 | 577,800 |
T-Knife Therapeutics, Inc. Series B | 6/30/21 | 1,392,911 |
Tenstorrent, Inc. Series C1 | 4/23/21 | 1,004,778 |
Tenstorrent, Inc. 0% | 4/23/21 | 940,000 |
The Beauty Health Co. | 12/08/20 | 4,286,430 |
The Oncology Institute, Inc. | 6/28/21 | 4,467,880 |
Treeline Biosciences Series A | 7/30/21 | 1,895,821 |
Waymo LLC Series A2 | 5/08/20 | 566,037 |
Wheels Up Experience, Inc. | 2/01/21 | 9,615,360 |
Wugen, Inc. Series B | 7/09/21 | 945,276 |
Xsight Labs Ltd. Series D | 2/16/21 | 977,119 |
Zomato Ltd. | 12/09/20 - 2/10/21 | 3,169,182 |
Affiliate | Value, beginning of period ($) | Purchases ($) | Sales Proceeds ($) | Dividend Income ($) | Realized Gain (loss) ($) | Change in Unrealized appreciation (depreciation) ($) | Value, end of period ($) | %ownership, end of period |
Fidelity Cash Central Fund 0.82% | 116,356,559 | 723,095,576 | 752,817,399 | 86,159 | - | - | 86,634,736 | 0.2% |
Fidelity Securities Lending Cash Central Fund 0.82% | 289,768,031 | 1,308,627,871 | 1,187,739,121 | 833,141 | - | - | 410,656,781 | 1.1% |
Total | 406,124,590 | 2,031,723,447 | 1,940,556,520 | 919,300 | - | - | 497,291,517 |
Valuation Inputs at Reporting Date: | ||||
Description | Total ($) | Level 1 ($) | Level 2 ($) | Level 3 ($) |
Investments in Securities: | ||||
Equities: | ||||
Communication Services | 957,947,334 | 942,995,439 | 11,520,675 | 3,431,220 |
Consumer Discretionary | 2,094,844,584 | 2,053,924,552 | 10,765,810 | 30,154,222 |
Consumer Staples | 548,777,021 | 537,962,642 | - | 10,814,379 |
Energy | 388,743,070 | 388,743,070 | - | - |
Financials | 198,676,527 | 198,181,675 | - | 494,852 |
Health Care | 1,319,227,376 | 1,230,375,858 | 16,394,077 | 72,457,441 |
Industrials | 633,872,597 | 590,974,855 | 2,988,883 | 39,908,859 |
Information Technology | 4,062,571,994 | 4,017,271,287 | - | 45,300,707 |
Materials | 249,028,316 | 238,277,833 | - | 10,750,483 |
Real Estate | 58,109,249 | 58,109,249 | - | - |
Utilities | 12,928,771 | - | 11,958,469 | 970,302 |
Corporate Bonds | 2,383,392 | - | - | 2,383,392 |
Preferred Securities | 4,281,021 | - | - | 4,281,021 |
Money Market Funds | 497,291,517 | 497,291,517 | - | - |
Total Investments in Securities: | 11,028,682,769 | 10,754,107,977 | 53,627,914 | 220,946,878 |
Investments in Securities: | |||
Beginning Balance | $ | 191,282,621 | |
Net Realized Gain (Loss) on Investment Securities | (1,048,645) | ||
Net Unrealized Gain (Loss) on Investment Securities | (24,813,173) | ||
Cost of Purchases | 55,914,233 | ||
Proceeds of Sales | (647,488) | ||
Amortization/Accretion | - | ||
Transfers into Level 3 | 2,781,798 | ||
Transfers out of Level 3 | (2,522,468) | ||
Ending Balance | $ | 220,946,878 | |
The change in unrealized gain (loss) for the period attributable to Level 3 securities held at May 31, 2022 | $ | (24,813,173) | |
Statement of Assets and Liabilities | ||||
May 31, 2022 (Unaudited) | ||||
Assets | ||||
Investment in securities, at value (including securities loaned of $391,427,201) - See accompanying schedule: | $10,531,391,252 | |||
Unaffiliated issuers (cost $9,594,867,369) | ||||
Fidelity Central Funds (cost $497,291,517) | 497,291,517 | |||
Total Investment in Securities (cost $10,092,158,886) | $ | 11,028,682,769 | ||
Receivable for investments sold | 12,489,389 | |||
Receivable for fund shares sold | 4,513,200 | |||
Dividends receivable | 5,734,479 | |||
Interest receivable | 38,740 | |||
Distributions receivable from Fidelity Central Funds | 134,640 | |||
Other receivables | 48,070 | |||
Total assets | 11,051,641,287 | |||
Liabilities | ||||
Payable to custodian bank | $35,765 | |||
Payable for investments purchased | 22,015,471 | |||
Payable for fund shares redeemed | 7,421,461 | |||
Accrued management fee | 3,903,301 | |||
Other payables and accrued expenses | 1,622,949 | |||
Collateral on securities loaned | 410,654,235 | |||
Total Liabilities | 445,653,182 | |||
Net Assets | $ | 10,605,988,105 | ||
Net Assets consist of: | ||||
Paid in capital | $ | 9,781,222,099 | ||
Total accumulated earnings (loss) | 824,766,006 | |||
Net Assets | $ | 10,605,988,105 | ||
Net Asset Value , offering price and redemption price per share ($10,605,988,105 ÷ 634,348,770 shares) | $ | 16.72 | ||
Statement of Operations | ||||
Six months ended May 31, 2022 (Unaudited) | ||||
Investment Income | ||||
Dividends | $ | 30,279,717 | ||
Interest | 15,112 | |||
Income from Fidelity Central Funds (including $833,141 from security lending) | 919,300 | |||
Total Income | 31,214,129 | |||
Expenses | ||||
Management fee | $ | 28,438,866 | ||
Independent trustees' fees and expenses | 22,929 | |||
Interest | 345 | |||
Total expenses before reductions | 28,462,140 | |||
Expense reductions | (39) | |||
Total expenses after reductions | 28,462,101 | |||
Net Investment income (loss) | 2,752,028 | |||
Realized and Unrealized Gain (Loss) | ||||
Net realized gain (loss) on: | ||||
Investment Securities: | ||||
Unaffiliated issuers | (87,996,969) | |||
Foreign currency transactions | 3,272 | |||
Total net realized gain (loss) | (87,993,697) | |||
Change in net unrealized appreciation (depreciation) on: | ||||
Investment Securities: | ||||
Unaffiliated issuers (net of decrease in deferred foreign taxes of $264,014) | (4,370,171,215) | |||
Unfunded commitments | 1,136,527 | |||
Assets and liabilities in foreign currencies | (3,645) | |||
Total change in net unrealized appreciation (depreciation) | (4,369,038,333) | |||
Net gain (loss) | (4,457,032,030) | |||
Net increase (decrease) in net assets resulting from operations | $ | (4,454,280,002) |
Statement of Changes in Net Assets | ||||
Six months ended May 31, 2022 (Unaudited) | Year ended November 30, 2021 | |||
Increase (Decrease) in Net Assets | ||||
Operations | ||||
Net investment income (loss) | $ | 2,752,028 | $ | (936,782) |
Net realized gain (loss) | (87,993,697) | 610,189,315 | ||
Change in net unrealized appreciation (depreciation) | (4,369,038,333) | 2,584,713,305 | ||
Net increase (decrease) in net assets resulting from operations | (4,454,280,002) | 3,193,965,838 | ||
Distributions to shareholders | (380,672,676) | (77,746,793) | ||
Share transactions | ||||
Proceeds from sales of shares | 2,047,419,638 | 6,585,080,711 | ||
Reinvestment of distributions | 379,380,027 | 77,746,793 | ||
Cost of shares redeemed | (1,956,193,481) | (2,808,800,801) | ||
Net increase (decrease) in net assets resulting from share transactions | 470,606,184 | 3,854,026,703 | ||
Total increase (decrease) in net assets | (4,364,346,494) | 6,970,245,748 | ||
Net Assets | ||||
Beginning of period | 14,970,334,599 | 8,000,088,851 | ||
End of period | $ | 10,605,988,105 | $ | 14,970,334,599 |
Other Information | ||||
Shares | ||||
Sold | 99,634,059 | 315,731,938 | ||
Issued in reinvestment of distributions | 16,416,271 | 4,040,894 | ||
Redeemed | (98,587,968) | (131,432,053) | ||
Net increase (decrease) | 17,462,362 | 188,340,779 | ||
Fidelity® Growth Company K6 Fund |
Six months ended (Unaudited) May 31, 2022 | Years ended November 30, 2021 | 2020 | 2019 A | |||||
Selected Per-Share Data | ||||||||
Net asset value, beginning of period | $ | 24.27 | $ | 18.67 | $ | 11.19 | $ | 10.00 |
Income from Investment Operations | ||||||||
Net investment income (loss) B,C | - D | - D,E | - D | .01 | ||||
Net realized and unrealized gain (loss) | (6.95) | 5.78 | 7.49 | 1.18 | ||||
Total from investment operations | (6.95) | 5.78 | 7.49 | 1.19 | ||||
Distributions from net investment income | - | (.02) | (.01) | - | ||||
Distributions from net realized gain | (.60) | (.16) | - | - | ||||
Total distributions | (.60) | (.18) | (.01) | - | ||||
Net asset value, end of period | $ | 16.72 | $ | 24.27 | $ | 18.67 | $ | 11.19 |
Total Return F,G | (29.31)% | 31.20% | 66.95% | 11.90% | ||||
Ratios to Average Net Assets C,H,I | ||||||||
Expenses before reductions | .45% J | .45% | .45% | .45% J | ||||
Expenses net of fee waivers, if any | .45% J | .45% | .45% | .45% J | ||||
Expenses net of all reductions | .45% J | .45% | .45% | .45% J | ||||
Net investment income (loss) | .04% J | (.01)% E | .01% | .29% J | ||||
Supplemental Data | ||||||||
Net assets, end of period (000 omitted) | $ | 10,605,988 | $ | 14,970,335 | $ | 8,000,089 | $ | 1,853,643 |
Portfolio turnover rate K,L | 26% J | 22% | 18% | 16% M |
Fidelity Central Fund | Investment Manager | Investment Objective | Investment Practices | Expense Ratio A |
Fidelity Money Market Central Funds | Fidelity Management & Research Company LLC (FMR) | Each fund seeks to obtain a high level of current income consistent with the preservation of capital and liquidity. | Short-term Investments | Less than .005% |
Asset Type | Fair Value | Valuation Technique(s) | Unobservable Input | Amount or Range/Weighted Average | Impact to Valuation from an Increase in Input A |
Equities | $214,282,465 | Market approach | Transaction price | $0.02 - $712.50 / $132.75 | Increase |
Discount rate | 5.3% - 58.3% / 33.4% | Decrease | |||
Liquidation value | $0.05 | Increase | |||
Recovery value | Transaction price | $12.76 | Increase | ||
Recovery value | $0.00 - $2.87 / $2.53 | Increase | |||
Discount for lack of marketability | 5.0% | Decrease | |||
Probability rate | 15.0% - 70.0% / 42.5% | Increase | |||
Market comparable | Enterprise value/Revenue multiple (EV/R) | 2.1 - 24.0 / 8.7 | Increase | ||
Enterprise value/Gross profit multiple (EV/GP) | 8.0 | Increase | |||
Discounted cash flow | Weighted average cost of capital (WACC) | 33.0% - 41.0% / 38.0% | Decrease | ||
Discount rate | 12.3% - 13.0% / 12.6% | Decrease | |||
Growth rate | 3.5% | Increase | |||
Exit multiple | 2.3 - 41.0 / 26.3 | Increase | |||
Corporate Bonds | $2,383,392 | Market approach | Transaction price | $100.00 | Increase |
Market comparable | Enterprise value/Revenue multiple (EV/R) | 2.8 | Increase | ||
Term | 1.4 | Increase | |||
Volatility | 75.0% | Increase | |||
Preferred Securities | $4,281,021 | Market approach | Transaction price | $100.00 | Increase |
Gross unrealized appreciation | $2,486,203,129 |
Gross unrealized depreciation | (1,593,292,632) |
Net unrealized appreciation (depreciation) | $892,910,497 |
Tax cost | $10,135,772,272 |
Investment to be Acquired | Commitment Amount | |
Fidelity Growth Company K6 Fund | Twitter, Inc. | $2,689,621 |
$ Amount | % of Net Assets | |
Fidelity Growth Company K6 Fund | 13,185,134 | .12 |
Purchases ($) | Sales ($) | |
Fidelity Growth Company K6 Fund | 1,620,881,760 | 1,688,155,547 |
Shares | Total net realized gain or loss ($) | Total Proceeds ($) | |
Fidelity Growth Company K6 Fund | 20,643,753 | 183,683,206 | 416,265,589 |
Shares | Total Proceeds ($) | |
Fidelity Growth Company K6 Fund | 27,416,021 | 597,679,925 |
Shares | Total net realized gain or loss ($) | Total Proceeds ($) | |
Fidelity Growth Company K6 Fund | 19,127,529 | 231,544,936 | 416,988,954 |
Shares | Total Proceeds ($) | |
Fidelity Growth Company K6 Fund | 142,380,312 | 2,958,974,001 |
Amount | |
Fidelity Growth Company K6 Fund | $40,040 |
Borrower or Lender | Average Loan Balance | Weighted Average Interest Rate | Interest Expense | |
Fidelity Growth Company K6 Fund | Borrower | $39,399,000 | .32% | $345 |
Purchases ($) | Sales ($) | Realized Gain (Loss) ($) | |
Fidelity Growth Company K6 Fund | 232,068,480 | 167,168,435 | (38,912,829) |
Total Security Lending Fees Paid to NFS | Security Lending Income From Securities Loaned to NFS | Value of Securities Loaned to NFS at Period End | |
Fidelity Growth Company K6 Fund | $90,935 | $11,006 | $403,020 |
The Example is based on an investment of $1,000 invested at the beginning of the period and held for the entire period (December 1, 2021 to May 31, 2022). |
Annualized Expense Ratio- A | Beginning Account Value December 1, 2021 | Ending Account Value May 31, 2022 | Expenses Paid During Period- C December 1, 2021 to May 31, 2022 | |||||||
Fidelity® Growth Company K6 Fund | .45% | |||||||||
Actual | $ 1,000 | $ 706.90 | $ 1.92 | |||||||
Hypothetical- B | $ 1,000 | $ 1,022.69 | $ 2.27 | |||||||
- Highly liquid investments - cash or convertible to cash within three business days or less
- Moderately liquid investments - convertible to cash in three to seven calendar days
- Less liquid investments - can be sold or disposed of, but not settled, within seven calendar days
- Illiquid investments - cannot be sold or disposed of within seven calendar days
Contents
Board Approval of Investment Advisory Contracts and Management Fees |
Top Holdings (% of Fund's net assets) | ||
Apple, Inc. | 10.9 | |
NVIDIA Corp. | 7.7 | |
Amazon.com, Inc. | 6.5 | |
Microsoft Corp. | 6.2 | |
Alphabet, Inc. Class A | 5.4 | |
lululemon athletica, Inc. | 3.4 | |
Alphabet, Inc. Class C | 3.1 | |
Tesla, Inc. | 2.2 | |
Salesforce.com, Inc. | 2.0 | |
Meta Platforms, Inc. Class A | 1.4 | |
48.8 | ||
Market Sectors (% of Fund's net assets) | ||
Information Technology | 39.0 | |
Consumer Discretionary | 19.9 | |
Communication Services | 11.6 | |
Health Care | 11.3 | |
Industrials | 6.1 | |
Consumer Staples | 4.4 | |
Energy | 3.1 | |
Materials | 2.0 | |
Financials | 1.8 | |
Real Estate | 0.4 | |
Utilities | 0.1 | |
Asset Allocation (% of Fund's net assets) |
Foreign investments - 5.4% |
Common Stocks - 97.5% | |||
Shares | Value ($) (000s) | ||
COMMUNICATION SERVICES - 11.5% | |||
Diversified Telecommunication Services - 0.1% | |||
IHS Holding Ltd. | 309,214 | 3,621 | |
Starry Group Holdings, Inc. (a) | 1,070,381 | 9,508 | |
Starry, Inc. | 5,820,526 | 48,980 | |
62,109 | |||
Entertainment - 0.8% | |||
Live Nation Entertainment, Inc. (b) | 128,245 | 12,190 | |
Netflix, Inc. (b) | 761,096 | 150,271 | |
Roblox Corp. (b)(c) | 997,721 | 29,872 | |
Roku, Inc. Class A (b) | 1,551,897 | 147,275 | |
The Walt Disney Co. (b) | 167,642 | 18,514 | |
358,122 | |||
Interactive Media & Services - 10.1% | |||
Alphabet, Inc.: | |||
Class A (b) | 1,079,816 | 2,456,841 | |
Class C (b) | 614,989 | 1,402,655 | |
IAC (b) | 41,574 | 3,546 | |
Kuaishou Technology Class B (b)(d) | 499,648 | 4,839 | |
Meta Platforms, Inc. Class A (b) | 3,239,090 | 627,217 | |
Snap, Inc. Class A (b) | 1,291,335 | 18,221 | |
Taboola.com Ltd. (b) | 1,227,738 | 3,978 | |
Twitter, Inc. (b) | 224,787 | 8,902 | |
Vimeo, Inc. (b) | 5,091,004 | 44,241 | |
4,570,440 | |||
Media - 0.0% | |||
Comcast Corp. Class A | 319,312 | 14,139 | |
Wireless Telecommunication Services - 0.5% | |||
T-Mobile U.S., Inc. (b) | 1,673,628 | 223,078 | |
TOTAL COMMUNICATION SERVICES | 5,227,888 | ||
CONSUMER DISCRETIONARY - 19.6% | |||
Automobiles - 2.7% | |||
Neutron Holdings, Inc. (a)(b)(e) | 1,546,251 | 45 | |
Rad Power Bikes, Inc. (a)(b)(e) | 1,182,568 | 6,551 | |
Rivian Automotive, Inc. (d) | 61,155 | 1,920 | |
Rivian Automotive, Inc. (c) | 5,790,588 | 181,824 | |
Tesla, Inc. (b) | 1,318,961 | 1,000,115 | |
XPeng, Inc. ADR (b) | 942,034 | 22,138 | |
1,212,593 | |||
Hotels, Restaurants & Leisure - 1.8% | |||
Airbnb, Inc. Class A (b) | 130,725 | 15,801 | |
Booking Holdings, Inc. (b) | 111,636 | 250,462 | |
Chipotle Mexican Grill, Inc. (b) | 42,326 | 59,364 | |
Dutch Bros, Inc. (c) | 152,102 | 5,711 | |
Expedia, Inc. (b) | 438,347 | 56,691 | |
F45 Training Holdings, Inc. | 655,503 | 4,169 | |
Hyatt Hotels Corp. Class A (b) | 135,913 | 12,013 | |
Marriott International, Inc. Class A | 1,287,841 | 220,968 | |
McDonald's Corp. | 2,992 | 755 | |
Penn National Gaming, Inc. (b) | 2,153,695 | 68,832 | |
Shake Shack, Inc. Class A (b)(c) | 68,698 | 3,342 | |
Sonder Holdings, Inc. (b)(c) | 2,427,770 | 5,462 | |
Sonder Holdings, Inc. | 3,589,611 | 7,673 | |
Sonder Holdings, Inc.: | |||
rights (b)(e) | 53,749 | 47 | |
rights (b)(e) | 53,749 | 42 | |
rights (b)(e) | 53,749 | 38 | |
rights (b)(e) | 53,749 | 34 | |
rights (b)(e) | 53,749 | 31 | |
rights (b)(e) | 53,748 | 29 | |
Starbucks Corp. | 896,995 | 70,414 | |
Sweetgreen, Inc. Class A | 1,196,651 | 21,875 | |
Yum China Holdings, Inc. (c) | 479,305 | 21,789 | |
825,542 | |||
Household Durables - 0.3% | |||
Lennar Corp. Class A | 1,253,323 | 100,579 | |
PulteGroup, Inc. | 217,282 | 9,834 | |
Purple Innovation, Inc. (b)(c) | 3,673,569 | 19,029 | |
Vizio Holding Corp. (b)(c) | 461,155 | 4,090 | |
133,532 | |||
Internet & Direct Marketing Retail - 7.2% | |||
Amazon.com, Inc. (b) | 1,219,217 | 2,931,229 | |
Etsy, Inc. (b) | 89,242 | 7,239 | |
JD.com, Inc. sponsored ADR | 81,768 | 4,589 | |
Ozon Holdings PLC ADR (b)(c)(e) | 21,378 | 45 | |
Pinduoduo, Inc. ADR (b) | 160,046 | 8,058 | |
Revolve Group, Inc. (b)(c) | 1,998,632 | 58,720 | |
RumbleON, Inc. Class B (b)(c) | 326,424 | 5,193 | |
The RealReal, Inc. (b)(c) | 276,991 | 909 | |
thredUP, Inc. (b)(c) | 1,660,363 | 6,940 | |
Wayfair LLC Class A (b)(c) | 3,506,581 | 208,256 | |
Zomato Ltd. (a)(b) | 31,811,600 | 29,073 | |
3,260,251 | |||
Leisure Products - 0.0% | |||
Peloton Interactive, Inc. Class A (b)(c) | 67,921 | 948 | |
Multiline Retail - 0.4% | |||
Dollar General Corp. | 155,270 | 34,212 | |
Dollar Tree, Inc. (b) | 251,287 | 40,289 | |
Ollie's Bargain Outlet Holdings, Inc. (b) | 1,846,843 | 86,746 | |
Target Corp. | 75,510 | 12,224 | |
173,471 | |||
Specialty Retail - 2.1% | |||
Carvana Co. Class A (b)(c) | 149,834 | 4,411 | |
Fanatics, Inc. Class A (a)(e) | 695,423 | 47,177 | |
Five Below, Inc. (b) | 215,147 | 28,096 | |
Floor & Decor Holdings, Inc. Class A (b) | 178,737 | 13,484 | |
Lowe's Companies, Inc. | 1,457,550 | 284,660 | |
RH (b) | 165,077 | 47,886 | |
The Home Depot, Inc. | 1,100,225 | 333,093 | |
TJX Companies, Inc. | 3,503,215 | 222,699 | |
Volta, Inc. (a)(b) | 2,923 | 7 | |
981,513 | |||
Textiles, Apparel & Luxury Goods - 5.1% | |||
Canada Goose Holdings, Inc. (b) | 1,225,622 | 24,612 | |
Deckers Outdoor Corp. (b) | 633,754 | 170,201 | |
lululemon athletica, Inc. (b) | 5,234,974 | 1,532,225 | |
NIKE, Inc. Class B | 1,405,656 | 167,062 | |
On Holding AG (c) | 4,542,127 | 93,795 | |
Skechers U.S.A., Inc. Class A (sub. vtg.) (b) | 7,668,892 | 302,154 | |
Tory Burch LLC: | |||
Class A (a)(b)(e)(f) | 950,844 | 41,335 | |
Class B (a)(b)(e)(f) | 324,840 | 15,241 | |
2,346,625 | |||
TOTAL CONSUMER DISCRETIONARY | 8,934,475 | ||
CONSUMER STAPLES - 4.3% | |||
Beverages - 1.6% | |||
Constellation Brands, Inc. Class A (sub. vtg.) | 102,071 | 25,055 | |
Fever-Tree Drinks PLC | 692,478 | 13,420 | |
Keurig Dr. Pepper, Inc. | 2,371,103 | 82,372 | |
Monster Beverage Corp. (b) | 2,293,336 | 204,382 | |
PepsiCo, Inc. | 591,552 | 99,233 | |
The Coca-Cola Co. | 4,448,868 | 281,969 | |
706,431 | |||
Food & Staples Retailing - 1.0% | |||
Albertsons Companies, Inc. | 436,828 | 13,345 | |
Blink Health LLC Series A1 (a)(b)(e) | 173,460 | 5,561 | |
Costco Wholesale Corp. | 457,338 | 213,220 | |
Grocery Outlet Holding Corp. (b)(c) | 377,492 | 14,439 | |
Kroger Co. | 1,449,332 | 76,771 | |
Performance Food Group Co. (b) | 1,407,495 | 61,001 | |
Sysco Corp. | 1,082,121 | 91,093 | |
The Real Good Food Co. LLC Class B (e) | 616,906 | 0 | |
475,430 | |||
Food Products - 0.5% | |||
Archer Daniels Midland Co. | 357,022 | 32,425 | |
Bunge Ltd. | 753,469 | 89,150 | |
Darling Ingredients, Inc. (b) | 558,588 | 44,726 | |
Kellogg Co. (c) | 214,254 | 14,942 | |
Laird Superfood, Inc. (b) | 38,989 | 93 | |
Mondelez International, Inc. | 301,005 | 19,132 | |
Oatly Group AB ADR (b)(c) | 1,966,369 | 8,121 | |
The Hershey Co. | 78,160 | 16,547 | |
The Real Good Food Co. LLC Class B unit (d) | 616,906 | 4,158 | |
The Real Good Food Co., Inc. | 55,431 | 374 | |
229,668 | |||
Household Products - 0.3% | |||
Church & Dwight Co., Inc. | 237,241 | 21,366 | |
Colgate-Palmolive Co. | 332,971 | 26,241 | |
Procter & Gamble Co. | 466,378 | 68,968 | |
116,575 | |||
Personal Products - 0.2% | |||
Olaplex Holdings, Inc. (c) | 3,393,404 | 54,702 | |
The Beauty Health Co. (a)(b) | 2,884,717 | 41,165 | |
The Beauty Health Co. (b)(c) | 1,212,154 | 17,297 | |
113,164 | |||
Tobacco - 0.7% | |||
Altria Group, Inc. | 2,357,665 | 127,526 | |
JUUL Labs, Inc. Class A (a)(b)(e) | 44,067 | 1,765 | |
Philip Morris International, Inc. | 1,855,287 | 197,124 | |
326,415 | |||
TOTAL CONSUMER STAPLES | 1,967,683 | ||
ENERGY - 3.1% | |||
Energy Equipment & Services - 0.7% | |||
Baker Hughes Co. Class A | 1,203,724 | 43,310 | |
Halliburton Co. | 3,382,456 | 136,989 | |
Schlumberger Ltd. | 2,340,216 | 107,556 | |
287,855 | |||
Oil, Gas & Consumable Fuels - 2.4% | |||
Cameco Corp. (c) | 832,733 | 20,377 | |
Devon Energy Corp. | 318,285 | 23,840 | |
EOG Resources, Inc. | 782,782 | 107,210 | |
Hess Corp. | 3,714,500 | 457,144 | |
Occidental Petroleum Corp. | 589,695 | 40,872 | |
Phillips 66 Co. | 164,028 | 16,536 | |
Pioneer Natural Resources Co. | 366,174 | 101,774 | |
Range Resources Corp. (b) | 3,301,781 | 112,095 | |
Reliance Industries Ltd. | 4,598,338 | 156,007 | |
Valero Energy Corp. | 542,443 | 70,301 | |
1,106,156 | |||
TOTAL ENERGY | 1,394,011 | ||
FINANCIALS - 1.8% | |||
Banks - 0.6% | |||
Bank of America Corp. | 2,583,095 | 96,091 | |
First Republic Bank | 332,768 | 51,589 | |
HDFC Bank Ltd. sponsored ADR | 1,433,284 | 82,514 | |
JPMorgan Chase & Co. | 391,197 | 51,728 | |
Wells Fargo & Co. | 158,641 | 7,261 | |
289,183 | |||
Capital Markets - 0.7% | |||
B3 SA - Brasil Bolsa Balcao | 3,626,300 | 9,744 | |
BlackRock, Inc. Class A | 125,762 | 84,145 | |
Charles Schwab Corp. | 2,786,475 | 195,332 | |
289,221 | |||
Consumer Finance - 0.2% | |||
American Express Co. | 575,821 | 97,210 | |
Discover Financial Services | 84,853 | 9,630 | |
106,840 | |||
Diversified Financial Services - 0.3% | |||
Adimab LLC (a)(b)(e)(f) | 3,162,765 | 130,499 | |
Ant International Co. Ltd. Class C (a)(b)(e) | 2,440,816 | 4,662 | |
135,161 | |||
TOTAL FINANCIALS | 820,405 | ||
HEALTH CARE - 10.7% | |||
Biotechnology - 5.7% | |||
4D Molecular Therapeutics, Inc. (b) | 103,716 | 787 | |
AbbVie, Inc. | 411,354 | 60,621 | |
ACADIA Pharmaceuticals, Inc. (b) | 4,528,150 | 73,130 | |
Adagio Therapeutics, Inc. (c)(g) | 5,770,997 | 17,082 | |
ADC Therapeutics SA (b) | 777,954 | 5,321 | |
Akouos, Inc. (b) | 927,156 | 2,893 | |
Akouos, Inc. (b)(d) | 362,038 | 1,130 | |
Alector, Inc. (b) | 1,293,921 | 11,464 | |
Allovir, Inc. (b)(c) | 2,278,383 | 8,817 | |
Alnylam Pharmaceuticals, Inc. (b) | 2,531,867 | 318,509 | |
Ambrx Biopharma, Inc. ADR | 392,395 | 1,542 | |
Amgen, Inc. | 370,673 | 95,167 | |
Arcutis Biotherapeutics, Inc. (b) | 652,928 | 13,633 | |
Argenx SE ADR (b) | 658,326 | 203,620 | |
Arrowhead Pharmaceuticals, Inc. (b) | 96,606 | 3,223 | |
Ascendis Pharma A/S sponsored ADR (b) | 63,114 | 5,334 | |
aTyr Pharma, Inc. (b) | 1,018,945 | 2,863 | |
Avidity Biosciences, Inc. (b)(c) | 1,127,053 | 15,700 | |
Axcella Health, Inc. (b) | 2,473,650 | 5,244 | |
Beam Therapeutics, Inc. (b)(c) | 192,629 | 6,777 | |
BeiGene Ltd. ADR (b) | 960,658 | 131,821 | |
BioNTech SE ADR (b) | 2,066 | 338 | |
BioXcel Therapeutics, Inc. (b)(c)(g) | 1,422,954 | 16,649 | |
Calyxt, Inc. (b)(c) | 227,619 | 74 | |
Century Therapeutics, Inc. | 1,404,280 | 12,203 | |
Cerevel Therapeutics Holdings (b) | 5,631,647 | 147,155 | |
ChemoCentryx, Inc. (b) | 2,896,930 | 64,515 | |
Cibus Corp.: | |||
Series C (a)(b)(e)(f) | 4,523,810 | 11,083 | |
Series D (a)(b)(e)(f) | 2,741,040 | 6,716 | |
Series E (a)(b)(e)(f) | 412,624 | 1,011 | |
Codiak Biosciences, Inc. (b)(g) | 1,147,045 | 3,200 | |
Connect Biopharma Holdings Ltd. ADR (b)(c) | 30,329 | 24 | |
CRISPR Therapeutics AG (b)(c) | 456,014 | 26,472 | |
Cyclerion Therapeutics, Inc. (b) | 229,594 | 143 | |
Cyclerion Therapeutics, Inc. (a)(b) | 543,695 | 339 | |
Day One Biopharmaceuticals, Inc. (b)(c) | 190,931 | 1,188 | |
Denali Therapeutics, Inc. (b) | 309,408 | 7,516 | |
Deverra Therapeutics, Inc. (e) | 59,780 | 85 | |
EQRx, Inc. (b)(c)(g) | 6,804,893 | 37,835 | |
EQRx, Inc.: | |||
rights (b)(e) | 441,931 | 1,180 | |
rights (b)(e) | 189,399 | 400 | |
Erasca, Inc. | 364,089 | 1,973 | |
Evelo Biosciences, Inc. (b)(c) | 5,079,337 | 10,667 | |
Exelixis, Inc. (b) | 170,164 | 3,119 | |
Foghorn Therapeutics, Inc. (b) | 1,005,347 | 12,969 | |
Gemini Therapeutics, Inc. (b)(c) | 136,628 | 175 | |
Generation Bio Co. (b) | 2,403,453 | 13,507 | |
Graphite Bio, Inc. | 247,486 | 582 | |
Icosavax, Inc. (b) | 323,946 | 2,200 | |
Imago BioSciences, Inc. | 172,978 | 2,795 | |
Immunocore Holdings PLC ADR (b) | 464,117 | 13,158 | |
Inhibrx, Inc. (b)(c) | 540,458 | 7,064 | |
Instil Bio, Inc. (b) | 418,819 | 2,515 | |
Intarcia Therapeutics, Inc. warrants 12/6/24 (b)(e) | 156,370 | 0 | |
Ionis Pharmaceuticals, Inc. (b)(g) | 7,348,165 | 268,355 | |
iTeos Therapeutics, Inc. (b) | 107,026 | 1,873 | |
Janux Therapeutics, Inc. | 527,178 | 5,867 | |
Karuna Therapeutics, Inc. (b) | 1,320,420 | 137,746 | |
Kinnate Biopharma, Inc. (b) | 256,455 | 2,036 | |
Kronos Bio, Inc. (b)(c) | 120,053 | 447 | |
Lexicon Pharmaceuticals, Inc. (b)(c) | 1,917,395 | 3,394 | |
Lyell Immunopharma, Inc. (c) | 794,707 | 3,290 | |
Moderna, Inc. (b) | 670,359 | 97,423 | |
Monte Rosa Therapeutics, Inc. | 1,116,905 | 8,645 | |
Morphic Holding, Inc. (b) | 1,138,647 | 26,690 | |
Nuvalent, Inc. Class A (b) | 1,367,185 | 12,113 | |
Omega Therapeutics, Inc. (b) | 1,259,959 | 2,860 | |
ORIC Pharmaceuticals, Inc. (b) | 1,034,288 | 3,455 | |
Poseida Therapeutics, Inc. (b) | 2,057,812 | 4,671 | |
Praxis Precision Medicines, Inc. (b) | 1,471,872 | 12,217 | |
Protagonist Therapeutics, Inc. (b) | 671,905 | 5,886 | |
Prothena Corp. PLC (b) | 649,713 | 17,692 | |
PTC Therapeutics, Inc. (b) | 897,712 | 26,366 | |
Recursion Pharmaceuticals, Inc. (b)(c) | 623,587 | 3,816 | |
Regeneron Pharmaceuticals, Inc. (b) | 286,980 | 190,767 | |
Relay Therapeutics, Inc. (b) | 614,776 | 10,009 | |
Rigel Pharmaceuticals, Inc. (b)(g) | 9,013,678 | 16,315 | |
Rubius Therapeutics, Inc. (b)(c)(g) | 4,634,562 | 5,098 | |
Sage Therapeutics, Inc. (b) | 1,890,992 | 59,131 | |
Saluda Medical Pty Ltd. warrants (a)(b)(e) | 174,424 | 501 | |
Sana Biotechnology, Inc. (b)(c) | 520,527 | 2,670 | |
Scholar Rock Holding Corp. (b) | 1,107,660 | 5,560 | |
Seagen, Inc. (b) | 45,250 | 6,140 | |
Seres Therapeutics, Inc. (b)(g) | 4,644,053 | 14,397 | |
Shattuck Labs, Inc. (b) | 1,328,045 | 3,798 | |
Sigilon Therapeutics, Inc. (b) | 404,961 | 307 | |
Silverback Therapeutics, Inc. (b)(c) | 1,441,529 | 5,031 | |
Springworks Therapeutics, Inc. (b)(g) | 2,576,253 | 48,794 | |
Synlogic, Inc. (b) | 2,432,665 | 2,652 | |
Syros Pharmaceuticals, Inc. (b)(d) | 938,007 | 771 | |
Syros Pharmaceuticals, Inc. warrants 10/10/22 (b) | 100,060 | 0 | |
Tango Therapeutics, Inc. (b) | 953,883 | 6,381 | |
Taysha Gene Therapies, Inc. (b) | 971,182 | 2,477 | |
Tenaya Therapeutics, Inc. (b) | 264,939 | 1,775 | |
TG Therapeutics, Inc. (b) | 1,541,644 | 6,814 | |
Twist Bioscience Corp. (b) | 845,076 | 28,766 | |
Tyra Biosciences, Inc. | 166,391 | 1,136 | |
Ultragenyx Pharmaceutical, Inc. (b) | 67,268 | 3,155 | |
uniQure B.V. (b) | 372,062 | 5,343 | |
UNITY Biotechnology, Inc. (b)(c) | 484,709 | 383 | |
Vaxcyte, Inc. (b) | 1,013,780 | 24,321 | |
Vera Therapeutics, Inc. (b) | 581,902 | 8,461 | |
Vertex Pharmaceuticals, Inc. (b) | 117,616 | 31,598 | |
Verve Therapeutics, Inc. | 316,556 | 4,799 | |
Vor Biopharma, Inc. (b) | 372,746 | 1,569 | |
Yumanity Therapeutics, Inc. (b) | 524,960 | 562 | |
Zai Lab Ltd. ADR (b) | 559,966 | 16,295 | |
Zentalis Pharmaceuticals, Inc. (b) | 729,422 | 17,586 | |
2,571,732 | |||
Health Care Equipment & Supplies - 2.5% | |||
Abbott Laboratories | 260,195 | 30,563 | |
DexCom, Inc. (b) | 292,000 | 86,998 | |
Insulet Corp. (b) | 1,654,749 | 353,256 | |
Intuitive Surgical, Inc. (b) | 721,431 | 164,227 | |
Novocure Ltd. (b) | 4,010,192 | 322,339 | |
Oddity Tech Ltd. (a)(e) | 10,306 | 4,436 | |
Outset Medical, Inc. (b) | 1,492,486 | 32,536 | |
Penumbra, Inc. (b) | 5,139 | 755 | |
Presbia PLC (b)(e)(g) | 1,099,338 | 16 | |
PROCEPT BioRobotics Corp. | 455,549 | 17,821 | |
PROCEPT BioRobotics Corp. (d) | 518,247 | 20,274 | |
Shockwave Medical, Inc. (b) | 595,654 | 97,812 | |
1,131,033 | |||
Health Care Providers & Services - 0.7% | |||
1Life Healthcare, Inc. (b) | 981,201 | 8,311 | |
23andMe Holding Co. Class A (b)(c) | 1,018,425 | 3,055 | |
Alignment Healthcare, Inc. (b) | 1,803,601 | 19,262 | |
AmerisourceBergen Corp. | 120,866 | 18,709 | |
Centene Corp. (b) | 684,892 | 55,778 | |
Guardant Health, Inc. (b) | 170,111 | 6,971 | |
Humana, Inc. | 90,713 | 41,205 | |
McKesson Corp. | 84,902 | 27,906 | |
Privia Health Group, Inc. (b)(c) | 106,685 | 2,556 | |
Progyny, Inc. (b)(c) | 270,965 | 8,565 | |
The Oncology Institute, Inc. (a) | 1,815,080 | 16,354 | |
UnitedHealth Group, Inc. | 239,271 | 118,865 | |
327,537 | |||
Health Care Technology - 0.0% | |||
DNA Script (a)(e) | 463 | 354 | |
DNA Script (a)(e) | 1,769 | 1,353 | |
1,707 | |||
Life Sciences Tools & Services - 0.8% | |||
10X Genomics, Inc. Class B (b)(d) | 2,870,040 | 146,917 | |
Absci Corp. (c) | 4,370,800 | 15,953 | |
Akoya Biosciences, Inc. (b)(c) | 60,706 | 707 | |
Danaher Corp. | 35,581 | 9,387 | |
ICON PLC (b) | 20,740 | 4,641 | |
Nanostring Technologies, Inc. (b) | 230,261 | 3,601 | |
Olink Holding AB ADR (b) | 1,452,651 | 17,083 | |
Seer, Inc. (b) | 1,403,604 | 12,464 | |
Thermo Fisher Scientific, Inc. | 144,243 | 81,868 | |
WuXi AppTec Co. Ltd. (H Shares) (d) | 1,167,084 | 14,404 | |
Wuxi Biologics (Cayman), Inc. (b)(d) | 8,317,218 | 61,503 | |
368,528 | |||
Pharmaceuticals - 1.0% | |||
4D Pharma PLC (b)(c) | 2,676,997 | 1,108 | |
Arvinas Holding Co. LLC (b) | 188,908 | 7,876 | |
Atea Pharmaceuticals, Inc. (b)(g) | 4,532,529 | 35,716 | |
Bristol-Myers Squibb Co. | 417,097 | 31,470 | |
Dragonfly Therapeutics, Inc. (a)(b)(e) | 481,725 | 5,516 | |
Eli Lilly & Co. | 73,501 | 23,038 | |
Fulcrum Therapeutics, Inc. (b) | 1,163,210 | 8,282 | |
GH Research PLC | 1,092,094 | 10,943 | |
Hansoh Pharmaceutical Group Co. Ltd. (d) | 2,043,823 | 3,683 | |
Harmony Biosciences Holdings, Inc. (b)(c) | 1,852,117 | 80,752 | |
Intra-Cellular Therapies, Inc. (b) | 3,174,169 | 182,197 | |
Jiangsu Hengrui Medicine Co. Ltd. (A Shares) | 292,440 | 1,329 | |
Nuvation Bio, Inc. (b)(c) | 4,462,816 | 15,754 | |
OptiNose, Inc. (b)(g) | 4,336,191 | 8,911 | |
Pfizer, Inc. | 345,592 | 18,330 | |
Pharvaris BV (b) | 141,628 | 2,510 | |
Pliant Therapeutics, Inc. (b) | 559,463 | 3,150 | |
Sienna Biopharmaceuticals, Inc. (b)(g) | 1,559,140 | 0 | |
Skyhawk Therapeutics, Inc. (a)(e) | 603,195 | 5,845 | |
Theravance Biopharma, Inc. (b) | 964,596 | 8,469 | |
Theseus Pharmaceuticals, Inc. | 258,287 | 1,743 | |
UCB SA | 103,333 | 9,114 | |
465,736 | |||
TOTAL HEALTH CARE | 4,866,273 | ||
INDUSTRIALS - 5.7% | |||
Aerospace & Defense - 0.9% | |||
AeroVironment, Inc. (b) | 35,700 | 3,283 | |
Lockheed Martin Corp. | 132,471 | 58,302 | |
Raytheon Technologies Corp. | 482,014 | 45,849 | |
Space Exploration Technologies Corp. Class A (a)(b)(e) | 4,182,100 | 292,747 | |
The Boeing Co. (b) | 100,633 | 13,223 | |
413,404 | |||
Air Freight & Logistics - 0.2% | |||
Delhivery Private Ltd. (a) | 2,969,100 | 18,260 | |
FedEx Corp. | 88,026 | 19,769 | |
United Parcel Service, Inc. Class B | 259,750 | 47,339 | |
85,368 | |||
Airlines - 1.5% | |||
Delta Air Lines, Inc. (b) | 3,475,090 | 144,877 | |
JetBlue Airways Corp. (b) | 8,399,710 | 90,213 | |
Ryanair Holdings PLC sponsored ADR (b) | 97,196 | 8,475 | |
Southwest Airlines Co. (b) | 4,806,096 | 220,408 | |
Spirit Airlines, Inc. (b) | 1,794,851 | 37,602 | |
United Airlines Holdings, Inc. (b) | 1,782,862 | 84,918 | |
Wheels Up Experience, Inc. (a)(b) | 166,281 | 421 | |
Wheels Up Experience, Inc.: | |||
Class A (b) | 7,059,184 | 17,860 | |
rights (b)(e) | 80,889 | 63 | |
rights (b)(e) | 80,889 | 51 | |
rights (b)(e) | 80,890 | 41 | |
Wizz Air Holdings PLC (b)(d) | 2,313,511 | 85,125 | |
690,054 | |||
Building Products - 0.0% | |||
Trane Technologies PLC | 138,179 | 19,077 | |
Construction & Engineering - 0.1% | |||
Fluor Corp. (b) | 339,014 | 9,570 | |
MasTec, Inc. (b)(c) | 175,136 | 14,640 | |
Quanta Services, Inc. | 103,577 | 12,326 | |
36,536 | |||
Electrical Equipment - 0.3% | |||
AMETEK, Inc. | 10,252 | 1,245 | |
Eaton Corp. PLC | 181,341 | 25,134 | |
Emerson Electric Co. | 324,864 | 28,802 | |
Fluence Energy, Inc. (c) | 199,159 | 1,952 | |
Generac Holdings, Inc. (b) | 160,054 | 39,546 | |
Rockwell Automation, Inc. | 112,684 | 24,024 | |
120,703 | |||
Industrial Conglomerates - 0.1% | |||
Honeywell International, Inc. | 110,860 | 21,465 | |
Machinery - 0.7% | |||
Caterpillar, Inc. | 400,943 | 86,544 | |
Deere & Co. | 308,775 | 110,474 | |
Illinois Tool Works, Inc. | 196,548 | 40,896 | |
Ingersoll Rand, Inc. | 278,994 | 13,155 | |
Xylem, Inc. | 763,462 | 64,322 | |
315,391 | |||
Professional Services - 0.0% | |||
Clarivate Analytics PLC (b) | 52,672 | 778 | |
LegalZoom.com, Inc. (c) | 443,409 | 5,809 | |
Sterling Check Corp. (c) | 258,466 | 4,802 | |
11,389 | |||
Road & Rail - 1.9% | |||
Avis Budget Group, Inc. (b) | 2,260,518 | 430,131 | |
Bird Global, Inc. (a) | 961,227 | 728 | |
Bird Global, Inc.: | |||
rights (b)(e) | 133,323 | 8 | |
rights (b)(e) | 133,322 | 4 | |
rights (b)(e) | 133,322 | 1 | |
Class A (b) | 3,591,576 | 2,720 | |
Canadian Pacific Railway Ltd. | 394,871 | 28,210 | |
CSX Corp. | 1,492,957 | 47,461 | |
Hertz Global Holdings, Inc. (c) | 1,446,001 | 29,021 | |
Lyft, Inc. (b) | 938,601 | 16,594 | |
Uber Technologies, Inc. (b) | 4,244,208 | 98,466 | |
Union Pacific Corp. (c) | 1,018,804 | 223,913 | |
877,257 | |||
TOTAL INDUSTRIALS | 2,590,644 | ||
INFORMATION TECHNOLOGY - 38.4% | |||
Communications Equipment - 0.5% | |||
Arista Networks, Inc. (b) | 330,189 | 33,772 | |
Ciena Corp. (b) | 2,848,889 | 144,781 | |
Infinera Corp. (b)(c)(g) | 11,326,603 | 64,901 | |
243,454 | |||
Electronic Equipment & Components - 0.1% | |||
Arlo Technologies, Inc. (b) | 869,927 | 6,159 | |
II-VI, Inc. (b)(c) | 382,647 | 23,915 | |
TE Connectivity Ltd. | 13,297 | 1,720 | |
Trimble, Inc. (b) | 532,684 | 36,249 | |
68,043 | |||
IT Services - 3.5% | |||
Accenture PLC Class A | 177,897 | 53,095 | |
Actua Corp. (b)(e) | 1,299,520 | 13 | |
Block, Inc. Class A (b)(c) | 729,470 | 63,836 | |
CI&T, Inc. Class A | 264,644 | 3,824 | |
Cloudflare, Inc. (b) | 4,275,082 | 239,405 | |
MasterCard, Inc. Class A | 1,293,408 | 462,872 | |
MongoDB, Inc. Class A (b) | 25,929 | 6,149 | |
Okta, Inc. (b) | 198,715 | 16,503 | |
PayPal Holdings, Inc. (b) | 1,663,598 | 141,755 | |
Shopify, Inc. Class A (b) | 200,142 | 75,137 | |
Snowflake, Inc. (b) | 113,729 | 14,518 | |
Thoughtworks Holding, Inc. | 238,007 | 4,120 | |
Toast, Inc. | 30,179 | 490 | |
Twilio, Inc. Class A (b) | 25,164 | 2,646 | |
Visa, Inc. Class A | 2,357,552 | 500,202 | |
1,584,565 | |||
Semiconductors & Semiconductor Equipment - 11.7% | |||
Advanced Micro Devices, Inc. (b) | 3,442,417 | 350,645 | |
Applied Materials, Inc. | 1,466,445 | 171,999 | |
ASML Holding NV | 164,387 | 94,735 | |
Broadcom, Inc. | 127,325 | 73,865 | |
Cirrus Logic, Inc. (b) | 1,583,110 | 129,087 | |
Enphase Energy, Inc. (b) | 185,192 | 34,481 | |
First Solar, Inc. (b) | 550,286 | 38,856 | |
GlobalFoundries, Inc. | 452,761 | 27,025 | |
Intel Corp. | 341,786 | 15,182 | |
KLA Corp. | 188,309 | 68,705 | |
Lam Research Corp. | 43,280 | 22,507 | |
Marvell Technology, Inc. | 2,245,045 | 132,794 | |
Micron Technology, Inc. | 178,097 | 13,151 | |
NVIDIA Corp. | 18,833,124 | 3,516,521 | |
onsemi (b) | 174,337 | 10,579 | |
Qualcomm, Inc. | 538,688 | 77,151 | |
Silicon Laboratories, Inc. (b)(g) | 1,966,237 | 293,284 | |
SiTime Corp. (b) | 323,575 | 68,921 | |
Taiwan Semiconductor Manufacturing Co. Ltd. sponsored ADR | 393,434 | 37,494 | |
Teradyne, Inc. | 229,754 | 25,103 | |
Texas Instruments, Inc. | 449,603 | 79,472 | |
Wolfspeed, Inc. (b)(c) | 323,888 | 24,366 | |
5,305,923 | |||
Software - 11.0% | |||
Adobe, Inc. (b) | 624,811 | 260,221 | |
Atlassian Corp. PLC (b) | 25,214 | 4,471 | |
Autodesk, Inc. (b) | 420,474 | 87,353 | |
Avalara, Inc. (b)(c) | 87,205 | 7,384 | |
AvidXchange Holdings, Inc. | 491 | 4 | |
Bill.Com Holdings, Inc. (b) | 13,216 | 1,563 | |
Black Knight, Inc. (b) | 256,647 | 17,429 | |
C3.Ai, Inc. (b)(c) | 655,220 | 12,397 | |
Clear Secure, Inc. | 2,511 | 69 | |
Clearwater Analytics Holdings, Inc. (c) | 177,403 | 2,503 | |
Coupa Software, Inc. (b) | 65,569 | 4,510 | |
Crowdstrike Holdings, Inc. (b) | 256,986 | 41,115 | |
Datadog, Inc. Class A (b) | 97,834 | 9,332 | |
Elastic NV (b) | 180,129 | 11,105 | |
Epic Games, Inc. (a)(b)(e) | 51,800 | 48,174 | |
ForgeRock, Inc. (c) | 176,255 | 3,377 | |
HubSpot, Inc. (b) | 94,978 | 32,073 | |
Informatica, Inc. (c) | 288,385 | 5,883 | |
Intuit, Inc. | 201,943 | 83,697 | |
Microsoft Corp. | 10,266,754 | 2,791,222 | |
Nutanix, Inc. Class A (b)(g) | 12,185,136 | 197,399 | |
Oracle Corp. | 2,941,761 | 211,571 | |
Paycom Software, Inc. (b) | 52,412 | 14,903 | |
Paylocity Holding Corp. (b)(c) | 82,983 | 14,510 | |
Pine Labs Private Ltd. (a)(e) | 4,120 | 2,306 | |
RingCentral, Inc. (b) | 30,141 | 1,903 | |
Riskified Ltd.: | |||
Class A (d) | 118,325 | 615 | |
Class B | 1,558,874 | 8,106 | |
Salesforce.com, Inc. (b) | 5,566,769 | 892,019 | |
Samsara, Inc. (c) | 272,621 | 3,067 | |
SentinelOne, Inc. (c) | 261,658 | 6,225 | |
ServiceNow, Inc. (b) | 190,513 | 89,059 | |
Stripe, Inc. Class B (a)(b)(e) | 205,500 | 5,579 | |
The Trade Desk, Inc. (b) | 78,983 | 4,111 | |
UiPath, Inc. Class A (b)(c) | 1,913,728 | 32,667 | |
Workday, Inc. Class A (b) | 99,100 | 15,489 | |
Zoom Video Communications, Inc. Class A (b) | 188,037 | 20,205 | |
Zscaler, Inc. (b) | 274,693 | 42,053 | |
4,985,669 | |||
Technology Hardware, Storage & Peripherals - 11.6% | |||
Apple, Inc. | 33,420,848 | 4,974,362 | |
Pure Storage, Inc. Class A (b) | 11,232,660 | 266,551 | |
Samsung Electronics Co. Ltd. | 416,325 | 22,585 | |
5,263,498 | |||
TOTAL INFORMATION TECHNOLOGY | 17,451,152 | ||
MATERIALS - 1.9% | |||
Chemicals - 0.9% | |||
Albemarle Corp. U.S. | 95,437 | 24,854 | |
CF Industries Holdings, Inc. | 908,929 | 89,775 | |
Corteva, Inc. | 2,511,006 | 157,239 | |
DuPont de Nemours, Inc. | 683,910 | 46,403 | |
Nutrien Ltd. | 462,538 | 45,202 | |
The Mosaic Co. | 828,341 | 51,896 | |
415,369 | |||
Containers & Packaging - 0.1% | |||
Sealed Air Corp. | 212,340 | 13,203 | |
Metals & Mining - 0.9% | |||
Barrick Gold Corp. (Canada) | 2,363,888 | 48,423 | |
Freeport-McMoRan, Inc. | 6,574,504 | 256,932 | |
Newmont Corp. | 893,978 | 60,656 | |
Rio Tinto PLC sponsored ADR | 670,515 | 49,243 | |
415,254 | |||
TOTAL MATERIALS | 843,826 | ||
REAL ESTATE - 0.4% | |||
Equity Real Estate Investment Trusts (REITs) - 0.2% | |||
American Tower Corp. | 290,199 | 74,329 | |
Equinix, Inc. | 20,903 | 14,362 | |
Simon Property Group, Inc. | 262,006 | 30,039 | |
118,730 | |||
Real Estate Management & Development - 0.2% | |||
CBRE Group, Inc. (b) | 409,075 | 33,888 | |
WeWork, Inc. (b) | 6,285,794 | 45,823 | |
79,711 | |||
TOTAL REAL ESTATE | 198,441 | ||
UTILITIES - 0.1% | |||
Electric Utilities - 0.1% | |||
ORSTED A/S (d) | 280,100 | 31,570 | |
TOTAL COMMON STOCKS (Cost $18,687,484) | 44,326,368 | ||
Preferred Stocks - 2.2% | |||
Shares | Value ($) (000s) | ||
Convertible Preferred Stocks - 2.1% | |||
COMMUNICATION SERVICES - 0.1% | |||
Interactive Media & Services - 0.1% | |||
Reddit, Inc.: | |||
Series B(a)(b)(e) | 384,303 | 14,181 | |
Series E(a)(e) | 24,203 | 893 | |
Series F(a)(e) | 114,996 | 4,243 | |
19,317 | |||
CONSUMER DISCRETIONARY - 0.2% | |||
Automobiles - 0.0% | |||
Rad Power Bikes, Inc.: | |||
Series A(a)(b)(e) | 154,174 | 854 | |
Series C(a)(b)(e) | 606,658 | 3,361 | |
Series D(a)(e) | 1,071,300 | 5,935 | |
10,150 | |||
Hotels, Restaurants & Leisure - 0.1% | |||
Discord, Inc. Series I (a)(e) | 7,000 | 3,854 | |
MOD Super Fast Pizza Holdings LLC: | |||
Series 3(a)(b)(e)(f) | 56,343 | 13,106 | |
Series 4(a)(b)(e)(f) | 5,142 | 1,136 | |
Series 5(a)(b)(e)(f) | 20,652 | 4,227 | |
22,323 | |||
Internet & Direct Marketing Retail - 0.1% | |||
GoBrands, Inc.: | |||
Series G(a)(b)(e) | 125,688 | 25,332 | |
Series H(a)(e) | 104,311 | 21,024 | |
Instacart, Inc.: | |||
Series H(a)(b)(e) | 72,310 | 3,502 | |
Series I(a)(b)(e) | 32,756 | 1,586 | |
51,444 | |||
Textiles, Apparel & Luxury Goods - 0.0% | |||
Freenome, Inc.: | |||
Series C(a)(b)(e) | 900,884 | 8,252 | |
Series D(a)(e) | 502,404 | 4,602 | |
Laronde, Inc. Series B (a)(e) | 344,496 | 5,784 | |
18,638 | |||
TOTAL CONSUMER DISCRETIONARY | 102,555 | ||
CONSUMER STAPLES - 0.1% | |||
Food & Staples Retailing - 0.1% | |||
Blink Health LLC Series C (a)(b)(e) | 927,374 | 29,732 | |
Food Products - 0.0% | |||
AgBiome LLC: | |||
Series C(a)(b)(e) | 1,060,308 | 6,468 | |
Series D(a)(e) | 852,431 | 5,140 | |
Bowery Farming, Inc. Series C1 (a)(e) | 130,916 | 4,654 | |
16,262 | |||
Tobacco - 0.0% | |||
JUUL Labs, Inc. Series E (a)(b)(e) | 22,033 | 883 | |
TOTAL CONSUMER STAPLES | 46,877 | ||
FINANCIALS - 0.0% | |||
Diversified Financial Services - 0.0% | |||
Paragon Biosciences Emalex Capital, Inc.: | |||
Series B(a)(b)(e) | 416,094 | 1,872 | |
Series C(a)(b)(e) | 559,977 | 2,520 | |
4,392 | |||
HEALTH CARE - 0.6% | |||
Biotechnology - 0.5% | |||
Ankyra Therapeutics Series B (a)(e) | 1,356,730 | 4,450 | |
Asimov, Inc. Series B (a)(e) | 82,174 | 5,024 | |
Bright Peak Therapeutics AG Series B (a)(e) | 1,272,915 | 2,928 | |
Caris Life Sciences, Inc. Series D (a)(e) | 1,235,035 | 6,842 | |
Castle Creek Biosciences, Inc.: | |||
Series D1(a)(e) | 19,720 | 3,224 | |
Series D2(a)(e) | 6,341 | 1,037 | |
Deep Genomics, Inc. Series C (a)(e) | 682,293 | 5,677 | |
Dianthus Therapeutics, Inc. Series A (a)(e) | 1,162,827 | 3,483 | |
Element Biosciences, Inc.: | |||
Series B(a)(b)(e) | 1,096,312 | 14,976 | |
Series C(a)(e) | 480,109 | 6,558 | |
ElevateBio LLC Series C (a)(b)(e) | 1,534,100 | 7,015 | |
Generate Biomedicines Series B (a)(e) | 820,747 | 5,532 | |
Inscripta, Inc.: | |||
Series D(a)(b)(e) | 1,690,173 | 10,276 | |
Series E(a)(b)(e) | 1,086,476 | 6,606 | |
Intarcia Therapeutics, Inc.: | |||
Series CC(a)(b)(e) | 1,051,411 | 0 | |
Series DD(a)(b)(e) | 1,543,687 | 0 | |
Korro Bio, Inc.: | |||
Series B1(a)(e) | 1,436,500 | 2,198 | |
Series B2(a)(e) | 1,348,657 | 2,063 | |
LifeMine Therapeutics, Inc. Series C (a)(e) | 7,794,524 | 10,678 | |
National Resilience, Inc.: | |||
Series B(a)(b)(e) | 1,277,345 | 77,663 | |
Series C(a)(e) | 379,000 | 23,043 | |
Quell Therapeutics Ltd. Series B (a)(e) | 3,870,630 | 3,793 | |
SalioGen Therapeutics, Inc. Series B (a)(e) | 51,683 | 3,092 | |
Saluda Medical Pty Ltd. Series D (a)(e) | 581,414 | 5,842 | |
Sonoma Biotherapeutics, Inc.: | |||
Series B(a)(e) | 2,497,760 | 3,497 | |
Series B1(a)(e) | 1,332,116 | 1,865 | |
T-Knife Therapeutics, Inc. Series B (a)(e) | 995,165 | 3,165 | |
Treeline Biosciences Series A (a)(e) | 1,219,600 | 5,781 | |
226,308 | |||
Health Care Equipment & Supplies - 0.0% | |||
Kardium, Inc. Series D6 (a)(b)(e) | 5,899,008 | 4,391 | |
Health Care Providers & Services - 0.0% | |||
Boundless Bio, Inc. Series B (a)(b)(e) | 2,899,016 | 2,174 | |
Conformal Medical, Inc. Series C (a)(b)(e) | 1,067,180 | 3,511 | |
Scorpion Therapeutics, Inc. Series B (a)(b)(e) | 1,325,354 | 1,339 | |
7,024 | |||
Health Care Technology - 0.1% | |||
Aledade, Inc.: | |||
Series B1(a)(e) | 101,470 | 5,054 | |
Series E1(a)(e) | 66,006 | 3,288 | |
DNA Script: | |||
Series B(a)(e) | 22 | 17 | |
Series C(a)(e) | 10,882 | 8,324 | |
Omada Health, Inc. Series E (a)(e) | 2,558,060 | 15,336 | |
PrognomIQ, Inc.: | |||
Series A5(a)(b)(e) | 372,687 | 775 | |
Series B(a)(b)(e) | 1,111,446 | 2,312 | |
Series C(a)(e) | 290,995 | 605 | |
Wugen, Inc. Series B (a)(e) | 493,529 | 2,137 | |
37,848 | |||
Pharmaceuticals - 0.0% | |||
Castle Creek Pharmaceutical Holdings, Inc.: | |||
Series B(a)(b)(e) | 16,803 | 2,987 | |
Series C(a)(b)(e) | 13,100 | 2,328 | |
Galvanize Therapeutics Series B (a)(e) | 4,342,265 | 7,518 | |
Nohla Therapeutics, Inc. Series B (a)(b)(e) | 9,124,200 | 0 | |
12,833 | |||
TOTAL HEALTH CARE | 288,404 | ||
INDUSTRIALS - 0.4% | |||
Aerospace & Defense - 0.4% | |||
Space Exploration Technologies Corp. Series G (a)(b)(e) | 216,276 | 151,393 | |
Construction & Engineering - 0.0% | |||
Beta Technologies, Inc.: | |||
Series A(a)(b)(e) | 54,111 | 5,583 | |
Series B, 6.00%(a)(e) | 71,156 | 7,341 | |
12,924 | |||
TOTAL INDUSTRIALS | 164,317 | ||
INFORMATION TECHNOLOGY - 0.6% | |||
Communications Equipment - 0.1% | |||
Meesho Series F (a)(e) | 309,354 | 21,698 | |
Xsight Labs Ltd. Series D (a)(b)(e) | 787,863 | 5,893 | |
27,591 | |||
Electronic Equipment & Components - 0.0% | |||
Enevate Corp. Series E (a)(b)(e) | 4,067,736 | 4,510 | |
Menlo Micro, Inc. Series C (a)(e) | 4,423,488 | 4,656 | |
9,166 | |||
IT Services - 0.1% | |||
AppNexus, Inc. Series E (Escrow) (a)(b)(e) | 923,523 | 29 | |
ByteDance Ltd. Series E1 (a)(b)(e) | 403,450 | 54,042 | |
54,071 | |||
Semiconductors & Semiconductor Equipment - 0.1% | |||
Alif Semiconductor Series C (a)(e) | 190,608 | 3,869 | |
Astera Labs, Inc.: | |||
Series A(a)(e) | 316,595 | 3,220 | |
Series B(a)(e) | 53,906 | 548 | |
Series C(a)(e) | 1,811,000 | 18,417 | |
Series D(a)(e) | 1,074,629 | 10,928 | |
GaN Systems, Inc.: | |||
Series F1(a)(e) | 287,190 | 1,927 | |
Series F2(a)(e) | 151,648 | 1,018 | |
SiMa.ai: | |||
Series B(a)(e) | 1,596,216 | 11,319 | |
Series B1(a)(e) | 106,922 | 758 | |
52,004 | |||
Software - 0.3% | |||
Bolt Technology OU Series E (a)(e) | 72,621 | 17,931 | |
Databricks, Inc.: | |||
Series G(a)(b)(e) | 83,432 | 12,185 | |
Series H(a)(e) | 91,057 | 13,299 | |
Dataminr, Inc. Series D (a)(b)(e) | 1,773,901 | 37,323 | |
Evozyne LLC Series A (a)(b)(e) | 444,700 | 5,754 | |
Jet.Com, Inc. Series B1 (Escrow) (a)(b)(e) | 7,578,338 | 0 | |
Nuvia, Inc. Series B (a)(b) | 1,235,787 | 1,010 | |
Skyryse, Inc. Series B (a)(e) | 568,445 | 14,029 | |
Stripe, Inc. Series H (a)(b)(e) | 88,200 | 2,395 | |
Tenstorrent, Inc. Series C1 (a)(b)(e) | 92,100 | 5,183 | |
109,109 | |||
TOTAL INFORMATION TECHNOLOGY | 251,941 | ||
MATERIALS - 0.1% | |||
Chemicals - 0.0% | |||
Farmers Business Network, Inc. Series G (a)(e) | 186,833 | 9,345 | |
Metals & Mining - 0.1% | |||
Diamond Foundry, Inc. Series C (a)(b)(e) | 1,704,625 | 48,735 | |
TOTAL MATERIALS | 58,080 | ||
UTILITIES - 0.0% | |||
Independent Power and Renewable Electricity Producers - 0.0% | |||
Redwood Materials Series C (a)(e) | 80,057 | 3,795 | |
TOTAL CONVERTIBLE PREFERRED STOCKS | 939,678 | ||
Nonconvertible Preferred Stocks - 0.1% | |||
CONSUMER DISCRETIONARY - 0.1% | |||
Automobiles - 0.0% | |||
Neutron Holdings, Inc. Series 1D (a)(b)(e) | 17,893,728 | 517 | |
Waymo LLC Series A2 (a)(b)(e) | 44,767 | 4,106 | |
4,623 | |||
Internet & Direct Marketing Retail - 0.1% | |||
Circle Internet Financial Ltd. Series E (a) | 604,608 | 29,147 | |
TOTAL CONSUMER DISCRETIONARY | 33,770 | ||
HEALTH CARE - 0.0% | |||
Pharmaceuticals - 0.0% | |||
Castle Creek Pharmaceutical Holdings, Inc. Series A4 (a)(b)(e) | 46,864 | 8,137 | |
Faraday Pharmaceuticals, Inc. Series B (a)(b)(e) | 641,437 | 552 | |
8,689 | |||
INFORMATION TECHNOLOGY - 0.0% | |||
Software - 0.0% | |||
Pine Labs Private Ltd.: | |||
Series 1(a)(e) | 9,846 | 5,510 | |
Series A(a)(e) | 2,460 | 1,377 | |
Series B(a)(e) | 2,677 | 1,498 | |
Series B2(a)(e) | 2,165 | 1,212 | |
Series C(a)(e) | 4,028 | 2,254 | |
Series C1(a)(e) | 848 | 475 | |
Series D(a)(e) | 907 | 508 | |
12,834 | |||
TOTAL NONCONVERTIBLE PREFERRED STOCKS | 55,293 | ||
TOTAL PREFERRED STOCKS (Cost $913,648) | 994,971 | ||
Convertible Bonds - 0.0% | |||
Principal Amount (h) (000s) | Value ($) (000s) | ||
CONSUMER DISCRETIONARY - 0.0% | |||
Automobiles - 0.0% | |||
Neutron Holdings, Inc.: | |||
4% 10/27/25 (a)(e)(i) | 7,504 | 6,877 | |
4% 5/22/27 (a)(e) | 3,596 | 4,168 | |
4% 6/12/27 (a)(e) | 743 | 861 | |
11,906 | |||
FINANCIALS - 0.0% | |||
Diversified Financial Services - 0.0% | |||
Paragon Biosciences Emalex Capital, Inc. 0% (a)(e)(j) | 1,190 | 1,190 | |
TOTAL CONVERTIBLE BONDS (Cost $13,033) | 13,096 | ||
Preferred Securities - 0.0% | |||
Principal Amount (h) (000s) | Value ($) (000s) | ||
HEALTH CARE - 0.0% | |||
Biotechnology - 0.0% | |||
Intarcia Therapeutics, Inc. 6% 7/18/22 (a)(e) | 13,682 | 2,679 | |
Health Care Equipment & Supplies - 0.0% | |||
Kardium, Inc. 0% (a)(e)(j) | 8,368 | 8,368 | |
TOTAL HEALTH CARE | 11,047 | ||
INFORMATION TECHNOLOGY - 0.0% | |||
Electronic Equipment & Components - 0.0% | |||
Enevate Corp. 0% 1/29/23 (a)(e) | 1,732 | 1,732 | |
Semiconductors & Semiconductor Equipment - 0.0% | |||
GaN Systems, Inc. 0% (a)(e)(j) | 6,731 | 6,731 | |
Software - 0.0% | |||
Tenstorrent, Inc. 0% (a)(e)(j) | 5,120 | 5,120 | |
TOTAL INFORMATION TECHNOLOGY | 13,583 | ||
TOTAL PREFERRED SECURITIES (Cost $35,633) | 24,630 | ||
Money Market Funds - 2.0% | |||
Shares | Value ($) (000s) | ||
Fidelity Cash Central Fund 0.82% (k) | 159,723,841 | 159,756 | |
Fidelity Securities Lending Cash Central Fund 0.82% (k)(l) | 747,927,097 | 748,002 | |
TOTAL MONEY MARKET FUNDS (Cost $907,754) | 907,758 | ||
TOTAL INVESTMENT IN SECURITIES - 101.7% (Cost $20,557,552) | 46,266,823 |
NET OTHER ASSETS (LIABILITIES) - (1.7)% | (783,761) |
NET ASSETS - 100.0% | 45,483,062 |
(a) | Restricted securities (including private placements) - Investment in securities not registered under the Securities Act of 1933 (excluding 144A issues). At the end of the period, the value of restricted securities (excluding 144A issues) amounted to $1,787,009,000 or 3.9% of net assets. |
(b) | Non-income producing |
(c) | Security or a portion of the security is on loan at period end. |
(d) | Security exempt from registration under Rule 144A of the Securities Act of 1933. These securities may be resold in transactions exempt from registration, normally to qualified institutional buyers. At the end of the period, the value of these securities amounted to $376,909,000 or 0.8% of net assets. |
(e) | Level 3 security |
(f) | Investment is owned by a wholly-owned subsidiary (Subsidiary) that is treated as a corporation for U.S. tax purposes. |
(g) | Affiliated company |
(h) | Amount is stated in United States dollars unless otherwise noted. |
(i) | Security initially issued at one coupon which converts to a higher coupon at a specified date. The rate shown is the rate at period end. |
(j) | Security is perpetual in nature with no stated maturity date. |
(k) | Affiliated fund that is generally available only to investment companies and other accounts managed by Fidelity Investments. The rate quoted is the annualized seven-day yield of the fund at period end. A complete unaudited listing of the fund's holdings as of its most recent quarter end is available upon request. In addition, each Fidelity Central Fund's financial statements are available on the SEC's website or upon request. |
(l) | Investment made with cash collateral received from securities on loan. |
Additional information on each restricted holding is as follows: | ||
Security | Acquisition Date | Acquisition Cost ($) (000s) |
Adimab LLC | 9/17/14 - 6/05/15 | 47,869 |
AgBiome LLC Series C | 6/29/18 | 6,716 |
AgBiome LLC Series D | 9/03/21 | 5,053 |
Aledade, Inc. Series B1 | 5/07/21 | 3,885 |
Aledade, Inc. Series E1 | 5/20/22 | 3,288 |
Alif Semiconductor Series C | 3/08/22 | 3,869 |
Ankyra Therapeutics Series B | 8/26/21 | 7,641 |
Ant International Co. Ltd. Class C | 5/16/18 | 9,303 |
AppNexus, Inc. Series E (Escrow) | 8/01/14 | 0 |
Asimov, Inc. Series B | 10/29/21 | 7,616 |
Astera Labs, Inc. Series A | 5/17/22 | 3,220 |
Astera Labs, Inc. Series B | 5/17/22 | 548 |
Astera Labs, Inc. Series C | 8/24/21 | 6,088 |
Astera Labs, Inc. Series D | 5/17/22 | 10,928 |
Beta Technologies, Inc. Series A | 4/09/21 | 3,965 |
Beta Technologies, Inc. Series B, 6.00% | 4/04/22 | 7,341 |
Bird Global, Inc. | 5/11/21 | 9,612 |
Blink Health LLC Series A1 | 12/30/20 | 4,699 |
Blink Health LLC Series C | 11/07/19 - 7/14/21 | 35,402 |
Bolt Technology OU Series E | 1/03/22 | 18,867 |
Boundless Bio, Inc. Series B | 4/23/21 | 3,914 |
Bowery Farming, Inc. Series C1 | 5/18/21 | 7,888 |
Bright Peak Therapeutics AG Series B | 5/14/21 | 4,972 |
ByteDance Ltd. Series E1 | 11/18/20 | 44,208 |
Caris Life Sciences, Inc. Series D | 5/11/21 | 10,004 |
Castle Creek Biosciences, Inc. Series D1 | 4/19/22 | 4,240 |
Castle Creek Biosciences, Inc. Series D2 | 6/28/21 | 1,087 |
Castle Creek Pharmaceutical Holdings, Inc. Series A4 | 9/29/16 | 15,506 |
Castle Creek Pharmaceutical Holdings, Inc. Series B | 10/09/18 | 6,920 |
Castle Creek Pharmaceutical Holdings, Inc. Series C | 12/09/19 | 5,395 |
Cibus Corp. Series C | 2/16/18 | 9,500 |
Cibus Corp. Series D | 5/10/19 | 3,426 |
Cibus Corp. Series E | 6/23/21 | 726 |
Circle Internet Financial Ltd. Series E | 5/11/21 | 9,813 |
Conformal Medical, Inc. Series C | 7/24/20 | 3,913 |
Cyclerion Therapeutics, Inc. | 4/02/19 | 8,052 |
Databricks, Inc. Series G | 2/01/21 | 14,798 |
Databricks, Inc. Series H | 8/31/21 | 20,074 |
Dataminr, Inc. Series D | 2/18/15 - 3/06/15 | 22,617 |
Deep Genomics, Inc. Series C | 7/21/21 | 9,894 |
Delhivery Private Ltd. | 5/20/21 | 14,493 |
Diamond Foundry, Inc. Series C | 3/15/21 | 40,911 |
Dianthus Therapeutics, Inc. Series A | 4/06/22 | 5,054 |
Discord, Inc. Series I | 9/15/21 | 3,854 |
DNA Script | 12/17/21 | 1,788 |
DNA Script Series B | 12/17/21 | 18 |
DNA Script Series C | 10/01/21 | 9,466 |
Dragonfly Therapeutics, Inc. | 12/19/19 | 12,746 |
Element Biosciences, Inc. Series B | 12/13/19 | 5,745 |
Element Biosciences, Inc. Series C | 6/21/21 | 9,869 |
ElevateBio LLC Series C | 3/09/21 | 6,436 |
Enevate Corp. Series E | 1/29/21 | 4,510 |
Enevate Corp. 0% 1/29/23 | 1/29/21 | 1,732 |
Epic Games, Inc. | 7/13/20 - 7/30/20 | 29,786 |
Evozyne LLC Series A | 4/09/21 | 9,992 |
Fanatics, Inc. Class A | 8/13/20 - 12/15/21 | 18,962 |
Faraday Pharmaceuticals, Inc. Series B | 12/30/19 | 843 |
Farmers Business Network, Inc. Series G | 9/15/21 | 11,613 |
Freenome, Inc. Series C | 8/14/20 | 5,958 |
Freenome, Inc. Series D | 11/22/21 | 3,789 |
Galvanize Therapeutics Series B | 3/29/22 | 7,518 |
GaN Systems, Inc. Series F1 | 11/30/21 | 2,435 |
GaN Systems, Inc. Series F2 | 11/30/21 | 1,286 |
GaN Systems, Inc. 0% | 11/30/21 | 6,731 |
Generate Biomedicines Series B | 11/02/21 | 9,726 |
GoBrands, Inc. Series G | 3/02/21 | 31,386 |
GoBrands, Inc. Series H | 7/22/21 | 40,524 |
Inscripta, Inc. Series D | 11/13/20 | 7,724 |
Inscripta, Inc. Series E | 3/30/21 | 9,594 |
Instacart, Inc. Series H | 11/13/20 | 4,339 |
Instacart, Inc. Series I | 2/26/21 | 4,095 |
Intarcia Therapeutics, Inc. Series CC | 11/14/12 | 14,331 |
Intarcia Therapeutics, Inc. Series DD | 3/17/14 | 50,000 |
Intarcia Therapeutics, Inc. 6% 7/18/22 | 2/26/19 | 13,682 |
Jet.Com, Inc. Series B1 (Escrow) | 3/19/18 | 0 |
JUUL Labs, Inc. Class A | 7/06/18 | 1,299 |
JUUL Labs, Inc. Series E | 7/06/18 | 650 |
Kardium, Inc. Series D6 | 12/30/20 | 5,992 |
Kardium, Inc. 0% | 12/30/20 | 8,368 |
Korro Bio, Inc. Series B1 | 12/17/21 | 3,749 |
Korro Bio, Inc. Series B2 | 12/17/21 | 3,749 |
Laronde, Inc. Series B | 8/13/21 | 9,646 |
LifeMine Therapeutics, Inc. Series C | 2/15/22 | 15,874 |
Meesho Series F | 9/21/21 | 23,719 |
Menlo Micro, Inc. Series C | 2/09/22 | 5,863 |
MOD Super Fast Pizza Holdings LLC Series 3 | 11/03/16 | 7,719 |
MOD Super Fast Pizza Holdings LLC Series 4 | 12/14/17 | 720 |
MOD Super Fast Pizza Holdings LLC Series 5 | 5/15/19 | 2,943 |
National Resilience, Inc. Series B | 12/01/20 | 17,449 |
National Resilience, Inc. Series C | 6/28/21 | 16,831 |
Neutron Holdings, Inc. | 2/04/21 | 15 |
Neutron Holdings, Inc. Series 1D | 1/25/19 | 4,339 |
Neutron Holdings, Inc. 4% 10/27/25 | 10/29/21 | 7,504 |
Neutron Holdings, Inc. 4% 5/22/27 | 6/04/20 | 3,596 |
Neutron Holdings, Inc. 4% 6/12/27 | 6/12/20 | 743 |
Nohla Therapeutics, Inc. Series B | 5/01/18 | 3,199 |
Nuvia, Inc. Series B | 3/16/21 | 1,010 |
Oddity Tech Ltd. | 1/06/22 | 4,436 |
Omada Health, Inc. Series E | 12/22/21 | 15,336 |
Paragon Biosciences Emalex Capital, Inc. Series B | 9/18/19 | 4,240 |
Paragon Biosciences Emalex Capital, Inc. Series C | 2/26/21 | 5,992 |
Paragon Biosciences Emalex Capital, Inc. 0% | 5/18/22 | 1,190 |
Pine Labs Private Ltd. | 6/30/21 | 1,536 |
Pine Labs Private Ltd. Series 1 | 6/30/21 | 3,671 |
Pine Labs Private Ltd. Series A | 6/30/21 | 917 |
Pine Labs Private Ltd. Series B | 6/30/21 | 998 |
Pine Labs Private Ltd. Series B2 | 6/30/21 | 807 |
Pine Labs Private Ltd. Series C | 6/30/21 | 1,502 |
Pine Labs Private Ltd. Series C1 | 6/30/21 | 316 |
Pine Labs Private Ltd. Series D | 6/30/21 | 338 |
PrognomIQ, Inc. Series A5 | 8/20/20 | 225 |
PrognomIQ, Inc. Series B | 9/11/20 | 2,540 |
PrognomIQ, Inc. Series C | 2/16/22 | 890 |
Quell Therapeutics Ltd. Series B | 11/24/21 | 7,315 |
Rad Power Bikes, Inc. | 1/21/21 | 5,705 |
Rad Power Bikes, Inc. Series A | 1/21/21 | 744 |
Rad Power Bikes, Inc. Series C | 1/21/21 | 2,926 |
Rad Power Bikes, Inc. Series D | 9/17/21 | 10,267 |
Reddit, Inc. Series B | 7/26/17 | 5,456 |
Reddit, Inc. Series E | 5/18/21 | 1,028 |
Reddit, Inc. Series F | 8/11/21 | 7,106 |
Redwood Materials Series C | 5/28/21 | 3,795 |
SalioGen Therapeutics, Inc. Series B | 12/10/21 | 5,471 |
Saluda Medical Pty Ltd. Series D | 1/20/22 | 7,416 |
Saluda Medical Pty Ltd. warrants | 1/20/22 | 0 |
Scorpion Therapeutics, Inc. Series B | 1/08/21 | 3,207 |
SiMa.ai Series B | 5/10/21 | 8,184 |
SiMa.ai Series B1 | 4/25/22 | 758 |
Skyhawk Therapeutics, Inc. | 5/21/21 | 9,904 |
Skyryse, Inc. Series B | 10/21/21 | 14,029 |
Sonoma Biotherapeutics, Inc. Series B | 7/26/21 | 4,936 |
Sonoma Biotherapeutics, Inc. Series B1 | 7/26/21 | 3,949 |
Space Exploration Technologies Corp. Class A | 10/16/15 - 4/06/17 | 38,201 |
Space Exploration Technologies Corp. Series G | 1/20/15 | 16,753 |
Starry Group Holdings, Inc. | 10/06/21 | 8,028 |
Stripe, Inc. Class B | 5/18/21 | 8,246 |
Stripe, Inc. Series H | 3/15/21 | 3,539 |
T-Knife Therapeutics, Inc. Series B | 6/30/21 | 5,741 |
Tenstorrent, Inc. Series C1 | 4/23/21 | 5,476 |
Tenstorrent, Inc. 0% | 4/23/21 | 5,120 |
The Beauty Health Co. | 12/08/20 | 28,847 |
The Oncology Institute, Inc. | 6/28/21 | 18,151 |
Tory Burch LLC Class A | 5/14/15 | 67,653 |
Tory Burch LLC Class B | 12/31/12 | 17,505 |
Treeline Biosciences Series A | 7/30/21 | 9,546 |
Volta, Inc. | 2/07/21 | 29 |
Waymo LLC Series A2 | 5/08/20 | 3,844 |
Wheels Up Experience, Inc. | 2/01/21 | 1,663 |
Wugen, Inc. Series B | 7/09/21 | 3,827 |
Xsight Labs Ltd. Series D | 2/16/21 | 6,300 |
Zomato Ltd. | 12/09/20 - 2/10/21 | 22,352 |
Affiliate (Amounts in thousands) | Value, beginning of period ($) | Purchases ($) | Sales Proceeds ($) | Dividend Income ($) | Realized Gain (loss) ($) | Change in Unrealized appreciation (depreciation) ($) | Value, end of period ($) | %ownership, end of period |
Fidelity Cash Central Fund 0.82% | 281,491 | 1,622,311 | 1,744,046 | 154 | - | - | 159,756 | 0.3% |
Fidelity Securities Lending Cash Central Fund 0.82% | 684,682 | 1,583,244 | 1,519,924 | 2,250 | - | - | 748,002 | 2.0% |
Total | 966,173 | 3,205,555 | 3,263,970 | 2,404 | - | - | 907,758 |
Affiliate (Amounts in thousands) | Value, beginning of period ($) | Purchases ($) | Sales Proceeds ($) | Dividend Income ($) | Realized Gain (loss) ($) | Change in Unrealized appreciation (depreciation) ($) | Value, end of period ($) |
Adagio Therapeutics, Inc. | - | - | - | - | - | - | - |
Adagio Therapeutics, Inc. | 178,946 | - | - | - | - | (148,614) | - |
Adagio Therapeutics, Inc. | 86,904 | 2,384 | 1,883 | - | (1,288) | (99,367) | 17,082 |
Atea Pharmaceuticals, Inc. | 38,238 | 40 | 1,403 | - | (919) | (240) | 35,716 |
Avis Budget Group, Inc. | 803,171 | - | 148,397 | - | 99,417 | (324,060) | - |
Axcella Health, Inc. | 6,027 | 964 | 185 | - | (118) | (1,444) | - |
BioXcel Therapeutics, Inc. | 34,070 | - | 1,071 | - | (575) | (15,775) | 16,649 |
Codiak Biosciences, Inc. | 15,271 | - | 337 | - | (130) | (11,604) | 3,200 |
EQRx, Inc. | - | 3,359 | 686 | - | 82 | (999) | 37,835 |
Infinera Corp. | 94,799 | 1,142 | 3,921 | - | (262) | (26,857) | 64,901 |
Ionis Pharmaceuticals, Inc. | 205,658 | 205 | 15,057 | - | 3,647 | 73,902 | 268,355 |
Kaleido Biosciences, Inc. | 8,455 | - | 708 | - | (29,701) | 21,954 | - |
Nutanix, Inc. Class A | 414,493 | 7,861 | 14,177 | - | 3,559 | (214,337) | 197,399 |
OptiNose, Inc. | 6,426 | 1,007 | 531 | - | (1,378) | 3,387 | 8,911 |
Presbia PLC | 16 | - | - | - | - | - | 16 |
Rigel Pharmaceuticals, Inc. | 25,645 | - | 1,547 | - | (1,182) | (6,601) | 16,315 |
Rubius Therapeutics, Inc. | 59,612 | 84 | 1,250 | - | (415) | (52,933) | 5,098 |
Seres Therapeutics, Inc. | 52,178 | - | 1,417 | - | 956 | (37,320) | 14,397 |
Sienna Biopharmaceuticals, Inc. | - | - | - | - | (172) | 172 | - |
Silicon Laboratories, Inc. | 480,477 | - | 81,229 | - | 30,653 | (136,617) | 293,284 |
Springworks Therapeutics, Inc. | 88,469 | 76,809 | 5,467 | - | 436 | (111,453) | 48,794 |
The Oncology Institute, Inc. | 10,602 | - | - | - | - | 5,752 | - |
Total | 2,609,457 | 93,855 | 279,266 | - | 102,610 | (1,083,054) | 1,027,952 |
Valuation Inputs at Reporting Date: | ||||
Description (Amounts in thousands) | Total ($) | Level 1 ($) | Level 2 ($) | Level 3 ($) |
Investments in Securities: | ||||
Equities: | ||||
Communication Services | 5,247,205 | 5,169,400 | 58,488 | 19,317 |
Consumer Discretionary | 9,070,800 | 8,787,107 | 65,900 | 217,793 |
Consumer Staples | 2,014,560 | 1,960,357 | - | 54,203 |
Energy | 1,394,011 | 1,394,011 | - | - |
Financials | 824,797 | 685,244 | - | 139,553 |
Health Care | 5,163,366 | 4,765,166 | 62,611 | 335,589 |
Industrials | 2,754,961 | 2,279,469 | 18,260 | 457,232 |
Information Technology | 17,715,927 | 17,396,090 | - | 319,837 |
Materials | 901,906 | 843,826 | - | 58,080 |
Real Estate | 198,441 | 198,441 | - | - |
Utilities | 35,365 | - | 31,570 | 3,795 |
Corporate Bonds | 13,096 | - | - | 13,096 |
Preferred Securities | 24,630 | - | - | 24,630 |
Money Market Funds | 907,758 | 907,758 | - | - |
Total Investments in Securities: | 46,266,823 | 44,386,869 | 236,829 | 1,643,125 |
(Amounts in thousands) | |||
Investments in Securities: | |||
Beginning Balance | $ | 1,721,781 | |
Net Realized Gain (Loss) on Investment Securities | (95,202) | ||
Net Unrealized Gain (Loss) on Investment Securities | (119,176) | ||
Cost of Purchases | 140,768 | ||
Proceeds of Sales | (3,166) | ||
Amortization/Accretion | - | ||
Transfers into Level 3 | 13,303 | ||
Transfers out of Level 3 | (15,183) | ||
Ending Balance | $ | 1,643,125 | |
The change in unrealized gain (loss) for the period attributable to Level 3 securities held at May 31, 2022 | $ | (211,626) | |
Statement of Assets and Liabilities | ||||
Amounts in thousands (except per-share amounts) | May 31, 2022 (Unaudited) | |||
Assets | ||||
Investment in securities, at value (including securities loaned of $720,108) - See accompanying schedule: | $44,331,113 | |||
Unaffiliated issuers (cost $17,769,749) | ||||
Fidelity Central Funds (cost $907,754) | 907,758 | |||
Other affiliated issuers (cost $1,880,049) | 1,027,952 | |||
Total Investment in Securities (cost $20,557,552) | $ | 46,266,823 | ||
Cash | 238 | |||
Receivable for investments sold | 47,440 | |||
Receivable for fund shares sold | 49,760 | |||
Dividends receivable | 25,705 | |||
Interest receivable | 374 | |||
Distributions receivable from Fidelity Central Funds | 290 | |||
Prepaid expenses | 10 | |||
Other receivables | 1,907 | |||
Total assets | 46,392,547 | |||
Liabilities | ||||
Payable for investments purchased | $58,368 | |||
Payable for fund shares redeemed | 59,304 | |||
Accrued management fee | 28,829 | |||
Other affiliated payables | 4,152 | |||
Other payables and accrued expenses | 10,887 | |||
Collateral on securities loaned | 747,945 | |||
Total Liabilities | 909,485 | |||
Net Assets | $ | 45,483,062 | ||
Net Assets consist of: | ||||
Paid in capital | $ | 16,336,922 | ||
Total accumulated earnings (loss) | 29,146,140 | |||
Net Assets | $ | 45,483,062 | ||
Net Asset Value and Maximum Offering Price | ||||
Growth Company : | ||||
Net Asset Value , offering price and redemption price per share ($36,160,559 ÷ 1,356,405 shares) | $ | 26.66 | ||
Class K : | ||||
Net Asset Value , offering price and redemption price per share ($9,322,503 ÷ 348,338 shares) | $ | 26.76 |
Statement of Operations | ||||
Amounts in thousands | Six months ended May 31, 2022 (Unaudited) | |||
Investment Income | ||||
Dividends | $ | 128,683 | ||
Interest | 115 | |||
Income from Fidelity Central Funds (including $2,250 from security lending) | 2,404 | |||
Total Income | 131,202 | |||
Expenses | ||||
Management fee | ||||
Basic fee | $ | 146,627 | ||
Performance adjustment | 53,866 | |||
Transfer agent fees | 25,424 | |||
Accounting fees | 1,244 | |||
Custodian fees and expenses | 395 | |||
Independent trustees' fees and expenses | 105 | |||
Registration fees | 242 | |||
Audit | 153 | |||
Legal | 13 | |||
Interest | 11 | |||
Miscellaneous | 113 | |||
Total expenses before reductions | 228,193 | |||
Expense reductions | (909) | |||
Total expenses after reductions | 227,284 | |||
Net Investment income (loss) | (96,082) | |||
Realized and Unrealized Gain (Loss) | ||||
Net realized gain (loss) on: | ||||
Investment Securities: | ||||
Unaffiliated issuers | 3,596,530 | |||
Affiliated issuers | 102,610 | |||
Foreign currency transactions | 26 | |||
Total net realized gain (loss) | 3,699,166 | |||
Change in net unrealized appreciation (depreciation) on: | ||||
Investment Securities: | ||||
Unaffiliated issuers (net of decrease in deferred foreign taxes of $2,725) | (22,274,971) | |||
Affiliated issuers | (1,083,054) | |||
Unfunded commitments | 3,549 | |||
Assets and liabilities in foreign currencies | (273) | |||
Total change in net unrealized appreciation (depreciation) | (23,354,749) | |||
Net gain (loss) | (19,655,583) | |||
Net increase (decrease) in net assets resulting from operations | $ | (19,751,665) |
Statement of Changes in Net Assets | ||||
Amounts in thousands | Six months ended May 31, 2022 (Unaudited) | Year ended November 30, 2021 | ||
Increase (Decrease) in Net Assets | ||||
Operations | ||||
Net investment income (loss) | $ | (96,082) | $ | (237,132) |
Net realized gain (loss) | 3,699,166 | 12,477,339 | ||
Change in net unrealized appreciation (depreciation) | (23,354,749) | 5,641,278 | ||
Net increase (decrease) in net assets resulting from operations | (19,751,665) | 17,881,485 | ||
Distributions to shareholders | (6,433,347) | (5,205,937) | ||
Share transactions - net increase (decrease) | 1,828,844 | (4,817,747) | ||
Total increase (decrease) in net assets | (24,356,168) | 7,857,801 | ||
Net Assets | ||||
Beginning of period | 69,839,230 | 61,981,429 | ||
End of period | $ | 45,483,062 | $ | 69,839,230 |
Fidelity® Growth Company Fund |
Six months ended (Unaudited) May 31, 2022 | Years ended November 30, 2021 | 2020 | 2019 | 2018 A | 2017 A | |||||||
Selected Per-Share Data | ||||||||||||
Net asset value, beginning of period | $ | 41.75 | $ | 34.49 | $ | 21.54 | $ | 18.79 | $ | 18.53 | $ | 14.28 |
Income from Investment Operations | ||||||||||||
Net investment income (loss) B,C | (.06) | (.14) D | (.10) | (.04) | (.01) E | (.01) | ||||||
Net realized and unrealized gain (loss) | (11.14) | 10.31 | 13.87 | 3.81 | 1.12 | 5.08 | ||||||
Total from investment operations | (11.20) | 10.17 | 13.77 | 3.77 | 1.11 | 5.07 | ||||||
Distributions from net investment income | - | - | - | - | - | (.01) | ||||||
Distributions from net realized gain | (3.89) | (2.91) | (.82) | (1.02) | (.85) | (.81) | ||||||
Total distributions | (3.89) | (2.91) | (.82) | (1.02) | (.85) | (.82) | ||||||
Net asset value, end of period | $ | 26.66 | $ | 41.75 | $ | 34.49 | $ | 21.54 | $ | 18.79 | $ | 18.53 |
Total Return F,G | (29.40)% | 31.76% | 66.23% | 22.05% | 6.19% | 37.34% | ||||||
Ratios to Average Net Assets C,H,I | ||||||||||||
Expenses before reductions | .83% J | .79% | .83% | .83% | .85% | .85% | ||||||
Expenses net of fee waivers, if any | .83% J | .79% | .83% | .83% | .85% | .85% | ||||||
Expenses net of all reductions | .83% J | .79% | .83% | .83% | .85% | .85% | ||||||
Net investment income (loss) | (.36)% J | (.38)% D | (.41)% | (.20)% | (.07)% E | (.04)% | ||||||
Supplemental Data | ||||||||||||
Net assets, end of period (in millions) | $ | 36,161 | $ | 53,845 | $ | 43,533 | $ | 28,861 | $ | 25,615 | $ | 25,256 |
Portfolio turnover rate K,L | 16% J | 16% | 18% | 16% | 18% | 15% |
Fidelity® Growth Company Fund Class K |
Six months ended (Unaudited) May 31, 2022 | Years ended November 30, 2021 | 2020 | 2019 | 2018 A | 2017 A | |||||||
Selected Per-Share Data | ||||||||||||
Net asset value, beginning of period | $ | 41.89 | $ | 34.57 | $ | 21.57 | $ | 18.80 | $ | 18.52 | $ | 14.27 |
Income from Investment Operations | ||||||||||||
Net investment income (loss) B,C | (.05) | (.12) D | (.08) | (.02) | - E,F | .01 | ||||||
Net realized and unrealized gain (loss) | (11.19) | 10.35 | 13.90 | 3.81 | 1.13 | 5.07 | ||||||
Total from investment operations | (11.24) | 10.23 | 13.82 | 3.79 | 1.13 | 5.08 | ||||||
Distributions from net investment income | - | - | - | - | - E | (.02) | ||||||
Distributions from net realized gain | (3.89) | (2.91) | (.82) | (1.02) | (.85) | (.81) | ||||||
Total distributions | (3.89) | (2.91) | (.82) | (1.02) | (.85) | (.83) | ||||||
Net asset value, end of period | $ | 26.76 | $ | 41.89 | $ | 34.57 | $ | 21.57 | $ | 18.80 | $ | 18.52 |
Total Return G,H | (29.40)% | 31.87% | 66.37% | 22.15% | 6.28% | 37.47% | ||||||
Ratios to Average Net Assets C,I,J | ||||||||||||
Expenses before reductions | .76% K | .73% | .75% | .75% | .76% | .75% | ||||||
Expenses net of fee waivers, if any | .76% K | .72% | .75% | .75% | .76% | .75% | ||||||
Expenses net of all reductions | .76% K | .72% | .75% | .75% | .76% | .75% | ||||||
Net investment income (loss) | (.29)% K | (.32)% D | (.33)% | (.12)% | .02% F | .06% | ||||||
Supplemental Data | ||||||||||||
Net assets, end of period (in millions) | $ | 9,323 | $ | 15,994 | $ | 18,449 | $ | 14,772 | $ | 15,468 | $ | 16,416 |
Portfolio turnover rate L,M | 16% K | 16% | 18% | 16% | 18% | 15% |
Fidelity Central Fund | Investment Manager | Investment Objective | Investment Practices | Expense Ratio A |
Fidelity Money Market Central Funds | Fidelity Management & Research Company LLC (FMR) | Each fund seeks to obtain a high level of current income consistent with the preservation of capital and liquidity. | Short-term Investments | Less than .005% |
Asset Type | Fair Value | Valuation Technique(s) | Unobservable Input | Amount or Range/Weighted Average | Impact to Valuation from an Increase in Input A |
Equities | $1,605,399 | Market approach | Transaction price | $0.02 - $712.50 / $174.84 | Increase |
Discount rate | 5.3% - 58.3% / 32.9% | Decrease | |||
Liquidation value | $0.05 | Increase | |||
Recovery value | Transaction price | $12.76 | Increase | ||
Recovery value | $0.00 - $2.87 / $2.30 | Increase | |||
Discount for lack of marketability | 5.0% | Decrease | |||
Probability rate | 15.0% - 70.0% / 42.5% | Increase | |||
Market comparable | Enterprise value/Revenue multiple (EV/R) | 1.9 - 24.0 / 8.6 | Increase | ||
Enterprise value/Gross profit multiple (EV/GP) | 8.0 | Increase | |||
Liquidity preference | $204.67 - $232.61 / $219.38 | Increase | |||
Book value | Book value multiple | 1.8 | Increase | ||
Discounted cash flow | Weighted average cost of capital (WACC) | 33.0% - 41.0% / 37.9% | Decrease | ||
Discount rate | 12.3% - 13.0% / 12.6% | Decrease | |||
Growth rate | 3.5 | Increase | |||
Exit multiple | 2.3 - 5.0 / 4.0 | Increase | |||
Corporate Bonds | $13,096 | Market approach | Transaction price | $100.00 | Increase |
Market comparable | Enterprise value/Revenue multiple (EV/R) | 2.8 | Increase | ||
Term | 1.4 | Increase | |||
Volatility | 75.0% | Increase | |||
Preferred Securities | $24,630 | Market approach | Transaction price | $100 | Increase |
Recovery value | Recovery value | $0.00 | Increase | ||
Fidelity Growth Company Fund | $1,714 |
Gross unrealized appreciation | $29,314,346 |
Gross unrealized depreciation | (3,775,036) |
Net unrealized appreciation (depreciation) | $25,539,310 |
Tax cost | $20,727,513 |
Investment to be Acquired | Commitment Amount | |
Fidelity Growth Company Fund | Twitter, Inc. | $9,029 |
$ Amount | % of Net Assets | |
Fidelity Growth Company Fund | 224,354 | .49 |
Purchases ($) | Sales ($) | |
Fidelity Growth Company Fund | 4,570,006 | 7,705,628 |
Shares | Total net realized gain or loss ($) | Total Proceeds ($) | Participating classes | |
Fidelity Growth Company Fund | 41,765 | 898,238 | 1,348,136 | Growth Company and Class K |
Shares | Total net realized gain or loss ($) | Total Proceeds ($) | Participating classes | |
Fidelity Growth Company Fund | 156,803 | 4,317,662 | 5,548,868 | Growth Company and Class K |
Amount | % of Class-Level Average Net Assets A | |
Growth Company | $23,031 | .11 |
Class K | 2,393 | .04 |
$25,424 |
% of Average Net Assets | |
Fidelity Growth Company Fund | - A |
Amount | |
Fidelity Growth Company Fund | $149 |
Borrower or Lender | Average Loan Balance | Weighted Average Interest Rate | Interest Expense | |
Fidelity Growth Company Fund | Borrower | $43,434 | .32% | $11 |
Purchases ($) | Sales ($) | Realized Gain (Loss) ($) | |
Fidelity Growth Company Fund | 449,107 | 993,910 | 323,432 |
Amount ($) | |
Fidelity Growth Company Fund | 2 |
Amount | |
Fidelity Growth Company Fund | $51 |
Total Security Lending Fees Paid to NFS | Security Lending Income From Securities Loaned to NFS | Value of Securities Loaned to NFS at Period End | |
Fidelity Growth Company Fund | $247 | $13 | $2,253 |
Six months ended May 31, 2022 | Year ended November 30, 2021 | |
Fidelity Growth Company Fund | ||
Distributions to shareholders | ||
Growth Company | $4,986,906 | $3,659,612 |
Class K | 1,446,441 | 1,546,325 |
Total | $6,433,347 | $5,205,937 |
Shares | Shares | Dollars | Dollars | |
Six months ended May 31, 2022 | Year ended November 30, 2021 | Six months ended May 31, 2022 | Year ended November 30, 2021 | |
Fidelity Growth Company Fund | ||||
Growth Company | ||||
Shares sold | 82,897 | 130,556 | $2,591,366 | $4,765,673 |
Reinvestment of distributions | 123,271 | 101,682 | 4,540,077 | 3,344,306 |
Shares redeemed | (139,434) | (204,725) | (4,404,800) | (7,392,548) |
Net increase (decrease) | 66,734 | 27,513 | $2,726,643 | $717,431 |
Class K | ||||
Shares sold | 24,969 | 75,170 | $800,276 | $2,721,138 |
Reinvestment of distributions | 39,098 | 46,864 | 1,445,449 | 1,545,583 |
Shares redeemed | (97,585) | (273,816) | (3,143,524) | (9,801,899) |
Net increase (decrease) | (33,518) | (151,782) | $(897,799) | $(5,535,178) |
Strategic Advisers Fidelity U.S. Total Stock Fund | |
Fidelity Growth Company Fund | 13% |
The Example is based on an investment of $1,000 invested at the beginning of the period and held for the entire period (December 1, 2021 to May 31, 2022). |
Annualized Expense Ratio- A | Beginning Account Value December 1, 2021 | Ending Account Value May 31, 2022 | Expenses Paid During Period- C December 1, 2021 to May 31, 2022 | |||||||
Fidelity® Growth Company Fund | ||||||||||
Fidelity® Growth Company Fund | .83% | |||||||||
Actual | $ 1,000 | $ 706.00 | $ 3.53 | |||||||
Hypothetical- B | $ 1,000 | $ 1,020.79 | $ 4.18 | |||||||
Class K | .76% | |||||||||
Actual | $ 1,000 | $ 706.00 | $ 3.23 | |||||||
Hypothetical- B | $ 1,000 | $ 1,021.14 | $ 3.83 | |||||||
- Highly liquid investments - cash or convertible to cash within three business days or less
- Moderately liquid investments - convertible to cash in three to seven calendar days
- Less liquid investments - can be sold or disposed of, but not settled, within seven calendar days
- Illiquid investments - cannot be sold or disposed of within seven calendar days
Contents
Board Approval of Investment Advisory Contracts and Management Fees |
Top Holdings (% of Fund's net assets) | ||
Cadence Design Systems, Inc. | 3.2 | |
Fortinet, Inc. | 3.0 | |
Mettler-Toledo International, Inc. | 2.6 | |
Synopsys, Inc. | 2.5 | |
ResMed, Inc. | 2.5 | |
MSCI, Inc. | 2.3 | |
Entegris, Inc. | 2.3 | |
EPAM Systems, Inc. | 2.2 | |
onsemi | 2.1 | |
West Pharmaceutical Services, Inc. | 2.0 | |
24.7 | ||
Market Sectors (% of Fund's net assets) | ||
Information Technology | 31.7 | |
Health Care | 16.1 | |
Consumer Discretionary | 15.2 | |
Industrials | 15.0 | |
Financials | 8.5 | |
Energy | 3.6 | |
Materials | 3.2 | |
Consumer Staples | 2.4 | |
Real Estate | 0.3 | |
Asset Allocation (% of Fund's net assets) |
Foreign investments - 3.7% |
Common Stocks - 96.0% | |||
Shares | Value ($) | ||
CONSUMER DISCRETIONARY - 15.2% | |||
Distributors - 1.7% | |||
LKQ Corp. | 29 | 1,490 | |
Pool Corp. | 41 | 16,343 | |
17,833 | |||
Hotels, Restaurants & Leisure - 6.7% | |||
Chipotle Mexican Grill, Inc. (a) | 8 | 11,220 | |
Churchill Downs, Inc. | 52 | 10,526 | |
Domino's Pizza, Inc. | 18 | 6,537 | |
Expedia, Inc. (a) | 117 | 15,132 | |
Hilton Worldwide Holdings, Inc. | 122 | 17,185 | |
Wyndham Hotels & Resorts, Inc. | 107 | 8,574 | |
69,174 | |||
Household Durables - 1.5% | |||
NVR, Inc. (a) | 1 | 4,451 | |
Tempur Sealy International, Inc. | 419 | 11,049 | |
15,500 | |||
Internet & Direct Marketing Retail - 0.4% | |||
eBay, Inc. | 80 | 3,894 | |
Multiline Retail - 0.5% | |||
Dollar General Corp. | 26 | 5,729 | |
Specialty Retail - 4.4% | |||
AutoZone, Inc. (a) | 9 | 18,537 | |
O'Reilly Automotive, Inc. (a) | 21 | 13,381 | |
Tractor Supply Co. | 61 | 11,429 | |
Williams-Sonoma, Inc. | 17 | 2,175 | |
45,522 | |||
Textiles, Apparel & Luxury Goods - 0.0% | |||
Deckers Outdoor Corp. (a) | 2 | 537 | |
TOTAL CONSUMER DISCRETIONARY | 158,189 | ||
CONSUMER STAPLES - 2.4% | |||
Beverages - 0.5% | |||
Brown-Forman Corp. Class B (non-vtg.) | 81 | 5,356 | |
Food Products - 1.7% | |||
Bunge Ltd. | 60 | 7,099 | |
Darling Ingredients, Inc. (a) | 129 | 10,329 | |
17,428 | |||
Personal Products - 0.2% | |||
Estee Lauder Companies, Inc. Class A | 7 | 1,783 | |
TOTAL CONSUMER STAPLES | 24,567 | ||
ENERGY - 3.6% | |||
Energy Equipment & Services - 1.0% | |||
Halliburton Co. | 250 | 10,125 | |
Oil, Gas & Consumable Fuels - 2.6% | |||
Coterra Energy, Inc. | 87 | 2,987 | |
Occidental Petroleum Corp. | 140 | 9,703 | |
PDC Energy, Inc. | 184 | 14,562 | |
27,252 | |||
TOTAL ENERGY | 37,377 | ||
FINANCIALS - 8.5% | |||
Capital Markets - 6.9% | |||
Ameriprise Financial, Inc. | 47 | 12,985 | |
LPL Financial | 31 | 6,082 | |
MarketAxess Holdings, Inc. | 26 | 7,324 | |
Moody's Corp. | 10 | 3,016 | |
MSCI, Inc. | 55 | 24,329 | |
Nordnet AB | 160 | 2,602 | |
Raymond James Financial, Inc. | 105 | 10,341 | |
S&P Global, Inc. | 10 | 3,495 | |
Tradeweb Markets, Inc. Class A | 14 | 947 | |
71,121 | |||
Consumer Finance - 0.8% | |||
Discover Financial Services | 77 | 8,739 | |
Insurance - 0.8% | |||
Arthur J. Gallagher & Co. | 54 | 8,745 | |
TOTAL FINANCIALS | 88,605 | ||
HEALTH CARE - 16.1% | |||
Biotechnology - 0.9% | |||
Horizon Therapeutics PLC (a) | 103 | 9,238 | |
Health Care Equipment & Supplies - 4.6% | |||
DexCom, Inc. (a) | 51 | 15,195 | |
Edwards Lifesciences Corp. (a) | 34 | 3,429 | |
Intuitive Surgical, Inc. (a) | 6 | 1,366 | |
Masimo Corp. (a) | 15 | 2,106 | |
ResMed, Inc. | 127 | 25,839 | |
47,935 | |||
Health Care Providers & Services - 2.6% | |||
Laboratory Corp. of America Holdings | 27 | 6,661 | |
McKesson Corp. | 29 | 9,532 | |
Tenet Healthcare Corp. (a) | 168 | 10,871 | |
27,064 | |||
Health Care Technology - 1.6% | |||
Doximity, Inc. | 141 | 4,934 | |
Veeva Systems, Inc. Class A (a) | 69 | 11,748 | |
16,682 | |||
Life Sciences Tools & Services - 6.4% | |||
Charles River Laboratories International, Inc. (a) | 78 | 18,258 | |
Mettler-Toledo International, Inc. (a) | 21 | 27,009 | |
West Pharmaceutical Services, Inc. | 68 | 21,106 | |
66,373 | |||
TOTAL HEALTH CARE | 167,292 | ||
INDUSTRIALS - 15.0% | |||
Aerospace & Defense - 1.2% | |||
TransDigm Group, Inc. (a) | 20 | 12,107 | |
Building Products - 3.1% | |||
Builders FirstSource, Inc. (a) | 160 | 10,414 | |
Carlisle Companies, Inc. | 43 | 10,940 | |
Carrier Global Corp. | 287 | 11,282 | |
32,636 | |||
Commercial Services & Supplies - 3.5% | |||
Cintas Corp. | 46 | 18,323 | |
Copart, Inc. (a) | 149 | 17,065 | |
Tetra Tech, Inc. | 8 | 1,080 | |
36,468 | |||
Construction & Engineering - 0.9% | |||
Quanta Services, Inc. | 77 | 9,163 | |
Electrical Equipment - 2.0% | |||
AMETEK, Inc. | 64 | 7,774 | |
Atkore, Inc. (a) | 76 | 8,278 | |
Generac Holdings, Inc. (a) | 19 | 4,695 | |
20,747 | |||
Machinery - 1.9% | |||
IDEX Corp. | 28 | 5,363 | |
Otis Worldwide Corp. | 82 | 6,101 | |
Toro Co. | 101 | 8,331 | |
19,795 | |||
Professional Services - 0.7% | |||
Booz Allen Hamilton Holding Corp. Class A | 35 | 3,005 | |
CoStar Group, Inc. (a) | 64 | 3,900 | |
6,905 | |||
Road & Rail - 1.7% | |||
Old Dominion Freight Lines, Inc. | 71 | 18,335 | |
TOTAL INDUSTRIALS | 156,156 | ||
INFORMATION TECHNOLOGY - 31.7% | |||
Electronic Equipment & Components - 3.0% | |||
Amphenol Corp. Class A | 172 | 12,188 | |
Keysight Technologies, Inc. (a) | 65 | 9,464 | |
Zebra Technologies Corp. Class A (a) | 29 | 9,808 | |
31,460 | |||
IT Services - 2.5% | |||
Adyen BV (a)(b) | 1 | 1,549 | |
EPAM Systems, Inc. (a) | 66 | 22,342 | |
Snowflake, Inc. (a) | 20 | 2,553 | |
26,444 | |||
Semiconductors & Semiconductor Equipment - 8.5% | |||
ASM International NV (Netherlands) | 4 | 1,243 | |
Broadcom, Inc. | 5 | 2,901 | |
Entegris, Inc. | 219 | 24,300 | |
KLA Corp. | 48 | 17,513 | |
Lam Research Corp. | 5 | 2,600 | |
Marvell Technology, Inc. | 52 | 3,076 | |
NXP Semiconductors NV | 28 | 5,313 | |
onsemi (a) | 353 | 21,420 | |
SolarEdge Technologies, Inc. (a) | 36 | 9,820 | |
88,186 | |||
Software - 17.7% | |||
Adobe, Inc. (a) | 6 | 2,499 | |
ANSYS, Inc. (a) | 42 | 10,935 | |
Atlassian Corp. PLC (a) | 20 | 3,546 | |
Cadence Design Systems, Inc. (a) | 217 | 33,359 | |
Citrix Systems, Inc. | 100 | 10,069 | |
Datadog, Inc. Class A (a) | 104 | 9,921 | |
Fortinet, Inc. (a) | 105 | 30,885 | |
HubSpot, Inc. (a) | 21 | 7,091 | |
Intuit, Inc. | 7 | 2,901 | |
Palo Alto Networks, Inc. (a) | 21 | 10,558 | |
Paycom Software, Inc. (a) | 42 | 11,942 | |
Qualtrics International, Inc. (a) | 202 | 2,868 | |
Roper Technologies, Inc. | 7 | 3,097 | |
Synopsys, Inc. (a) | 81 | 25,855 | |
The Trade Desk, Inc. (a) | 350 | 18,218 | |
183,744 | |||
TOTAL INFORMATION TECHNOLOGY | 329,834 | ||
MATERIALS - 3.2% | |||
Chemicals - 1.1% | |||
LyondellBasell Industries NV Class A | 72 | 8,226 | |
Sherwin-Williams Co. | 12 | 3,216 | |
11,442 | |||
Metals & Mining - 1.4% | |||
Steel Dynamics, Inc. | 170 | 14,515 | |
Paper & Forest Products - 0.7% | |||
Louisiana-Pacific Corp. | 97 | 6,699 | |
TOTAL MATERIALS | 32,656 | ||
REAL ESTATE - 0.3% | |||
Equity Real Estate Investment Trusts (REITs) - 0.3% | |||
SBA Communications Corp. Class A | 8 | 2,693 | |
TOTAL COMMON STOCKS (Cost $723,593) | 997,369 | ||
Money Market Funds - 0.4% | |||
Shares | Value ($) | ||
Fidelity Cash Central Fund 0.82% (c) (Cost $3,900) | 3,899 | 3,900 | |
TOTAL INVESTMENT IN SECURITIES - 96.4% (Cost $727,493) | 1,001,269 |
NET OTHER ASSETS (LIABILITIES) - 3.6% | 37,868 |
NET ASSETS - 100.0% | 1,039,137 |
(a) | Non-income producing |
(b) | Security exempt from registration under Rule 144A of the Securities Act of 1933. These securities may be resold in transactions exempt from registration, normally to qualified institutional buyers. At the end of the period, the value of these securities amounted to $1,549 or 0.1% of net assets. |
(c) | Affiliated fund that is generally available only to investment companies and other accounts managed by Fidelity Investments. The rate quoted is the annualized seven-day yield of the fund at period end. A complete unaudited listing of the fund's holdings as of its most recent quarter end is available upon request. In addition, each Fidelity Central Fund's financial statements are available on the SEC's website or upon request. |
Affiliate | Value, beginning of period ($) | Purchases ($) | Sales Proceeds ($) | Dividend Income ($) | Realized Gain (loss) ($) | Change in Unrealized appreciation (depreciation) ($) | Value, end of period ($) | %ownership, end of period |
Fidelity Cash Central Fund 0.82% | 3,900 | - | - | 5 | - | - | 3,900 | 0.0% |
Total | 3,900 | - | - | 5 | - | - | 3,900 |
Valuation Inputs at Reporting Date: | ||||
Description | Total ($) | Level 1 ($) | Level 2 ($) | Level 3 ($) |
Investments in Securities: | ||||
Equities: | ||||
Consumer Discretionary | 158,189 | 158,189 | - | - |
Consumer Staples | 24,567 | 24,567 | - | - |
Energy | 37,377 | 37,377 | - | - |
Financials | 88,605 | 88,605 | - | - |
Health Care | 167,292 | 167,292 | - | - |
Industrials | 156,156 | 156,156 | - | - |
Information Technology | 329,834 | 328,285 | 1,549 | - |
Materials | 32,656 | 32,656 | - | - |
Real Estate | 2,693 | 2,693 | - | - |
Money Market Funds | 3,900 | 3,900 | - | - |
Total Investments in Securities: | 1,001,269 | 999,720 | 1,549 | - |
Statement of Assets and Liabilities | ||||
May 31, 2022 (Unaudited) | ||||
Assets | ||||
Investment in securities, at value - See accompanying schedule: | $997,369 | |||
Unaffiliated issuers (cost $723,593) | ||||
Fidelity Central Funds (cost $3,900) | 3,900 | |||
Total Investment in Securities (cost $727,493) | $ | 1,001,269 | ||
Cash | 31,426 | |||
Receivable for investments sold | 5,945 | |||
Dividends receivable | 489 | |||
Distributions receivable from Fidelity Central Funds | 3 | |||
Other receivables | 5 | |||
Total assets | 1,039,137 | |||
Net Assets | $ | 1,039,137 | ||
Net Assets consist of: | ||||
Paid in capital | $ | 801,718 | ||
Total accumulated earnings (loss) | 237,419 | |||
Net Assets | $ | 1,039,137 | ||
Net Asset Value , offering price and redemption price per share ($1,039,137 ÷ 175,270 shares) | $ | 5.93 | ||
Statement of Operations | ||||
Six months ended May 31, 2022 (Unaudited) | ||||
Investment Income | ||||
Dividends | $ | 2,873 | ||
Income from Fidelity Central Funds | 5 | |||
Total Income | 2,878 | |||
Expenses | ||||
Independent trustees' fees and expenses | 2 | |||
Total Expenses | 2 | |||
Net Investment income (loss) | 2,876 | |||
Realized and Unrealized Gain (Loss) | ||||
Net realized gain (loss) on: | ||||
Investment Securities: | ||||
Unaffiliated issuers | (36,110) | |||
Foreign currency transactions | 2 | |||
Total net realized gain (loss) | (36,108) | |||
Change in net unrealized appreciation (depreciation) on: | ||||
Investment Securities: | ||||
Unaffiliated issuers | (291,509) | |||
Assets and liabilities in foreign currencies | (3) | |||
Total change in net unrealized appreciation (depreciation) | (291,512) | |||
Net gain (loss) | (327,620) | |||
Net increase (decrease) in net assets resulting from operations | $ | (324,744) |
Statement of Changes in Net Assets | ||||
Six months ended May 31, 2022 (Unaudited) | Year ended November 30, 2021 | |||
Increase (Decrease) in Net Assets | ||||
Operations | ||||
Net investment income (loss) | $ | 2,876 | $ | 4,620 |
Net realized gain (loss) | (36,108) | 155,555 | ||
Change in net unrealized appreciation (depreciation) | (291,512) | 188,152 | ||
Net increase (decrease) in net assets resulting from operations | (324,744) | 348,327 | ||
Distributions to shareholders | (158,516) | (119,224) | ||
Share transactions | ||||
Reinvestment of distributions | 158,516 | 119,224 | ||
Net increase (decrease) in net assets resulting from share transactions | 158,516 | 119,224 | ||
Total increase (decrease) in net assets | (324,744) | 348,327 | ||
Net Assets | ||||
Beginning of period | 1,363,881 | 1,015,554 | ||
End of period | $ | 1,039,137 | $ | 1,363,881 |
Other Information | ||||
Shares | ||||
Sold | - | - | ||
Issued in reinvestment of distributions | 20,015 | 17,105 | ||
Redeemed | - | - | ||
Net increase (decrease) | 20,015 | 17,105 | ||
Fidelity Flex® Mid Cap Growth Fund |
Six months ended (Unaudited) May 31, 2022 | Years ended November 30, 2021 | 2020 | 2019 | 2018 | 2017 A | |||||||
Selected Per-Share Data | ||||||||||||
Net asset value, beginning of period | $ | 8.78 | $ | 7.35 | $ | 14.28 | $ | 11.64 | $ | 11.25 | $ | 10.00 |
Income from Investment Operations | ||||||||||||
Net investment income (loss) B,C | .02 | .03 | .04 D | .12 | .13 E | .10 F | ||||||
Net realized and unrealized gain (loss) | (1.85) | 2.26 | 2.28 | 2.60 | .35 | 1.15 | ||||||
Total from investment operations | (1.83) | 2.29 | 2.32 | 2.72 | .48 | 1.25 | ||||||
Distributions from net investment income | (.03) | (.05) | (1.53) | (.08) | (.09) | - | ||||||
Distributions from net realized gain | (.99) | (.81) | (7.72) | - | - | - | ||||||
Total distributions | (1.02) | (.86) | (9.25) | (.08) | (.09) | - | ||||||
Net asset value, end of period | $ | 5.93 | $ | 8.78 | $ | 7.35 | $ | 14.28 | $ | 11.64 | $ | 11.25 |
Total Return G | (23.75)% | 34.25% | 39.97% | 23.66% | 4.29% | 12.50% | ||||||
Ratios to Average Net Assets C,H,I | ||||||||||||
Expenses before reductions J | -% K | -% | -% | -% | -% | -% K | ||||||
Expenses net of fee waivers, if any J | -% K | -% | -% | -% | -% | -% K | ||||||
Expenses net of all reductions J | -% K | -% | -% | -% | -% | -% K | ||||||
Net investment income (loss) | .49% K | .38% | .68% D | .98% | 1.11% E | 1.29% F,K | ||||||
Supplemental Data | ||||||||||||
Net assets, end of period (000 omitted) | $ | 1,039 | $ | 1,364 | $ | 1,016 | $ | 726 | $ | 15,447 | $ | 711 |
Portfolio turnover rate L | 67% K | 71% | 94% | 83% | 88% | 38% K |
Fidelity Central Fund | Investment Manager | Investment Objective | Investment Practices | Expense Ratio A |
Fidelity Money Market Central Funds | Fidelity Management & Research Company LLC (FMR) | Each fund seeks to obtain a high level of current income consistent with the preservation of capital and liquidity. | Short-term Investments | Less than .005% |
Gross unrealized appreciation | $314,386 |
Gross unrealized depreciation | (42,294) |
Net unrealized appreciation (depreciation) | $272,092 |
Tax cost | $729,177 |
Purchases ($) | Sales ($) | |
Fidelity Flex Mid Cap Growth Fund | 391,723 | 408,239 |
Amount | |
Fidelity Flex Mid Cap Growth Fund | $9 |
Purchases ($) | Sales ($) | Realized Gain (Loss) ($) | |
Fidelity Flex Mid Cap Growth Fund | 11,942 | 5,702 | (501) |
Affiliated % | |
Fidelity Flex Mid Cap Growth Fund | 100% |
The Example is based on an investment of $1,000 invested at the beginning of the period and held for the entire period (December 1, 2021 to May 31, 2022). |
Annualized Expense Ratio- A | Beginning Account Value December 1, 2021 | Ending Account Value May 31, 2022 | Expenses Paid During Period- C December 1, 2021 to May 31, 2022 | |||||||
Fidelity Flex® Mid Cap Growth Fund | -%- D | |||||||||
Actual | $ 1,000 | $ 762.50 | $- E | |||||||
Hypothetical- B | $ 1,000 | $ 1,024.93 | $- E | |||||||
- Highly liquid investments - cash or convertible to cash within three business days or less
- Moderately liquid investments - convertible to cash in three to seven calendar days
- Less liquid investments - can be sold or disposed of, but not settled, within seven calendar days
- Illiquid investments - cannot be sold or disposed of within seven calendar days
Item 2.
Code of Ethics
Not applicable.
Item 3.
Audit Committee Financial Expert
Not applicable.
Item 4.
Principal Accountant Fees and Services
Not applicable.
Item 5.
Audit Committee of Listed Registrants
Not applicable.
Item 6.
Investments
(a)
Not applicable.
(b)
Not applicable
Item 7.
Disclosure of Proxy Voting Policies and Procedures for Closed-End Management Investment Companies
Not applicable.
Item 8.
Portfolio Managers of Closed-End Management Investment Companies
Not applicable.
Item 9.
Purchase of Equity Securities by Closed-End Management Investment Company and Affiliated Purchasers
Not applicable.
Item 10.
Submission of Matters to a Vote of Security Holders
There were no material changes to the procedures by which shareholders may recommend nominees to the Fidelity Mt. Vernon Street Trust’s Board of Trustees.
Item 11.
Controls and Procedures
(a)(i) The President and Treasurer and the Chief Financial Officer have concluded that the Fidelity Mt. Vernon Street Trust’s (the “Trust”) disclosure controls and procedures (as defined in Rule 30a-3(c) under the Investment Company Act) provide reasonable
assurances that material information relating to the Trust is made known to them by the appropriate persons, based on their evaluation of these controls and procedures as of a date within 90 days of the filing date of this report.
(a)(ii) There was no change in the Trust’s internal control over financial reporting (as defined in Rule 30a-3(d) under the Investment Company Act) that occurred during the period covered by this report that has materially affected, or is reasonably likely to materially affect, the Trust’s internal control over financial reporting.
Item 12.
Disclosure of Securities Lending Activities for Closed-End Management
Investment Companies
Not applicable.
Item 13.
Exhibits
(a) | (1) | Not applicable. |
(a) | (2) | |
(a) | (3) | Not applicable. |
(b) |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
Fidelity Mt. Vernon Street Trust
By: | /s/Stacie M. Smith |
Stacie M. Smith | |
President and Treasurer | |
Date: | July 21, 2022 |
Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.
By: | /s/Stacie M. Smith |
Stacie M. Smith | |
President and Treasurer | |
Date: | July 21, 2022 |
By: | /s/John J. Burke III |
John J. Burke III | |
Chief Financial Officer | |
Date: | July 21, 2022 |